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1.1 General introduction 
Cryptosporidium was first described in 1907 in the gastric mucosa and later in the 
small intestine of laboratory mice. The first detailed description of Giardia dates from 
1859, although Antonie van Leeuwenhoek already described protozoan trophozoites 
looking like Giardia in 1681. Studies of coprolites from Peru indicate that both 
Cryptosporidium and Giardia were already prevalent in ancient human populations 
(Ortega and Bonavia, 2003), but the clinical relevance of both parasites in human 
patients was not acknowledged until late in the 20th century. Cryptosporidiosis is 
nowadays considered as a life threathening disease in AIDS patients and as a common 
cause of diarrhea in human patients, both in sporadic cases and in outbreaks, such as 
the large waterborne cryptosporidiosis outbreak in Milwaukee in 1993 (Mac Kenzie et 
al., 1994; Fayer, 2004). Giardia is recognised as the most common parasitological 
cause of human diarrhea, with an estimated 280 million infections worldwide per 
year. In children chronic giardiosis can result in long-term growth retardation (Fraser 
et al., 2000) and poor cognitive functions (Berkman et al., 2002). Both giardiosis and 
cryptosporidiosis are a frequently diagnosed waterborne infection and are a major 
concern to water utilities. Because of the impact on socio-economic development, 
especially in developing countries, both Giardia and Cryptosporidium are since 2004 
included in the ‘Neglected Disease Initiative’ of the World Health Organization 
(WHO) (Savioli et al., 2006).  
In veterinary medicine Cryptosporidium and Giardia are at present considered as 
important pathogens in the aetiology of diarrhea in housed calves. However, the 
pathogenicity of both parasites was not recognised until the end of the last century. In 
calves Cryptosporidium was associated with diarrhea in 1971 (Panciera et al., 1971), 
although the primary pathogenic effect of Cryptosporidium was only later confirmed 
(Tzipori et al., 1980b). Since then Cryptosporidium has been identified in 40 to 70% 
of the faecal samples collected from diarrhetic calves younger than 1 month both in 
Europe and in the USA (Moore and Zeman, 1991; Otto et al., 1995; de Graaf et al., 
1999b; de la Fuente et al., 1999; Constant, 2001; Tartera, 2002). Therefore, 
Cryptosporidium is considered as the most important pathogen in the aetiology of 
neonatal calf diarrhea (de Graaf et al., 1999b). Although the first case of bovine 
giardiosis was reported in 1921 (Fantham, 1921) and despite the high prevalence in 
farm animals, the clinical importance of giardiosis in cattle was not described until 
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quite recently (St. Jean, 1987). Since then Giardia has increasingly been recognised 
as an important pathogen in young calves and considered as an important differential 
diagnosis for coccidiosis in the aetiology of diarrhea in calves older than 1 month. 
Based on high prevalence of both parasites, cattle have been considered as potential 
sources for human infection, although in the last decade molecular tools have 
provided a more differentiated and detailed insight in the epidemiology of 
Cryptosporidium and Giardia. 
The aim of the literature review is to present an overview of the current knowledge on 
Cryptosporidium and Giardia, with emphasis on molecular epidemiology, zoonotic 
aspects, diagnosis, treatment and control. In chapters 2, 3 and 4 the experimental work 
of this thesis is presented. In chapter 5 the general outcome, the conclusions and 
future perspectives are discussed. 
 
1.2 Cryptosporidium  
1.2.1 Classification 
Cryptosporidium is an apicomplexan protozoan parasite and was until recently 
classified as a coccidian parasite, despite the many unique characteristics, such as the 
lack of host specificity, resistance to anticoccidial treatment, ability for autoinfection 
and the particular location within the host cell (Hijjawi et al., 2004). Phylogenetic 
analysis on the small-subunit rRNA locus indicated that Cryptosporidium is indeed 
not related to the coccidia (Xiao et al., 1999). Cross-reaction of an anti-
cryptosporidial monoclonal antibody with gregarines suggested a close relation (Bull 
et al., 1998), which was later confirmed by molecular (Carreno et al., 1999) and life 
cycle similarities (Hijjawi et al., 2001, 2002, 2004; Rosales et al., 2005). It is now 
believed that Cryptosporidium should be placed in a taxonomic group separate from 
the coccidians and close to the gregarine parasites (Barta and Thompson, 2006).  
Cryptosporidium spp. infect a wide range of hosts, including 155 mammalian species 
(Fayer, 2004). Similar to Giardia the traditional taxonomy was largely based on host 
occurence. Genetically related hosts have related Cryptosporidium parasites, although 
there are two important exceptions to this ‘host-parasite co-evolution’ theory. The 
first considers the C. parvum bovine genotype, which forms a monophyletic group 
with the C. parvum human, mouse, rabbit and monkey genotypes. Rodents, primates 
and lagomorphs originate from a common ancestor which is however different from 
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the ancestor of ruminants. It is therefore possible that the C. parvum bovine genotype 
was originally a parasite of rodents and only recently established in ruminants. This 
‘host expansion’ also occured for C. meleagridis, which was originally a mammalian 
parasite that has established in birds (Xiao et al., 2002). Furthermore, the assumption 
of a tight host-specificity was rejected based on cross-transmission experiments 
(Tzipori et al., 1980a; Moon et al., 1982a).  
The application of PCR on faecal and environmental samples indicated that 
Cryptosporidium is a heterogeneous cluster of morphologically identical species and 
genotypes (Monis and Thompson, 2003), with the distinction of a gastric and an 
intestinal group. To date 16 Cryptosporidium species and multiple genotypes have 
been described (Table 1.1). Although the genotype designation reflects significant 
genetic differences, not all genotypes differ from each other to the same extent. The 
challenge is therefore to determine what genotypes can be considered as separate 
species, based not only on genetic, but also on biological and morphological 
differences (Xiao et al., 2004). Several new species have thus been described, such as 
C. bovis (Fayer et al., 2005) and C. suis (Ryan et al., 2004).  
Most research focused on C. parvum, which has been identified in a wide range of 
hosts, including man. Izoenzyme and molecular analysis indicated the existence of at 
least two distinct genotypes within C. parvum: the human genotype (genotype 1 or H) 
and the zoonotic bovine genotype (genotype 2 or C). The human genotype was shown 
to be largely human specific and was reclassified as C. hominis (Morgan-Ryan et al., 
2002). The bovine genotype is refered to as C. parvum. Recently, C. pestis was 
proposed as a new species name, although still not formerly accepted (Slapeta, 2006; 
Xiao et al., 2006).  
Based on highly polymorphic microsatellite and minisatellite markers, intra-species 
variation has been described, especially within C. parvum (Caccio et al., 2000; Feng 
et al., 2000). Within C. parvum the level of polymorphism is high, with indications of 
genetic exchange (panmixia). The occurence of panmixia is due to the high 
transmission between hosts, which is supported by the high prevalence of C. parvum 
in human patients and farm animals (Mallon et al., 2003a). Despite the existence of 
panmixia, discrete lineages of both human specific and zoonotic subgenotypes 
specific to geographical regions have been identified within C. parvum. This might 
indicate the existence of both host and geographical specific alleles (Caccio et al., 
2001), although a rather limited number of these lineages has been described so far.  
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Table 1.1: Currently recognised species and genotypes of Cryptosporidium, along with their former 
name and major host range. For the recognised species the reference of species description is 
provided. 
 
 
 
 
Species or genotype Former name Major hosts Reference 
Intestinal species    
C. hominis human genotype man (Morgan-Ryan et al., 2002) 
C. pestis (C. parvum) bovine genotype livestock, man (Slapeta, 2006) 
C. parvum mouse genotype mice (Tyzzer, 1912) 
 rabbit genotype  lagomorphs  
 monkey genotype  monkeys  
 ferret genotype  ferrets  
 horse genotype  horses  
C. bovis genotype Bovine B cattle (Fayer et al., 2005) 
C. suis pig genotype I pigs (Ryan et al., 2004) 
C. canis  dogs (Fayer et al., 2001) 
C. felis  cats (Iseki, 1979) 
C. wrairi guinea  pig genotype guinea pigs (Vetterling et al., 1971) 
C. meleagridis  birds (Slavin, 1955) 
C. bayleyi  poultry (Current et al., 1986) 
C. saurophilum  lizards (Koudela and Modry, 1998) 
(C. nasorum; nomen nudum?)  fish  
C. molnari  fish (Alvarez-Pellitero and Sitja-
Bobadilla, 2002) 
Skunk genotype  skunks  
Opposum genotype I and II  opposums  
Marsupial genotype I and II  marsupials  
Deer / cervid genotype  Deer, sheep  
Squirrel genotype  squirrels  
Goose genotype I and II  geese  
Duck genotype  ducks  
Snake genotype  snakes  
Bear genotype  bears  
Fox genotype  foxes  
Coyote genotype  coyotes  
Deer mouse genotype  deer mice  
Muskrat genotype I and II  muskrats  
Pig genotype II  pigs  
Gastric species    
C. andersoni C. muris cattle (Lindsay et al., 2000a) 
C. muris  rodents (Tyzzer, 1907) 
C. galli  chickens (Ryan et al., 2003) 
C. serpentis  reptiles (Levine, 1980) 
Lizard genotype  lizards  
Tortoise genotype  turtles  
Woodcock genotype  woodcocks  
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Panmixia therefore seems to occur, however not frequently among natural isolates, 
probably due to the limited opportunity for the union of dissimilar subgenotypes 
(Feng et al., 2000). In contrast, limited polymorphism has been observed in C. 
hominis and subsequent predominance of a small number of subgenotypes, which 
might reflect the epidemic nature of C. hominis infections: originating from one or 
few individuals the infection spreads rapidely in a susceptible population, with limited 
opportunity for genetic recombination with other genotypes. 
 
1.2.2 Life cycle 
Cryptosporidium has a complex life cycle with an asexual and a sexual developmental 
phase. The life cycle can be completed within 3 to 5 days in the host small intestine. 
Until recently Cryptosporidium was considered as an obligate intracellular parasite, 
but in vitro studies revealed that the entire life cycle can be completed without the 
need for host cells, although not readily accomplished. The amplification in vivo 
occurs in the host cell, which might suggest that Cryptosporidium only recently 
adapted to its intracellular habitat (Hijjawi et al., 2004; Girouard et al., 2006). 
 
Figure 1.1: Cryptosporidium life cycle with (a) the infective oocyst; (b) the sporozoite released from the 
oocyst; (c) the trophozoite; (d) and (e) Type I meront; (f) Type II meront; (g) Microgamont; (h) 
Macrogamont; (i) Zygote  (Source accessed on December 5th 2006: 
http://www.dpd.cdc.gov/dpdx/HTML) 
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The life cycle (Figure 1.1) initiates with the ingestion of the infective oocyst (a) and 
the excystation of 4 sporozoites (b), which is mainly triggered by temperature and pH 
(Hijjawi et al., 2002; Smith et al., 2005a). The respiratory tract is occasionally 
infected after inhalation of infective oocysts (Mascaro et al., 1994; Okhuysen et al., 
1999). During cell invasion, the developmental stages are not located in the host 
cytoplasm, but are surrounded by host microvillous membranes that rise up and link 
over the top of the parasite to form the parasitoforous membrane. Hence, the parasite 
lies protected between the cell membrane and the cell cytoplasm in the so-called 
parasitophorous vacuole. This intracellular yet extracytoplasmatic location is unique 
for Cryptosporidium and enables the parasite to evade both the extracellular and 
intracellular host defense mechanisms (Hijjawi et al., 2004).  
After cell invasion the sporozoite forms a circular stage known as the trophozoite (c). 
The first part of the cycle consists of an asexual development with two successive 
generations of merogony, resulting in the formation of meronts (d). Although the 
number varies in vitro, type I meronts (e) usualy contain 8 small merozoites which 
penetrate new host cells to form type II meronts (f) with 4 large merozoites. Type I 
merozoites are also believed to have the ability to recycle contineously and to be 
responsible for auto-infection, especially in immunocompromised human patients. 
The type II merozoites develop into sexual developmental stages known as the micro-
and macrogamonts (g and h), which further develop into micro-and macrogametes. 
The microgametes are released from the host cells and penetrate cells harbouring 
macrogametes. Their union results in a zygote (i), which further develops into an 
oocyst with resistant oocyst wall. After 2 asexual divisions (sporogony) the oocyst 
contains 4 sporozoites. Approximately 80% of the oocysts have a thick wall (j) and 
are excreted in the faeces. These thick-walled oocysts are the environmentally 
resistant stage of the parasite. The remaining 20% are known as thin-walled oocysts 
(k) and are believed to contribute to autoinfection through the continous recycling of 
sporozoites from ruptured thin-walled oocysts (Hijjawi et al., 2001). 
Most extracellular stages in the life cycle of Cryptosporidium are very succeptible to 
the protective mechanisms of the small intestine. They therefore remain under the 
protective mucus layer upon release from the host cell and infect adjacant intestinal 
cells within a few seconds, to limit contact with the hostile gut environment (Meloni 
and Thompson, 1996). However, two new extracellular stages, commonly refered to 
as the extracellular trophozoite/gamont-like stages, have been described in the life 
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cycle of C. parvum and C. andersoni. These new stages seem to be adapted to 
extended extracellular existence and have been described in in vitro cultures, but also 
in vivo in infected mice and in an infected steer. Similar extracellular stages have also 
been reported in gregarines, suggesting close taxonomic affinity. Whether these stages 
can be fertilised and encyst (syzygy), as in gregarines, is unclear (Hijjawi et al., 
2002).  
 
1.2.3 Epidemiology and prevalence  
Epidemiology 
Calves are infected by oral ingestion of infectious oocysts. The oro-faecal 
transmission may be direct through contact with infected animals, or indirect through 
a contaminated environment or through the ingestion of contaminated feed and water. 
Mechanical transmission through vectors such as tools, care-takers, or even 
arthropods and birds is possible (Graczyk et al., 1999; Fayer et al., 2000). Especially 
young calves and to a lesser extent the dam should be considered as direct sources for 
calfhood infection. Calves start excreting oocysts as soon as 3-5 days after parturition 
but the peak excretion, with up to 10
10
 oocysts per gram of faeces (OPG), occurs 
around the age of 12 days. The oocyst excretion lasts for 6-14 days (O'Handley et al., 
1999; Nydam et al., 2001; Castro-Hermida et al., 2002b). High oocyst excretion is 
most frequently observed in calves younger than one month and from the age of 5 
weeks onwards the OPG decreases (Fayer et al., 1998a; Maldonado-Camargo et al., 
1998; O'Handley et al., 1999; Becher et al., 2004; Kvac et al., 2006). Although the 
excretion of oocysts by adult cattle is generally low, dams have been advocated as a 
potential source of infection, based on a presumed periparturient rise, which has been 
reported in ewes (Xiao et al., 1994), and also in cattle for C. andersoni (Ralston et al., 
2003b). Others did not confirm the periparturient rise of C. parvum in cattle (Scott et 
al., 1995; Atwill et al., 1998; Atwill and Pereira, 2003), or did not differentiate the 
oocysts (Faubert and Litvinsky, 2000). Due to the low OPG (Atwill et al., 2003) and 
the predominance of C. andersoni in adult cattle (Fayer et al., 2006b), dams are 
probably of minor importance, especially on dairy farms (Naciri et al., 1999; Sturdee 
et al., 2003). 
As indirect sources for infection the housing should be contemplated, such as the 
maternity pen and the calf facilities (Sturdee et al., 2003). The role of the maternity 
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pen in the epidemiology largely depends on the time of stay before transfer to the calf 
facilities and on the number of cows in the maternity pen (Garber et al., 1994). When 
calves are transposed shortly after birth, the calf housing facilities are more relevant. 
In group housing direct contact between calves favours transmission (Castro-Hermida 
et al., 2002a), but also in individual pens transmission is frequent, either by a vector, 
such as the care-taker, or by effluent of faecal material. Furthermore, transmission to 
subsequent calves in one particular pen is possible (O'Handley et al., 1999). In 
general, calves housed in indoor calf pens are at greater risk of infection than calves 
housed outside in hutches (Quigley et al., 1994).  
As for Giardia, several parasite characteristics contribute to the succesfull 
transmission of Cryptosporidium infections in calves (Table 1.3). The high number of 
infective oocysts excreted by calves with patent cryptosporidiosis is in contrast with 
the low number of oocysts needed for infection. Furthermore, oocysts can survive for 
more than 12 weeks in soil and up to 24 weeks in water at temperatures between -4°C 
and 20°C. Due to faecal micro-organisms the degradation of oocysts is precipitated in 
bovine faeces, but still oocysts remain infective for at least 70 days in cattle manure 
(Fayer et al., 1998c; Olson et al., 1999; Jenkins et al., 2002). Freezing is lethal for 
oocysts, although a small proportion of the oocysts can remain viable at freezing 
temperatures for up to 2 months. Whether these viable oocysts are still infective is 
uncertain (Robertson et al., 1992; Walker et al., 2001). Desiccation is 100% lethal 
within 4 hours. Oocyst infectivity decreases after heating at temperatures above 55°C, 
with shorter exposure time as temperature increases (Fayer, 1994; Fujino et al., 2002). 
Several risk factors for infection have been identified, including management factors 
such as herd size, the number of young calves, the stocking rate or the length of the 
calving season. Higher stocking densities increase the likelihood of transmission 
between infected and succeptible animals by increasing the contact rate, especially 
between young animals (Garber et al., 1994). A long calving season or year round 
calvings result in a prolonged recruitement of susceptible calves (Atwill et al., 1999b; 
Hoar et al., 2001). Seasonal fluctuations in prevalence and oocyst shedding have been 
identified in human and wildlife populations (Atwill et al., 2004; Roy et al., 2004), 
but not in cattle (Atwill et al., 1999b; Wade et al., 2000b; Becher et al., 2004), except 
when coinciding with the calving season and the resulting higher stocking densities 
(Huetink et al., 2001; Sturdee et al., 2003; Lorino et al., 2005;). An important animal 
feature seems to be the age of the calf: on Cryptosporidium positive farms there is a 
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cumulative incidence of 100% (O'Handley et al., 1999), with a maximum risk for 
infection between 9 and 12 days of age. On these positive farms 50% of the calves is 
infected before the age of 10 days. Furthermore, the younger the calf acquiring 
infection, the longer the period of oocyst shedding (Maldonado-Camargo et al., 1998; 
Castro-Hermida et al., 2002b). Occasionally calves older than one month get a 
primary infection with C. parvum, mostly due to the absence of previous infection 
(Huetink et al., 2001).  
 
Prevalence 
Out of the 16 Cryptosporidium species, several have been described in cattle. Next to 
the ubiquitous C. parvum the ruminant specific species C. bovis and C. andersoni, and 
the cervine genotype have been described on a regular basis in cattle. Occasionally 
reported are C. suis (Fayer et al., 2006b), C. felis (Bornay-Llinares et al., 1999) and 
C. hominis (Smith et al., 2005b). The relevance of the latter species to the 
development of clinical symptoms in cattle or to the zoonotic reservoir function of 
cattle is probably minimal. 
A wide range of calf (0-59%) and farm (0-100%) prevalence estimates has been 
reported  in calves (Table 1.2). Although part of this variation is certainly due to 
substantial differences in prevalence between farms, the variation is also due to 
differences in study design, such as the number of animals or farms included, the age 
and breed of the animals. The choice of diagnostic technique might also influence the 
prevalence estimate, since some techniques are more sensitive than others. However, 
there is no gold standard reference test for the diagnosis of Cryptosporidium, which 
troubles the comparison of studies using different diagnostic techniques. 
Breed might be important, since in beef calves the Cryptosporidium prevalence is 
lower compared to dairy calves of similar age (Table 1.2), although the lower 
prevalence can be largely attributed to a combination of risk factors. In a cow-calf 
system with seasonal calving periods applied on many beef farms the calves remain 
with the dam, resulting in a more efficient transfer of colostrum and lower calf 
stocking densities. Furthermore, the cow-calf herds tend to stay on pasture, where the 
Cryptosporidium oocysts are more exposed to dessication and direct sunlight, 
especially in arid areas such as California (Atwill et al., 1999a) or Zambia (Geurden 
et al., 2006). Cow-calf herds are therefore considered a limited risk for environmental 
contamination (Gow and Waldner, 2006).  
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Table 1.2: Overview of prevalence studies of Cryptosporidium in cattle in different countries, with the 
diagnostic technique (D); the farming type (Farm: d=dairy and b=beef); the number of animals (#C) and 
farms (#F), the age of the animals, the calf (PC) and farm (PF) prevalence in percentage (%)  
 
Overall, the highest prevalence is observed in animals under the age of 5 weeks 
(Quilez et al., 1996b). An age-related resistance to infection has been observed both 
in calves and in lambs (Harp et al., 1990; Ortega-Mora and Wright, 1994). In post-
weaned calves and adult animals the Cryptosporidium prevalence is generally low, 
although high but undifferentiated Cryptosporidium prevalences have been reported 
(Villacorta et al., 1991a; Scott et al., 1995). In the majority of these prevalence 
studies, molecular or morphological identification is not performed. Recent data 
however confirm that C. parvum is most prevalent in calves up to 3 months, although 
Country   D   Farm     # C    # F Age PC (%) PF (%) Reference 
Calves < 6months         
Canada   M      d   500   51  7-21d    41    76 (Trotz-Williams et al., 2005a) 
France ELISA      d+b   2,068  196  <21d    23    - (Lefay et al., 2000) 
Mexico  M      d   512   31  <28d    25    93 (Maldonado-Camargo et al., 1998) 
USA  IFA      d   393   14  <2m    41   100 (Santin et al., 2004) 
Czech 
Republic 
 M      d  2,056   11  <2m    27   100 (Kvac et al., 2006) 
       b    367   11  <2m    1    27  
Tanzania   M      d   116    5  <3m    16    100 (Mtambo et al., 1997) 
Zambia ELISA      d   250   37  <3m   43    76 (Geurden et al., 2006) 
       b   238   25  <3m     8     44  
USA  IFA      d  7,369 1,103  <4m    22    59 (Garber et al., 1994) 
USA   M      d  2,943   109  <6m     2    13 (Wade et al., 2000b) 
Trinidad   M      -   298   <6m     9    - (Kaminjolo et al., 1993) 
Norway IFA     d  1,386  136  <6m    12   53 (Hamnes et al., 2006a) 
Canada   M     d     -  505  <6m      -    89 (Ruest et al., 1998)  
Canada  IFA     d   386   20  <6m    59    80 (Olson et al., 1997a) 
Canada  IFA     b   605   100  <6m     3    15 (Olson et al., 1997a) 
Calves > 6months         
USA  IFA      d   447   14  3-11m    26   100 (Santin et al., 2004) 
Denmark  IFA      d   895   50  <12m    40   96 (Maddox-Hyttel et al., 2006) 
USA  PCR      d   571   14 12-24m    12    93 (Fayer et al., 2006b) 
Spain   M     d+b   329   30  <24m    21    64 (Quilez et al., 1996b) 
Czech 
Republic 
  M      d  2,217   11  >3m     0   0 (Kvac et al., 2006) 
       b  2,381   11  >3m     0    0  
Canada  IFA      b   560   59  >24m     1    5 (Olson et al., 1997a) 
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in extensive rearing systems the host specific C. bovis seems most prevalent (Feng et 
al., 2006; Geurden et al., 2006). In older calves C. bovis and the Cryptosporidum 
deer-like genotype predominate, next to C. andersoni. In adult cattle C. andersoni and 
C. bovis are most frequently reported (Santin et al., 2004; Fayer et al., 2006b). 
 
1.2.4 Zoonotic aspects 
In industrialised countries, the prevalence of Cryptosporidium in immunocompetent 
hosts varies from 0.2% in asymptomatic persons to 2.2% in patients with diarrhea 
(Guerrant, 1997). Especially children less than 5 years of age are at risk and, to a 
lesser extent, their parents, since changing diapers has been associated with infection 
(Hunter et al., 2004). Human cryptosporidiosis can be due to infections with either the 
human specific C. hominis or the zoonotic C. parvum, and in a limited number of 
cases with C. meleagridis (Pedraza-Diaz et al., 2001b). Other Cryptosporidium 
species, such as C. canis, C. suis, C. muris and C. felis have occasionally been 
reported, especially in immunodeficient patients (Pedraza-Diaz et al., 2001a; Caccio 
et al., 2005). For most Cryptosporidium species zoonotic transmission is contradicted 
by the host-parasite co-evolution theory, despite occasional identification in mostly 
immunocompromised human patients. For C. parvum and C. meleagridis, the host 
expansion hypothesis however supports the possibility of zoonotic infections (Xiao et 
al., 2002), although the identification of C. parvum in human stool samples does not 
conclusively implicate zoonotic transmission. Subgenotype analysis at the 60kDa 
glycoprotein locus (GP60) (Peng et al., 2001; Alves et al., 2003; Sulaiman et al., 
2005; Trotz-Williams et al., 2006) and multilocus microsatellite genotyping (Caccio 
et al., 2000; Mallon et al., 2003b), revealed both human specific and zoonotic 
subgenotypes within C. parvum. Moreover, in most waterborne outbreaks, including 
the large Milwaukee outbreak in 1993, human sources of infection are indeed 
identified (Peng et al., 1997), and in only 1 waterborne outbreak in Canada livestock 
was implicated (Fayer et al., 2000). This might indicate that next to a zoonotic cycle a 
human specific cycle of C. parvum exists, and that human infections are largely due to 
human sources of infection. However, molecular information is mainly obtained from 
outbreaks, whereas most human cryptosporidial infections are not outbreak related 
(Feltus et al., 2006). Although in sporadic cases the source of infection is mostly 
unknown, direct contact with infected farm animals has repeatedly been associated 
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with infection (Hunter et al., 2004; Hunter and Thompson, 2005). Other risk factors 
are traveling abroad, contact with a diarrhetic patient or swimming (Robertson et al., 
2002; Roy et al., 2004).  
It is clear that C. parvum can be maintained in a variety of independent transmission 
cycles that do not require interaction. The frequency and the circumstances of 
interaction mainly depend on the opportunity for contact between infected and 
susceptible hosts. Hence the proportion of C. parvum infections is much higher in 
rural areas, in the proximity of animal reservoirs, than in urban areas (Learmonth et 
al., 2004). In Europe, the contact between livestock industry and drinking water 
resources or habitation and recreational areas, might account for the high prevalence 
of C. parvum in human patients, while in other parts of the world most human 
infections are due to C. hominis. Similarly, regulations imposed during the foot and 
mouth disease outbreak in 2001, including limited acces to the countryside and 
massive slaughter of cattle, resulted in a decline of human cryptosporidial infections 
in Scotland (Strachan et al., 2003). Therefore, cattle and in particular young calves 
should be considered as a reservoir for C. parvum (Heitman et al., 2002). 
Furthermore, mixed C. parvum and C. hominis infections (Tanriverdi et al., 2003) and 
single C. hominis infections (Smith et al., 2005b) have occasionally been reported in 
cattle. Sheep and other livestock seem to be of lesser importance (Ryan et al., 2005) 
and companion animals are probably negligible as reservoir for human infection 
(Hunter and Thompson, 2005). Although wildlife, such as deer, elk and bison, can be 
infected with the same species as cattle and man (Olson et al., 2004), the relevance of 
wildlife in the epidemiology of bovine or human cryptosporidiosis in Northwestern 
Europe is uncertain. Cattle seem therefore to be the most important reservoir for 
zoonotic transmission (Hunter and Thompson, 2005). 
Although direct contact with calves caused infections in farm households (Miron et 
al., 1991; Lengerich et al., 1993) and farm visitors (Evans and Gardner, 1996; Sayers 
et al., 1996) or veterinarians (Preiser et al., 2003), the majority of the zoonotic 
infections are due to indirect transmission through water or food (Sulaiman et al., 
1999; Stantic-Pavlinic et al., 2003; Hunter et al., 2004). The oocysts are transported to 
surface water by the drainage from manure storage areas, run-off from manure-laden 
soil or direct contamination of water by cows (Fayer et al., 1998b; Graczyk et al., 
2000; Sischo et al., 2000; Jellison et al., 2002). Cryptosporidium oocysts are 
prevalent in agricultural soil (Barwick et al., 2003) and able to survive for several 
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months (Jenkins et al., 2002). Rainfall and run-off are major contributers to the total 
Cryptosporidium load in surface waters and drinking water reservoirs (Kistemann et 
al., 2002) and highest oocyst levels in agricultural surface waters coincide with the 
calving season (Bodley-Tickell et al., 2002). Since most commonly used disinfection 
procedures in water treatment plants do not completely remove oocysts, water should 
be considered as an important vehicle for zoonotic infections. 
 
1.2.5 Pathogenesis and clinical symptoms 
The intestinal Cryptosporidium species, C. bovis and C. parvum, complete their life 
cycle in the ileum, and occasionally in the colon, caecum and duodenum (Sanford and 
Josephson, 1982). The pathogenicity of C. bovis is believed to be limited, probably 
due to immunity in older calves (Harp et al., 1990; Santin et al., 2004). In young 
calves C. parvum predominates and is considered as highly pathogenic. The invasion 
and colonisation of the epithelial surface by the different parasite stages result in loss 
of epithelial cells and microvillus brush border. Furthermore, the epithelial tight 
junctions are disrupted leading to an increased epithelial permeability. As a 
consequence there is a decreased intestinal surface area, a loss of membrane-bound 
digestive enzymes, such as lactase, and an impaired nutrient and electrolyte transport. 
Furthermore, neuropeptides lead to chloride secretion. In histo-pathological 
preparations villus shortening and fusion, as well as crypt hyperplasia and an increase 
in intra-epithelial lymphocytes can be observed (Sanford and Josephson, 1982; 
Tzipori et al., 1983; Fayer et al., 1998a; Robinson et al., 2003).  
Clinical symptoms are most frequently observed in calves between the age of 5 days 
and 1 month and include a malabsorptive and secretory diarrhea which is usually self-
limiting within 2 weeks (O'Handley et al., 1999). The diarrhea can be mild to severe 
with pale yellowish watery or mucoid faeces. Calves can be dehydrated, depressed 
and anorectic. The severity and duration of the clinical symptoms is highly variable, 
depending on concurrent viral, bacterial or parasitic infections, but also on host 
factors (Fayer et al., 1998a). Mortality is variable and is most often observed in calves 
with multiple infections and in certain beef breeds, such as the Belgian Blue and 
White (de Graaf et al., 1999b). Calves with severe cryptosporidiosis can take several 
weeks to fully recover, and there is certainly an initial negative impact on production 
due to weight loss or impaired weight gain, and due to treatment expenses. Whether 
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cryptosporidial infections early in life have long-term detrimental effects is uncertain 
(Ralston et al., 2003a). Calves that recover from a Cryptosporidium-associated 
diarrhea usually do not have recurrent clinical infections. The oocyst shedding also 
appears to be minimal after infection.  
Infection with C. andersoni has been reported world-wide in post-weaned cattle 
(Enemark et al., 2002; Olson et al., 2004). C. andersoni invades the peptic and pyloric 
glands of the abomasum causing glandular dilatation and hypertrophy of the gastric 
mucosa and thinning of the epithelial lining. Although occasionally reported (Daniel 
et al., 2005), infection with C. andersoni does usually not result in a pronounced 
diarrhea, but mainly causes maldigestion by inhibition of protein digestion due to 
increased gastric pH and subsequent decreased gastric proteolytic activity. This 
results in a moderate to severe impairment of weight gain, decreased feed efficiency 
and reduced milk production (Anderson, 1987; Esteban and Anderson, 1995; Ralston 
et al., 2003a).  
 
1.2.6 Diagnosis 
The diagnosis of cryptosporidiosis in calves is traditionally performed by 
microscopical examination of a faecal smear, although immunological assays and 
PCR are increasingly applied in human and veterinary medicine. Most clinically 
affected calves excrete a high number of oocysts (Mohammed et al., 1999; Uga et al., 
2000; Nydam et al., 2001), facilitating clinical diagnosis. In epidemiological studies 
however, the intermittent excretion of oocysts needs to be taken into account, 
although multiple samplings do not necessarily yield an increased sensitivity 
(Hanscheid and Valadas, 2006). 
 
Microscopical examination 
The most widely used technique for the diagnosis of Cryptosporidium is the detection 
of oocysts in a faecal smear, either native or after staining. The most commonly used 
staining methods are the modified Ziehl-Neelsen staining (Henricksen and Pohlenz, 
1981) and the carbolfuchsine staining (Heine, 1982) (Figure 1.2). The oocysts of 
Cryptosporidium parasites from the intestinal group, such as C. parvum, C. hominis 
and many other Cryptosporidium species and genotypes are morphologically 
indistinguisable. They are spherical to elipsoidal with a mean size of 5.0 by 4.5μm 
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(range 4.5-5.4 by 4.2-5.0) (Upton and Current, 1985; Fayer et al., 2005). The oocysts 
of the gastric C. andersoni, are larger and measure 7.4 by 5.5μm (range 6.0-8.1 by 
5.0-6.5μm) (Lindsay et al., 2000a). In addition, other faecal components (‘ghosts’) of 
similar size and shape, such as yeasts or Cyclospora, are difficult to distinguish from 
Cryptosporidium oocysts (Henriksen and Pohlenz, 1981; Clarke and McIntyre, 2001), 
which troubles interpretation and can lead to large variability between laboratories 
depending on the experience of the microscopist. Overall, microscopy has a low 
sensitivity compared to immunological techniques and PCR, especially for the 
diagnosis of mild infections. Even after concentration many of the infections with low 
oocyst excretion are not diagnosed by microscopy (Fayer et al., 2000). 
 
Figure 1.2: Cryptosporidium oocysts as diagnosed by microscopical examination (1000X) using a 
modified Ziehl-Neelsen staining (a) or the carbolfuchsine (b) staining  
(a)       (b) 
 
     
 Immunological assays 
Immunological assays commonly used in veterinary medicine comprise 
immunofluorescence assay (IFA), antigen enzym-linked immunosorbent assays 
(ELISA) and solid-phase qualitative immunochromatographic assays (dip sticks). 
Immunoserological detection of specific antibodies is unsuitable for clinical 
diagnosis, as the increase in specific antibody titer can not be detected until after the 
clinical phase of infection (O'Donoghue, 1995). Although developed and evaluated 
for use in human stool samples, both IFA and ELISA are applied on a regular basis 
for the diagnosis of clinical cryptosporidiosis in calves. IFA (Figure 1.3) can be used 
as a qualitative and a quantitative assay and the detection limit is believed to be as low 
as 1,000 oocysts per gram of faeces (Xiao and Herd, 1993), although in human stool 
samples a 100% recovery rate was not reached until seeded with 10,000 OPG (Weber 
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et al., 1991). The major advantage is the high sensitivity and specificity compared to 
microscopy, both for IFA (Quilez et al., 1996a) and for ELISA (McCluskey et al., 
1995). A major disadvantage is the need for appropriate equipment and qualified 
personel. In contrast, dip sticks do not need laboratory settings and can be used on site 
by the veterinarian. In human stool samples, the dip sticks seem to be both sensitive 
and specific (Depierreux et al., 2001; Llorente et al., 2002), and also in calves they 
have been shown to be a valid alternative for laboratory diagnosis (Trotz-Williams et 
al., 2005b). 
 
Figure 1.3: Cryptosporidium oocysts (small and round) and Giardia cysts (large and ovoid) visualised 
using a mixture of fluorescein labelled monoclonal antibodies 
(http://www.dpd.cdc.gov/dpdx/HTML/Cryptosporidiosis.asp?body=Frames).  
                                       
 
Polymerase chain reaction (PCR) 
PCR is an alternative for microscopy and immunology, especially for the diagnosis of 
chronic or asymptomatic cryptosporidiosis in immunocompromised human patients 
(McLauchlin et al., 2003). Several genes are commonly targeted (Caccio et al., 2005). 
Both in human and in animal (Webster et al., 1996; Scorza et al., 2003) faecal 
samples, PCR has a superior sensitivity compared to conventional methods with a 
detection limit close to 1 oocyst (Widmer, 1998). Furthermore, several PCR protocols 
are able to distinguish between different Cryptosporidium species and genotypes, 
which might be important from an epidemiological perspective. Despite the multiple 
advantages PCR has several limitations, next to the requirement of equipment and 
trained staff. False positive amplification results from the detection of naked nucleic 
acids, non-viable microorganisms or laboratory contamination. False negative results 
can occur through DNA denaturation or the presence of inhibitors in DNA extracted 
from faecal samples (Fayer et al., 2000; Higgins et al., 2001). Given the high 
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excretion of oocysts during patent infections, the use of PCR as a routine technique 
for the diagnosis of clinical cryptosporidiosis in calves is probably not required, 
although it might be useful as a diagnostic tool for tracking outbreak sources.  
 
1.2.7 Treatment and control 
Several chemotherapeutic agents have been tested for the treatment of bovine 
cryptosporidiosis, but none resulted in a 100% reduction of oocyst excretion.  
In Belgium and other European countries, only halofuginone lactate is registered for 
treatment in calves, at a dose rate of 100μg/kg bodyweight (BW) per day during seven 
consecutive days. Toxicity can be observed at a dose rate of 500 μg/kg. For 
preventive treatment, halofuginone should be administered within 48h after 
parturition, and for curative treatment, within 24h after the onset of the clinical 
symptoms. Treatment with halofuginone lactate reduces the occurence of diarrhea and 
postpones the oocyst excretion. Overall, results were better in experimental settings 
than under natural conditions with a high environmental infection pressure (Villacorta 
et al., 1991b; Naciri et al., 1993; Lefay et al., 2001; Joachim et al., 2003; Jarvie et al., 
2005). Since infection is not completely eliminated, treatment with halofuginone 
lactate allows the development of a specific immunity (Peeters et al., 1993).   
Although not registered for the treatment of cryptosporidiosis, prophylaxis with 
paromomycin sulphate is effective in preventing oocyst excretion and clinical signs 
and mortality in calves and goat kids, at a dose rate of 100mg/kg BW per day during 
10 or 11 consecutive days. Similar to halofuginone, efficacy was higher under 
experimental (Fayer and Ellis, 1993b; Mancassola et al., 1995) compared to natural 
conditions (Chartier et al., 1996; Grinberg et al., 2002; Johnson et al., 2000). In 
naturally infected lambs curative treatment with paromomycin at a similar dose rate 
during 2-3 consecutive days resulted in a reduction of oocyst excretion and clinical 
symptoms (Viu et al., 2000).  
Azithromycin is another antibiotic with therapeutic efficacy against Cryptosporidium 
(Elitok et al., 2005), but is not registered for use in calves. Furthermore, the efficacy 
of several chemotherapeutics, such as sulphamidine (Moon et al., 1982b; Joachim et 
al., 2003), and coccidiostatics, such as decoquinate (Mancassola et al., 1997; Lindsay 
et al., 2000b; Moore et al., 2003), have been tested, with no or limited reduction of 
oocyst excretion. Several new compounds have been shown to decrease severity of 
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diarrhea and to shorten the duration of oocyst shedding, such as the excipients - 
(Castro-Hermida and Ares-Mazas, 2003) and especially -cyclodextrin (Castro-
Hermida et al., 2001 a and b) and in human patients nitazoxanide (Rossignol et al., 
2006). Alternative treatment with lactic acid-producing bacteria (Harp et al., 1996b) 
or with concentrated garlic preparations (Hoflack et al., 2006) were shown to be not 
effective to prevent oocyst excretion and clinical symptoms. 
Since halofuginone only partially reduces oocyst excretion under natural conditions, 
the control of cryptosporidiosis relies on a combination of animal treatment and 
appropriate hygienic measures and management. Due to the particular parasite 
characteristics (Table 1.3), such as the high oocyst excretion by infected calves, the 
environmental resistance of excreted oocysts and the presence of asymptomatic 
carriers, cryptosporidiosis should be considered as an endemic problem on infected 
farms. Hygienic measures must therefore aim to minimize the environmental infection 
pressure in order to prevent the spread of infection to susceptible calves and to break 
the transmission cycle. Frequent removal of bedding and thourough cleaning 
combined with disinfection help to reduce the oocyst load in the environment (Garber 
et al., 1994; Castro-Hermida et al., 2002a). Unfortunately, Cryptosporidium is 
extremely resistant to commonly used disinfectants (Carpenter et al., 1999). The most 
effective, but also the most toxic disinfectants against cryptosporidial oocysts are 
ammonia, methyl bromide, ethylene oxide and ozone (Jenkins et al., 1998; Fayer, 
2004). Oocysts are susceptible to extreme temperatures and to dessication (Fujino et 
al., 2002). Cleaning with hot water followed by drying is therefore an effective way to 
reduce oocyst infectivity (Harp et al., 1996a). 
Good management practices include warm and dry individual calf facilities, 
preferably outside (Castro-Hermida et al., 2002a; Quigley et al., 1994). High stocking 
densities are to be avoided (Atwill et al., 1999b). Furthermore, a quarantaine unit 
should be present at the farm to isolate clinically affected calves, with separate tools, 
boots and coveralls to prevent spread of infection. It is also important to ensure 
adequate colostrum intake (Mohammed et al., 1999), since colostral antibodies 
protect calves from developing severe clinical symptoms by blocking parasite 
invasion and immobilisation of gut luminal parasitic forms. Micronutrients may also 
play a significant role in the clinical outcome of cryptosporidiosis as severe clinical 
signs were observed in calves with selenium deficiency (McAllister et al., 2005; 
Olson et al., 2004). 
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Table 1.3: Parasite characteristics of Cryptosporidium and Giardia, epidemiological consequence and 
the appropriate preventive measures 
 
*hygiëne:         - frequent removal of faeces 
           - thourough cleaning, preferably high pressure water cleaning 
                         - if possible, followed by vacancy during several weeks  
 
Vaccination could provide a valuable alternative to chemotherapeutic treatment. In 
experimental settings calves were protected against a single infection dose after active 
vaccination with gamma-irradiated (Jenkins et al., 2004) or lyophilized oocysts (Harp 
and Goff, 1995). Due to the occurence of clinical symptoms and oocyst excretion 
within days after parturition, a single vaccination of the calves is not capable of 
mediating a significant immune protection prior to infection (Harp et al., 1996b). 
Furthermore, maternal antibodies have a blocking effect on orally procured vaccinal 
antigens (de Graaf et al., 1999a). Passive immunisation via colostral antibodies, 
through immunisation of the dam prior to parturition, has been shown to be effective 
in calves (Perryman et al., 1999) and goat kids (Sagodira et al., 1999). Although 
colostral immunisation provides the most promising alternative for chemotherapeutic 
treatment, the succesful use of vaccines should be supported by hygienic and 
management measures to minimize the exposure of calves to cryptosporidial oocysts 
in the initial days of life and to allow the protective immune responses to be 
generated. 
Parasite characteristic Epidemiological consequence Preventive measure 
-high excretion of (oo)cysts in  
 the faeces 
-infection pressure can increase in a 
 short period of time 
-avoid crowding 
-isolation of excreting calves 
-hygiene* 
-(oo)cysts are extremely resistant 
 to environmental conditions 
-excreted oocysts can survive for  
 several weeks or months in the 
 environment 
-hygiene* 
 
-(oo)cysts are extremely resistant 
 to chemical disinfection 
-disinfection with common  
 desinfectants (chlorination) is not 
effective enough 
-products based on ammonia, 
 chlorine dioxide, hydrogen  
 dioxide or ozone 
-(oo)cysts are only sensitive for  
 heat and desiccation 
-infection is mostly seen in the  
 humid environment of stables 
-disinfection using steam  
-avoid crowding 
-hygiene* 
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1.3 Giardia  
1.3.1 Classification 
Members of the genus Giardia are eukaryotic organisms and belong to the Class of 
Zoomastigophorea, Order Diplomonadida and Family Hexamitidae. The Hexamitidae 
are diplozoic flagellated protozoa that possess paired organelles, including two 
equivalent nuclei (Figure 1.4). The ventral adhesive disc delineates Giardia from 
other Hexamitidae. The genus name Giardia was proposed in honour of the Belgian 
taxonomist Alfred Mathieu Giard (Kunstler, 1882). To commemorate the man who 
gave the first detailed parasite decription, Lamblia (Blanchard, 1888) was also 
proposed as generic name. Lambl himself had named the parasite Cercomonas 
intestinalis in 1859. In human medical literature the names Lamblia intestinalis and 
Giardia lamblia have both consistently been used to designate Giardia isolates from 
human patients. Furthermore, the species names intestinalis and duodenalis were both 
frequently used (Thompson et al., 2000). At present G. duodenalis is considered the 
only valid species name for the protozoan parasite as described by Filice (1952). 
 
Figure 1.4: Trophozoite and cyst morphology of Giardia duodenalis, G. muris and G. agilis (redrawn 
from Thompson et al., 2004) 
 
 
Over 50 different Giardia species have been described, principally based on host 
specificity. This host-specific taxonomy was later replaced by a taxonomy based on 
morphological characteristics such as trophozoite shape and lenght and shape of the 
median bodies (Filice, 1952). Three morphological distinct groups or Giardia species 
were described (Figure 1.4), of which G. muris and G. duodenalis are able to infect 
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mammals. The third species, G. agilis, is isolated from amphibians. Since the 
introduction of the new taxonomy, morphological characteristics have been used to 
describe 3 additional Giardia species (Table 1.4): G. psittaci and G. ardeae originate 
from birds and have been described based on morphological differences in the 
trophozoites observed by scanning electron microscopy (Erlandsen and Bemrick, 
1987; Erlandsen et al., 1990); G. microti has been differentiated based on cyst 
morphology and is found in a variety of rodents (Erlandsen et al., 1988).  
 
Although morphological characteristics still provide the basis of the current 
taxonomy, it was only a temporary solution in expectation of more discriminatory 
criteria. Phenotypic studies (Farbey et al., 1995; Homan and Mank, 2001; Read et al., 
2002), along with epidemiological observations (Cribb and Spracklin, 1986), cross-
transmission experiments (Kirkpatrick and Green, 1985; Erlandsen et al., 1988; 
Majewska, 1994; Monis et al., 1999; McDonnell et al., 2003; Monis and Thompson, 
2003), electrophoretic studies (Meloni et al., 1995; Monis et al., 2003) and genetic 
characterisation, have since revealed that G. duodenalis should be considered a 
species complex. At present 7 major assemblages (A to G) have been identified within 
G. duodenalis, some of which have distinct host preferences or a limited host range 
(Ey et al., 1997; Mayrhofer et al., 1995; Monis et al., 1998, 1999). The first 
assemblages to be described were assemblage A and B (Monis et al., 1996), named 
the Polish and Belgian group in Europe (Homan et al., 1992) and groups 1-2 and 3 in 
Northern America (Nash, 1997), respectively. Next to the assemblages A and B which 
are both prevalent in human patients, several host-specific assemblages have been 
identified in animals. Assemblages C and D primarily infect dogs, the hoofed 
livestock assemblage or assemblage E is identified in artiodactyl species, assemblage 
F is primarily identified in cats and assemblage G in rats. Since the genetic distance 
separating these assemblages within G. duodenalis is at the same level as that 
separating G. duodenalis from other recognised species of Giardia (Mayrhofer et al., 
1995; Monis et al., 1996, 1998), species names for each of these assemblages have 
been proposed, resulting in 5 new species names (Thompson and Monis, 2004). 
Including the six species previously recognised in the morphological taxonomy, a 
total of 11 Giardia species have currently been described (Table 1.4). Since these new 
species names have only recently been introduced and are not yet commonly used, the 
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‘assemblage nomenclature’ is preferred throughout the manuscript to designate the 
different species within the G. duodenalis morphological group. 
 
Table 1.4: Giardia species and G. duodenalis assemblages, with the proposed new species name, and 
host range 
 
Giardia species Host range  
G. agilis Amphibians  
G. ardeae Birds  
G. psitacci Budgerigar  
G. microti Rodents   
G. muris Rodents  
G. duodenalis  New species name 
     assemblage A Man, dog, cat, livestock,... G. duodenalis 
     assemblage B Man, dog, cat, rodents,... G. enterica 
     assemblage C / D Dog, coyote, mouse G. canis 
     assemblage E Livestock G. bovis 
     assemblage F Cat G. cati 
     assemblage G Rat G. simondi 
 
 
1.3.2 Life cycle  
Giardia has a simple and direct life cycle consisting of two stages: an infectious cyst 
which is resistant to many environmental stressors, and a trophozoite stage, which 
colonizes the intestinal lumen of the host and is responsible for the clinical symptoms. 
After oral ingestion, cysts are exposed to the acidic environment of the proximal 
gastro-intestinal tract resulting in the release of the excyzoite in the upper part of the 
small intestine. The short-living excyzoite has eight flagellae and a metabolism 
intermediate between a trophozoite and a cyst. The excyzoite has 4 nuclei with 4N 
nuclear ploidy, following a nuclear DNA replication in the trophozoite and another 
one in the cyst stage. After release from the differentiated cyst, the excyzoite 
undergoes cel division, without further DNA replication, generating four disease-
causing trophozoites with diploid nuclear ploidy. The cellular amplification might 
explain the low dose (10 to 100 cysts) needed for infection (Bernander et al., 2001). 
The trophozoites have a convex dorsal surface and a ventral adhesive disk which is 
used to attach to the intestinal mucosa (figure 1.4).  
30  Chapter 1 
____________________________________________________________________________________________ 
For the colonisation of the duodenum and the jejunum, attachment to epithelial cells is 
essential. Hydrodynamic forces generated beneath the ventral adhesive disc by 
continuous activity of the ventral flagella, contractile cytoskeletal proteins and lectins 
have been suggested as possible attachment mechanisms (Inge et al., 1988; Farthing, 
1997; Sousa et al., 2001). Unlike Cryptosporidium, the trophozoites of Giardia are 
not invasive. They multiply asexually by binary fission in the lumen of the small 
intestine, although a sexual phase has been suggested (Meloni et al., 1989). Finally, 
exposure to biliary salts leads to encystation of trophozoites in the jejunum. Cysts are 
passed in the faeces and are immediately infectious upon excretion allowing 
completion of the life cycle within 72h (Thompson et al., 1993; Adam, 2001;).  
 
1.3.3 Epidemiology and prevalence 
Epidemiology 
Calves are infected by oral intake of infectious cysts. As soon as 3 days after infection 
(Xiao and Herd, 1994) cysts can be recovered from the faeces. The maximum cyst 
excretion (up to 10
6
 cysts per gram of faeces) is observed at the age of 2 to 3 weeks. 
This coincides with the depletion of colostral immunity within 2 weeks after birth 
(O'Handley et al., 2003). From the age of 3 to 4 weeks cyst excretion starts to 
decrease and becomes intermittent. Around 2 to 3 months of age the number of 
excreted cysts further decreases and in older calves and adult animals cyst excretion is 
minimal (Xiao et al., 1994; Nydam et al., 2001). Young calves can therefore be 
considered as the major source of infection for susceptible calves. Dams and older 
calves can however not be excluded, since a limited number of cysts can be sufficient 
for infection (Bernander et al., 2001). As in sheep, horses and pigs, a periparturient 
rise of the cyst excretion has been suggested in cattle, but has not been confirmed 
(Xiao and Herd, 1994; Wade et al., 2000a). 
Similar to Cryptosporidium, several parasite characteristics facilitate infection with 
Giardia, such as the high excretion of cysts by infected calves and the low dose 
needed for infection. Furthermore, Giardia cysts are immediately infectious upon 
excretion and do not need to sporulate in the environment. Cysts are also very 
resistant and are able to survive for several months in the environment, resulting in a 
gradual increase in environmental infection pressure (Xiao et al., 1993; Olson et al., 
1999; Wade et al., 2000a). Infection can occur either by direct contact with an 
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infected animal or indirectly through the environment, such as maternity pens or calf 
housing. Although the maternity pen should be considered, it is probably a minor 
source of infection, given the colostral immunity and the low number of cysts 
excreted by the dam. Furthermore, most dairy and to a lesser extent beef calves are 
removed from the dam shortly after parturition and housed in calf facilities, which are 
probably the major source of indirect infection. Calves kept indoors are three times 
more likely to acquire infection than calves reared outside (Ruest et al., 1998). Similar 
to Cryptosporidium, particularly group housing, but also individual housing is 
considered to favour transmission. Infection can occur via vectors or through the 
subsequent use of calf pens, due to the environmental resistance of the infectious cyst.  
 
Prevalence 
Worldwide cross-sectional studies have reported a Giardia prevalence varying from 
20% to 73% in calves younger than six months. In calves older than 6 months the 
prevalence seems somewhat lower. Substantial differences in prevalence partially 
account for this variability, next to differences in study design, such as the number of 
animals or farms included in the studies. Since there is no gold standard reference test 
for the diagnosis of Giardia in calves, the sensitivity and specificity of each test is not 
known. Therefore the use of different diagnostic techniques might thwart comparison 
between prevalence studies. Furthermore, the age of the animals needs to be 
considered, since the highest prevalence is reported in calves up to 3 months of age 
(Ralston et al., 2003b; Becher et al., 2004). In contrast to Cryptosporidium (Ralston et 
al., 2003b; Gow and Waldner, 2006; Kvac et al., 2006), Giardia seems to be equally 
prevalent in dairy and beef calves. The number of farms with Giardia positive calves 
is between 45% and 100% (Table 1.5). On these positive farms, the cumulative 
incidence is assumed to be 100% (Xiao, 1994; O'Handley et al., 1999), indicating that 
every calf on that farm will get infected. In cattle the livestock specific assemblage E 
is most prevalent, although up to 20% zoonotic assemblage A isolates have been 
reported, either in pre-weaned calves (O'Handley et al., 2000b; Appelbee et al., 2003; 
Becher et al., 2004; Berrilli et al., 2004; Trout et al., 2004; Itagaki et al., 2005), post-
weaned calves (Trout et al., 2005), or adult cattle (Trout et al., 2006; Uehlinger et al., 
2006a). 
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Table 1.5: The calf prevalence (PC) and farm prevalence (PF) of Giardia in different countries. The type 
of farm (Farm: b=beef and d=dairy), the number of calves (#C) and farms (#F) is presented along with the 
diagnostic assay (D) used in the study: Immunofluorescence assay (IFA), polymerase chain reaction 
(PCR) or microscopy (M).  
 
 
1.3.4 Zoonotic aspects 
Zoonotic transmission either occurs by direct faeco-oral transmission or indirectly, by 
the ingestion of contaminated water or food. The high prevalence of Giardia in a wide 
range of domestic and wild animals suggests a possible reservoir function for human 
infection, although little is known about the frequency of zoonotic transmission 
(Heitman et al., 2002; Hoque et al., 2002; Jakubowski and Graun, 2002; Caccio et al., 
2003). In 1979 the WHO recognised the zoonotic potential of Giardia. Cross-
transmission experiments (Kirkpatrick and Green, 1985; Erlandsen et al., 1988; 
Majewska, 1994; Monis et al., 1999; McDonnell et al., 2003; Monis and Thompson, 
2003) and immunoblotting of sera from both human and animal carriers (Buret et al., 
1990a) later confirmed the zoonotic transmission. Several of these cross-transmission 
experiments however displayed contradictory results, which could only partially be 
attributed to differences in experimental design (Monis and Thompson, 2003), 
suggesting that not all Giardia isolates have zoonotic potential. The development of 
Country   D 
 
Farm  
 
#C #F  age PC  PF Reference 
Calves < 6m         
USA IFA   d 407 14 <2m 40 100 (Trout et al., 2004) 
New Zealand IFA   d 715 12 <2m 40 100 (Hunt et al., 2000) 
Canada IFA   b 495 9 <3m 34 100 (Appelbee et al., 2003) 
Canada IFA   b 605 100 <6m 23 48 (Gow and Waldner, 2006) 
Canada IFA   d 386 20 <6m 73 100 (Olson et al., 1997a) 
Canada M   d    - 505 <6m   - 45 (Ruest et al., 1998) 
Norway IFA   d 1,386 136 <6m 49 93 (Hamnes et al., 2006b) 
USA M   d 2,943 109 <6m 20 70 (Wade et al., 2000b) 
Calves > 6m         
USA IFA   d 464 14 3-11m 31 100 (Trout et al., 2005) 
Denmark IFA   d 895 50 <12m 50 100 (Maddox-Hyttel et al., 2006) 
USA PCR   d 571 514 12-24m 36 100 (Trout et al., 2006) 
Spain M   d 199 30 <24m 26 53 (Quilez et al., 1996b) 
Canada IFA   b 605 100 >24m 17 69 (Gow and Waldner, 2006) 
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axenic culturing has certainly contributed to the understanding that not all Giardia 
cysts from animal sources contribute to human infections. Since not all isolates of G. 
duodenalis amplify equally in laboratory axenic culture (Andrews et al., 1992), 
including a large proportion of human isolates, early genetic data are biased by the 
rather small pool of axenic culture-selected isolates (Monis et al., 2003) and can 
hardly be considered as representative of the extensive gene pool existing in nature 
(Thompson, 2004). The introduction of polymerase chain reaction (PCR) has 
circumvented the need for in-vitro culture, with direct characterisation of parasite 
DNA from faecal and environmental samples. Based on the notion of genetic 
difference within G. duodenalis and based on geographically dispersed prevalence 
estimates in different animal species and in humans, several major cycles of 
transmission have been described (Figure 1.5). 
 
Figure 1.5: Major transmission cycles of Giardia duodenalis (redrawn from Thompson et al., 2004) 
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The human cycle 
In industrialised countries Giardia is detected in up to 14% of symptomatic patients 
(Homan and Manck, 2001). The greatest zoonotic risk results from infection with 
assemblage A isolates and to a lesser extent isolates from assemblage B. 
Epidemiological evidence however suggests that man should be considered as the 
main reservoir for human infections (Caccio et al., 2003; Sulaiman et al., 2004). 
Transmission  among human hosts occurs either indirectly through the ingestion of 
cysts in contaminated water or food, or directly in environments were hygiene levels 
may be compromised, such as day care centres. In particular nappy handling, 
traveling and swimming seem to be important risk factors for infection (Hoque et al., 
2002, 2003). Although both assemblage A and B are commonly identified in human 
stool samples, assemblage B seems most prevalent in human infections (Amar et al., 
2002; Read et al., 2002; Traub et al., 2004; van der Giessen et al., 2006).  
 
The wildlife cycle 
Both terrestrial and marine wildlife have been considered as a possible source for 
waterborne infections. In Northern America the beaver has been implicated most 
often in water contamination, to the extent that giardiosis is commonly refered to as 
‘beaver fever’. Next to beavers, Giardia has been reported in muskrats, moose and 
deer (Rickard et al., 1999; Dunlap and Thies, 2002; Heitman et al., 2002; Hamnes et 
al., 2006b;). In Uganda, Giardia has been reported in gorillas (Graczyk et al., 2002). 
Similarly, high prevalences of Giardia were reported in marine wildlife, such as 
oysters, mussels (Graczyk and Schwab, 2000), seals and whales (Olson et al., 1997b; 
Measures and Olson, 1999; Appelbee et al., 2005). Although the zoonotic 
assemblages A and B of G. duodenalis were identified in wildlife (Appelbee et al., 
2002, 2003; Trout et al., 2003; Santin et al., 2005;), it is more likely that wildlife is 
itself infected by cysts originating from human faecal material instead of being the 
source of human infections. The genetic characterisation of isolates from marsupials 
in Australia indicated that they are probably not an important source of infection, 
despite the high prevalence reported in these animals (Thompson, 2004). The 
importance of wildlife as a source of infection for human infections in more densily 
populated areas such as North-West Europe, has yet to be determined. 
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The companion animal cycle 
Giardia is considered as one of the most common enteric parasites in dogs and cats. A 
number of studies indicate that Giardia is highly prevalent in cats worldwide (Swan 
and Thompson, 1986; Collins et al., 1987; Hill et al., 2000; Spain et al., 2001; 
Barutzki and Schaper, 2003; McGlade et al., 2003). Although the zoonotic 
assemblages A and B have been reported (van Keulen et al., 2002; Berrilli et al., 
2004), most cat isolates are identified as either assemblage D (McGlade et al., 2003) 
or the cat specific assemblage F (McGlade et al., 2003; Itagaki et al., 2005; Lalle et 
al., 2005b; Fayer et al., 2006a). Therefore cats should be considered as a possible 
although not important reservoir for zoonotic transmission. The prevalence of Giardia 
in dogs has been reported with considerable variation, mainly depending on the 
population under study. Overall prevalence seems to be moderate in well-cared 
household dogs (Jacobs et al., 2001) and higher in puppies (Hahn et al., 1988) and 
breeding kennels (Swan and Thompson, 1986; Bugg et al., 1999; Barutzki and 
Schaper, 2003; Capelli et al., 2003; Papini et al., 2005). Molecular characterisation of 
dog isolates identified both host-adapted and zoonotic assemblages. High contact 
frequency between dogs leads to competitive interactions and a domination of the dog 
specific assemblages, such as in the Aboriginal communities in Australia where dogs 
tend to stay in packs, favouring dog to dog transfer and resulting in infections with 
predominantly dog specific assemblages C and D, despite a close contact with human 
sources of infection, such as human faeces with predominantly assemblage A isolates 
(Hopkins et al., 1997; Monis et al., 1998). In remote tea growing communities in 
northeast India dogs are however not allowed to roam free. Hence, dogs are more 
likely to be exposed to human rather than canine sources of infection and 
predominantly assemblage A infections were identified in these dogs (Traub et al., 
2002, 2004). The Aboriginal and Indian community settings can be considered as high 
infection pressure environments, facilitating the transmission from one host to 
another. In domestic households in Western urban settings, dogs seem to be just as 
likely to harbour the zoonotic assemblage A as the dog specific assemblage D (van 
Keulen et al., 2002; Abe et al., 2003; Berrilli et al., 2004; Itagaki et al., 2005; Lalle et 
al., 2005a). Dogs should therefore be considered as an important reservoir of 
infection. 
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The livestock cycle 
High prevalences of Giardia have been reported in farm animals, such as cattle, sheep 
and goats (Xiao, 1994; Ryan et al., 2005; Bomfim et al., 2005). In horses the 
prevalence is low (Atwill et al., 2000) and the relevance to human epidemiology is 
probably minor, although the zoonotic assemblage A has been identified in equine 
samples (Traub et al., 2005). In sheep the livestock specific assemblage E was mainly 
identified (Ryan et al., 2005), except in Europe where assemblage A and B infections 
were reported (Giangaspero et al., 2005; Aloisio et al., 2006). In cattle the livestock 
specific assemblage E is most prevalent, although up to 20% zoonotic assemblage A 
isolates have been reported (O'Handley et al., 2000b; Appelbee et al., 2003; Becher et 
al., 2004; Berrilli et al., 2004; Trout et al., 2004; Itagaki et al., 2005). Occassionally, 
assemblage B is identified in calves (van Keulen et al., 2002; Lalle et al., 2005b;). 
However, even a low prevalence of assemblage A or B isolates could pose a 
significant public health risk, since infected animals tend to excrete a large number of 
cysts.  
Due to the limited prevalence and the probable transient nature of zoonotic 
assemblage infections in cattle and small ruminants (Thompson, 2004), these studies 
might suggest that the public health risk from domestic ruminants is minimal, at least 
in rural regions of Northern America and Australia. Anthropozoonotic transmission 
seems to occur more frequently when contact between human and livestock sources of 
infection is more intensive (Graczyk et al., 2002; Uehlinger et al., 2006a). 
Furthermore, a significant association was found between human giardiosis and both 
livestock density and manure use on agricultural land (Odoi et al., 2004). 
Transmission from cattle to humans may therefore be more important in North-
Western European regions, with more intensified cattle industry and closer contact 
between agriculture and human populations, compared to rural areas in Northern 
America and Australia. Studies from Europe seem indeed to indicate that the zoonotic 
assemblage A might be equally or more prevalent than assemblage E in cattle, 
although data are limited (van der Giessen et al., 2002; Lalle et al., 2005b). 
Furthermore, PCR favours the propagation of the most abundant gene present in a 
sample. Hence, the occurence of mixed assemblage A/E infections might be 
underestimated in calves.  
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1.3.5 Pathogenesis and clinical symptoms 
Pathogenesis 
Although the clinical significance of Giardia is beyond dispute in man and animals 
(StJean, 1987; Farthing et al., 1997), the pathogenesis of giardiosis is not clearly 
understood. The pathogenesis has been studied in human epithelial cell lines (Buret et 
al., 1990b), in laboratory animals (Buret et al., 1990c; Buret et al., 2002; Scott et al., 
2002), in goat kids (Koudela and Vitovec, 1998) and in calves (Taminelli et al., 1989; 
Ruest et al., 1997). Giardiosis essentially leads to microvillus alterations. These are 
not only a direct consequence of the interaction between trophozoites and epithelium, 
but are also mediated by host factors, since B-and T-cell deficient mice do not exhibit 
the changes in microvillus height or digestive enzymes in response to a Giardia 
infection (Scott et al., 2000). The pathogenesis of giardiosis can therefore be 
considered as a multifactorial process, involving both parasitic and host immune 
factors. 
The most significant alteration is an increase in epithelial permeability which appears 
to result from enterocyte apoptosis (Cevallos et al., 1995; Chin et al., 2002) and from 
cytoskeletal reorganisation induced by trophozoite toxic products (Buret et al., 2002; 
Scott et al., 2002). The cytoskeletal alterations lead to local disruption of tight-
junctional proteins and to contraction of the circumferential filament bands. Whether 
Giardia secretory-excretory products induce direct proteolytic degradation of tight-
junctional proteins is uncertain. The increased epithelial permeability leads to a higher 
number of intraepithelial lymphocytes (IEL) and to activation of T-lymphocytes. Both 
CD4+ and CD8+ T-cells are activated, resulting in villus atrophy and crypt 
hyperplasia (Buret et al., 1992; Ruest et al., 1997; Scott et al., 2002, 2004). In human 
patients malabsorption has been associated with an increased number of IEL and a 
decreased villus to crypt ratio (Farthing, 1997; Ruest et al., 1997). Trophozoite toxins 
and T-cell activation also initiate a diffuse shortening of brush border microvilli and a 
decreased activity of the small intestinal brush border enzymes, especially lipase, 
some proteases and the dissacharidases lactase, maltase and sucrase (Buret et al., 
1990b; Scott et al., 2000). 
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Clinical symptoms 
Since the pathogenesis of giardiosis is a combination of parasite and host factors, the 
subsequent clinical symptoms may vary considerably from host to host. The diffuse 
microvillus shortening leads to a decrease in overall absorptive area in the small 
intestine and an impaired intake of water and nutritients (Buret et al., 1992; Cevallos 
et al., 1995). The combined effect of the decreased resorption and the brush border 
enzyme deficiencies results in malabsorptive diarrhea and lower weight gain, both in 
murine models (Buret et al., 1990b) and in ruminant experimental models (Ruest et 
al., 1997; Koudela and Vitovec, 1998). The reduced activity of lipase and the 
increased production of mucine by goblet cells may explain the steatorrhea and 
muceous diarrhea which has been described in Giardia infected hosts (Zajac, 1992; 
Moncada et al., 2003). The primary pathogenic effect of natural Giardia infections in 
ruminants was prone to debate (Quilez et al., 1996b; Ruest et al., 1998; Hunt et al., 
2000; Huetink et al., 2001), but is at present well recognised (Aloisio et al., 2006; 
O'Handley et al., 1999). Surprisingly, a mixed infection with Cryptosporidium was 
found to cause less morphological damage in the small intestine of calves than a 
single Giardia infection, which could indicate that these parasites have an 
antagonistic effect on each other rather than a synergestic effect (Ruest et al., 1997).  
Human patients infected with assemblage A are more likely to develop clinical 
symptoms that infections with assemblage B (Read et al., 2002), although infections 
with assemblage B seem to result in more persistent diarrhea (Homan and Mank, 
2001). Whether a similar difference in clinical outcome occurs between the host 
specific assemblage E and the zoonotic assemblage A in calves, is not known. 
 
1.3.6 Diagnosis 
Due to the vague symptoms, the clinical diagnosis of giardiosis in calves is difficult. 
The most consistent is the excretion of pasty to fluid faeces, often with mucus. 
Sometimes steatorrhoea is observed (Moncada et al., 2003). The diarrhea does not 
respond well to antibiotic treatment. Although acute diarrhea can occur, more often a 
chronic and intermittent diarrhea is observed. Next to diarrhea, an impaired weight 
gain despite good appetite seems to be a typical clinical symptom of giardiosis in 
calves (St. Jean, 1987). The diagnosis based on clinical symptoms needs to be 
confirmed by the detection of the parasite in a faecal sample, either by microscopical 
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examination, antigen detection or polymerase chain reaction (PCR). Given the 
intermittent excretion of cysts, especially in the chronic phase of infection, multiple 
samplings can be necessary, either from the same animal for 3 consecutive days 
(O'Handley et al., 1999) or from several calves within the same housing. Since the 
peak excretion is observed in animals around 2-4 weeks of age, preferentially young 
animals are sampled for diagnosis.  
 
Microscopical examination 
Both the trophozoites and the cysts of Giardia can be detected by microscopy, either 
directly or after concentration with sucrose, zinc sulphate or formalin. Steathorrhea, 
which is often observed in giardiosis, can interfere with sucrose flotation (Xiao and 
Herd, 1993). Trophozoites can sometimes be detected in faecal samples from calves 
with diarrhea due to the increased peristalsis. Trophozoites are bilaterally 
symmetrical, piriform to ellipsoidal in shape with a lenght of 12-15μm and a width of 
6-8μm (Figure 1.4 and 1.6). Median bodies, four pairs of flagellae and a ventral disk 
can be seen (Thompson et al., 1993). Given the characteristic movement of the 
trophozoites, they are preferably visualized in a native smear using recently obtained 
faeces.  
 
Figure 1.6: Giardia trophozoite in a native smear (a) and Giardia cyst after iodine staining (b) using 
microscopy at 400x magnification 
 
(a)                (b)  
 
More frequently the detection of cysts in the faeces is prefered for diagnosis. Prior to 
examination cysts can be stained. Frequently used stains are iodine (Figure 1.6) 
(Zajac, 1992) and trichrome (Addiss et al., 1991). The major advantage of 
microscopical examination is the limited cost of consumables. The major 
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disadvantage is the need for a skilled and experienced microscopist and the alledgedly 
lower sensitivity compared to immunological assays. 
 
Immunological diagnosis 
For the detection of parasite antigen immunofluoresence assays (IFA) (Garcia et al., 
1992; Xiao and Herd, 1993; Zimmerman and Needham, 1995), enzyme-linked 
immunosorbent assays (ELISA) (Zimmerman and Needham, 1995; Mank et al., 1997; 
Boone et al., 1999) and rapid solid-phase qualitative immunochromatography assays 
(Garcia et al., 2003) are commercially available. All tests were developed and 
evaluated for use in human stool samples. IFA (Figure 1.3) and ELISA use 
monoclonal antibodies against cyst wall proteins. IFA can be used as a quantitative 
test. In calves the detection limit is estimated to be around 1000 cysts per gram of 
faeces (CPG) (Xiao and Herd, 1993).  
Partially due to the requirement of laboratory settings and trained personnel, the main 
disadvantage of IFA and ELISA is the high cost compared to microscopical 
examination, and the time lost by transport to and analysis in the laboratory. This 
could be circumvented by the use of immunochromatography enabling on-site 
diagnosis within 15 minutes. Immunochromatography uses monoclonal antibodies 
directed against specific trophozoite or cyst wall proteins. In human medicine several 
assays are commercialised, including dip-sticks  and  rapid membrane assays. In 
veterinary medicine an immunochromathographic assay is commercialised for use in 
cats and dogs (Idexx®Snap Giardia test, Idexx Laboratories, Schiphol-Rijk, The 
Netherlands). 
 
Polymerase Chain Reaction (PCR) 
PCR has primarily been used for the identification of different species and genotypes 
of Giardia for taxonomical research, although there is potential for diagnostic use. 
Several genes have been commonly used for genotyping (Caccio et al., 2005). The 
detection limit of PCR is theoretically 1 cyst (Amar et al., 2002), which improves 
considerably the diagnostic sensitivity (McGlade et al., 2003). However, several 
factors can interfere with PCR such as inhibition, which is known to occur frequently 
in DNA extracted from faecal samples. Furthermore, the extraction of parasite DNA 
from faeces needs to be standardised for diagnostic use. At present PCR is considered 
as too expensive for use in veterinary diagnostics (da Silva et al., 1999). In human 
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medicine and in public health services however, PCR is considered as a promising 
diagnostic tool. 
 
1.3.7 Treatment and control 
Nitroimidazoles (NZs), quinacrine or furazolidine are frequently used to treat 
giardiosis in human patients. Although therapy with these compounds is effective, 
considerable side-effects have been demonstrated. Metronidazole is even considered 
to be carcinogenic (Morgan et al., 1993; Harris et al., 2001). Furthermore, resistance 
to treatment has been described both for metronidazole and furazolidine (Upcroft et 
al., 1990). In veterinary medicine metronidazole (St. Jean, 1987; Xiao et al., 1993) 
and dimetridazole (St. Jean, 1987) have been used in companion animals and in 
calves, achieving symptomatic improvement. Data on reduction of cyst excretion are 
however not available. Furthermore, the NZs are no longer approved for use in 
livestock. Recently, nitazoxanide has been shown in vitro to be a promising new drug 
against Giardia (Cedillo-Rivera et al., 2002), but no data on in vivo activity in calves 
are available. 
Since most treatments against Giardia do not have a persistent efficacy, vaccination 
could provide a valid and long term alternative, especially for the prevention of 
disease. In the United States a Giardia vaccine is now commercially available for use 
in cats and dogs (Fel-O-Vax Giardia or Giardia Vax, Fort Dodge Animal Health), but 
the efficacy of a preventive (Olson et al., 1996) or curative (Olson et al., 2001; Payne 
et al., 2002; Stein et al., 2003; Anderson et al., 2004) vaccination seems to be 
variable. In calves vaccination against Giardia did not result in a protective immune 
respons (Uehlinger et al., 2006b).  
 
Benzimidazoles  
An alternative for treatment of giardiosis in cattle are the benzimidazole compounds 
(BZs) which have been well known anthelmintics over the last 30 years with a broad 
spectrum against gastrointestinal nematodes. Because BZs are not absorbed from the 
host intestine, they are believed to have a high safety margin and a selective toxicity 
(Muser and Paul, 1984; Xiao et al., 1996). In vitro studies indicated that BZs are more 
efficacious against Giardia than either metronidazole or tinidazole (Edlind et al., 
1990; Meloni et al., 1990; Morgan et al., 1993) and that this anti-Giardia effect is 
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irreversible (Morgan et al., 1993). The BZs interfere with the polymerisation of 
tubulin and are believed to induce mutations in the tubulin encoding gene. Tubulin is 
a major component of the Giardia trophozoite cytoskeletal structures. Therefore all 
functional activities of tubulin dependent structures such as the median body and the 
ventral disk, are inhibited. BZ seem not to affect flagellar tubulin, which has a 
different tubulin subunit structure (Clark and Holberton, 1988). As a result BZs 
interfere with trophozoite attachment to the intestinal mucosa and prevent intestinal 
colonisation. The BZ mode of action might also include binding to giardins, which are 
Giardia specific proteins restricted to the ventral disk (Edlind et al, 1990; Meloni et 
al., 1990).  
There have been several studies to evaluate the in vivo efficacy of oxfendazole 
(Villeneuve et al., 2000), albendazole (Barr et al., 1993) and fenbendazole (Barr et 
al., 1994) in dogs. In calves data on reduction in cyst excretion are only available for 
treatment with fenbendazole (Xiao et al., 1996; O'Handley et al., 1997) and 
albendazole (Xiao et al., 1996). Both have been shown to significantly reduce the 
peak and the duration of cyst excretion and to result in a clinical benefit (O'Handley et 
al., 2000a), although the dosage of both BZs needed for Giardia treatment (5 to 20 
mg per kg bodyweight per day during three consecutive days) is higher compared to 
helminth treatment. Furthermore, the cyst suppressing effect of BZ treatment was 
either not complete or short-lasting in field conditions, despite the high in vitro 
efficacy of both drugs. This might be either due to a high environmental infection 
pressure which counters the effect of treatment or to the lack of persistent efficacy of 
BZs against Giardia in calves, resulting in a rapid reinfection shortly after the end of 
the treatment. 
To prevent re-infection from the environment and to improve long term production 
parameters, it has been hypothezised that calves should be treated with a continuous 
low dosage of BZs (O'Handley et al., 2000a), since the treatment duration seems to be 
more important than treatment dosage (O'Handley et al., 1997). However, there are no 
data on the safety of a long term treatment with BZs and there might be a potential for 
developing BZs resistant Giardia field strains. It seems therefore more advisable to 
combine animal treatment with environmental measures to reduce infection pressure. 
The environmental measures are similar to those used for the treatment of 
cryptosporidiosis (Table 1.3). 
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Paromomycin  
Paromomycin or aminosidin is a broad-spectrum amino-glycoside antibiotic, with 
well-known efficacy against several protozoan parasites like Cryptosporidium in 
calves (Fayer and Ellis, 1993a; Mancassola et al., 1995; Chartier et al., 1996; Viu et 
al., 2000; Grinberg et al., 2002), Histomonas meleagridis in chickens (Hu and 
McDougald, 2004) and Giardia in rats (Awadalla et al., 1995) and humans (Wright et 
al., 2003). Paromomycin binds to the small subunit rRNA and inhibits protein 
synthesis, which has either a direct effect on Giardia or an indirect effect of nutrient 
withdrawal caused by the inhibition of bacterial protein synthesis and destruction of 
the bacterial flora  (Edlind, 1989; Harder et al., 2001; Harris et al., 2001). 
Paromomycin is poorly absorbed from the gastrointestinal tract and is therefore well 
tolerated by calves  (Grinberg et al., 2002). No data are available on the efficacy of 
paromoycin against Giardia in calves. 
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1.4 Conclusions 
Many studies indicate that Cryptosporidium and Giardia occur in cattle worldwide, 
although the prevalence reports vary markedly. Besides substantial differences 
between farms, regions or countries, the variation in prevalence can also be ascribed 
to differences in study design (cross-sectional versus longitudinal), in number of 
farms or animals, or to differences in age and breed of the animals under study. 
Another reason for variation is the technique used for parasite diagnosis. Both for 
Cryptosporidium and Giardia there is no gold standard reference technique. 
Moreover, the most commonly used diagnostic techniques have not been evaluated 
for use in cattle. Both in human and veterinary medicine most often a frequentist 
approach using contingency tables have been applied for the evaluation of diagnostic 
assays. Contingency tables might however result in an over-or underestimation of the 
test characteristics, depending on the choice of gold standard reference test. Although 
able to thwart the estimation of parasite prevalence and the comprehension of the 
epidemiology, these considerations are rarely taken into acount.  
 
Cattle have always been considered as a potential zoonotic reservoir for human 
Cryptosporidium and Giardia infections. More recently, molecular epidemiological 
studies and subgenotype analysis have provided a more detailed insight in the 
zoonotic potential of ruminant Cryptosporidium and Giardia isolates, suggesting a 
more limited contribution of cattle to human infections. However, most studies were 
conducted in Northern America and in Australia, while a number of reports in Europe 
seem to contradict the limited reservoir function of cattle, especially for Giardia. Due 
to the higher population density and a more intensified contact between the human 
population and agricultural activity in North Western Europe, frequency of 
transmission might be higher compared to rural areas in Northern America and 
Australia, resulting in a higher frequency of zoonotic species and genotypes both in 
human patients and in cattle. Furthermore, in molecular epidemiological studies 
amplification of parasite DNA is performed by standard PCR which favours the 
detection of the most abundant species or genotype in a sample, underestimating the 
possible occurence of mixed infections with both non-zoonotic and zoonotic 
genotypes in cattle.  
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In Belgium, halofuginone is registered for the preventive and curative treatment of 
Cryptosporidium in calves, and was shown to be efficacious both in experimental and 
in natural conditions. For the treatment of Giardia in calves, there is however no drug 
registration, although several benzimidazole compounds were shown to be efficacious 
in experimental and to a lesser extent in natural conditions. Moreover, the efficacy of 
animal treatment in combination with hygienic measures in natural conditions has 
never been evaluated in cattle. A promising alternative for benzimidazole treatment 
seems to be paromomycin, which has however never been evaluated for the treatment 
of bovine giardiosis. 
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The main objective of the thesis is to obtain better insight in the molecular 
epidemiology of Cryptosporidium and Giardia in calves in Belgium, and to focus on 
the treatment and control of Giardia in calves. The three specific sub-objectives are: 
 
1- To estimate the prevalence of Cryptosporidium and Giardia in dairy and beef  
calves in the province of East Flanders (Belgium) based on a reliable estimate of the 
test characteristics of the applied diagnostic assays, using a Bayesian approach 
(chapter 2) 
 
2- To evaluate the zoonotic potential of bovine Cryptosporidium and Giardia isolates  
by molecular identification, with emphasis on subgenotype analysis for   
Cryptosporidium (chapter 3.1) and on mixed assemblage A/E infections for Giardia 
(chapter 3.2) 
 
3- To evaluate the efficacy of different dosages of paromomycin against an 
experimental Giardia infection in calves (chapter 4.1), and to determine the efficacy 
of a combination of fenbendazole treatment and hygienic measures for the control of a 
natural Giardia infection in calves (chapter 4.2) 
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Estimation of diagnostic test 
characteristics and prevalence of 
Giardia in calves in Belgium, using a 
Bayesian approach 
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2.1.1 Introduction 
Worldwide a Giardia prevalence between 20% (Wade et al., 2000) and 73% (Olson et 
al., 1997a) has been reported in calves. The number of farms with positive calves in 
these studies varies from 45 (Ruest et al., 1998) to 100% (Olson et al., 1997 a, b). The 
wide variation in both calf and farm prevalence is not only due to differences in 
management practice or climate (Xiao et al., 1994), but also to differences in study 
design, such as the number of farms or animals under study or the sampling strategy 
(Xiao et al., 1993; Fayer et al., 2000). Another important factor is the age of the 
animals under study, since both the prevalence and the cyst excretion of Giardia peak 
among young animals. The prevalence is highest in the age group under six months, 
although the parasite can be found in all age categories (Xiao, 1994; Quilez et al., 
1996; Olson et al., 1997b; Fayer et al., 2000; Wade et al., 2000). The number of cysts 
in the faeces peaks around two weeks of age, continuing to be high until six weeks of 
age. In older animals the cyst excretion is lower (Xiao, 1994; Nydam et al., 2001), 
which can thwart diagnosis, especially when using diagnostic techniques with a low 
sensitivity.  
In general, different diagnostic techniques can result in a substantial variation in 
prevalence estimates, due to differences in sensitivity and specificity. In cattle, for 
example, the highest Giardia prevalences were found by IFA (Olson et al., 1997a; 
Hunt et al., 2000; Trout et al., 2004; Maddox-Hyttel et al., 2006). Next to IFA, 
several other diagnostic assays, such as ME or ELISA, have been used to estimate the 
prevalence (Xiao and Herd, 1993; Xiao, 1994; Quilez et al., 1996; Olson et al., 1997 
a, b; Ruest et al., 1998; Fayer et al., 2000; Hunt et al., 2000; Wade et al.,2000). 
Neither the sensitivity nor the specificity of these tests is known for a bovine 
population, yet reliable estimates of these parameters are needed to adjust prevalence 
estimates. Using a frequentist approach, both ELISA and IFA have been compared 
with ME and with each other for use in human faecal samples, and were considered to 
be more sensitive and specific than ME. The differences in test characteristics 
between IFA and ELISA seem to be minimal (Addiss et al., 1991; Scheffler and Van 
Etta, 1994; Alles et al., 1995; Zimmerman and Needham, 1995; Garcia and Shimizu, 
1997; Mank et al., 1997). Similar results have been described in cats (McGlade et al., 
2003). However, the estimates of the test characteristics vary considerably among 
these validation studies. Furthermore, general scepticism is appropriate when 
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extrapolating test parameters validated on human samples to bovine samples, because 
these test characteristics would not apply in populations with a different prevalence 
and epidemiology (Greiner and Gardner, 2000). Since there is no gold standard for the 
diagnosis of Giardia in calves, the infection status of the population under study is 
uncertain and the accuracy assessment of a new test can be biased by the use of an 
imperfect reference test as gold standard. In the frequentist approach test evaluation 
relies on the comparison with a gold standard reference test in a contingency table. 
Because a gold standard reference test is not as infallible as inherently assumed in the 
frequentist approach, the evaluation of the new test might result in an underestimation 
of the test characteristics of the assay to be evaluated. A novel approach to circumvent 
the gold standard problem is Bayesian analysis, which has proven its potential in 
validating diagnostic techniques and providing a reliable estimate of the disease 
prevalence, when at least three independent diagnostic test results are available 
(Pouedet et al., 2002; Basanez et al., 2004; Dorny et al., 2004; Berkvens et al., 2006).  
 
2.1.2 Materials and methods 
Study design 
A cross-sectional epidemiological study was conducted. One hundred dairy farms and 
50 beef farms in the province of East-Flanders, Belgium, were randomly selected and 
visited on a single occasion between September 2001 and August 2005. All dairy 
calves were Holstein or local breed mixed with Holstein. All beef calves were Belgian 
blue and white (BBW) or local breed mixed with BBW. Faecal specimens were 
collected from all calves aged from newborn to 10 weeks, present on the farm at the 
time of the visit and transported to the laboratory. A subset of the dairy samples (the 
first 235 samples collected on the first 50 farms) was examined using three different 
diagnostic assays. These data were used in a Bayesian analysis in order to estimate 
both the sensitivity and the specificity of these three tests in a bovine population and 
to estimate the prevalence of Giardia in dairy calves. The 235 samples were examined 
within 48 hours after collection with ME and IFA. Afterwards, all samples were 
preserved at –20°C and examined with ELISA. The faeces collected on the remaining 
dairy farms and on the beef farms were examined using IFA within 48 hours after 
collection. The complete dataset of the 100 dairy and of the 50 beef farms was used in 
order to estimate the overall farm and calf prevalence, the intensity of cyst excretion 
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and the average prevalence in each age category. The difference in age between dairy 
and beef calves was compared with a Mann-Withney U test. Probability (P) values 
<0.05 were considered to indicate a significant difference. The farm prevalence was 
calculated as the number of farms with at least one positive calf, compared to the total 
number of farms in the study. The apparent prevalence was calculated as the number 
of Giardia positive calves, as diagnosed by the respective technique, compared to the 
total number of animals. 
 
Detection of Giardia cysts 
Microscopical examination (ME) 
A sucrose flotation technique was used to demonstrate the presence of Giardia cysts 
in calf faeces. One gram of faeces was suspended in distilled water and strained 
through a layer of surgical gauze to withhold the large debris. After sedimentation for 
1h, the supernatant was decanted and the sediment was collected into a centrifuge 
tube. After centrifugation at 3000g for 5min, the sediment was resuspended in a 
sucrose solution (1.27 sp gr.) and centrifuged at 1500g for 5min. Sucrose solution was 
added up to the rim of the tube and a cover glass was put on top of the tube. After one 
min, the cover glass was removed from the tube, placed on a microscope slide and 
stained with iodine. The entire slide was examined at 400x magnification. An animal 
was considered positive if a cyst with the correct morphology (12-14μm in length 
with an axostyle and 2 or 4 nuclei) was observed. 
 
Direct Immunofluorescence Assay (IFA) 
The quantitative IFA was developed by using the commercial Merifluor 
Cryptosporidium/Giardia kit (Meridian Diagnostics Inc., Cincinnati, Ohio) and by 
modifying the method of Xiao and Herd (1993). Again 1g of the sample was 
suspended in distilled water and strained through a layer of surgical gauze. After 
sedimentation for 1h and centrifugation at 3000g for 5min, the sediment was 
resuspended in distilled water up to a volume of 1ml. After thorough vortexing, an 
aliquot of 10μl was pippeted onto a treated IFA-slide. After staining the slide, as 
instructed by the manufacturer, the entire smear was examined at a 400x 
magnification under a fluorescence microscope. The number of cysts per gram faeces 
(CPG) was obtained by multiplying the total number of cysts on the smear by 100.  
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Enzyme-linked immunosorbent assay (ELISA) 
The TechLab Giardia test (Techlab Inc., Blacksburg, Va.) was used to demonstrate 
the prevalence of cysts in frozen samples. The monoclonal antibody based ELISA 
was used as instructed by the manufacturer. This assay demonstrates Cyst Wall 
Protein 1 which is found in the wall of mature cysts and is secreted in large amounts 
by the encysting trophozoites. Therefore, the antigen can be detected in the early stage 
of excretion (Boone et al., 1999). 
 
Statistical analysis 
A one test approach (Appendix A) was used to estimate the true prevalence, based on 
the number of negative and positive samples found in the 100 dairy farms and in the 
50 beef farms, and on the sensitivity and specificity of the IFA. To estimate the 
sensitivity and specificity of three assays used for the diagnosis of Giardia, a three 
test Bayesian approach (Pouedet et al., 2002) was used (Appendix B) based on a 
subset of the data, obtained from the first 50 dairy farms. Different models were 
constructed and run in WinBugs 1.4 (Spiegelhalter et al., 2003). Typically, a burn-in 
phase of 5000 iterations was used and the models were run for another 10,000 
iterations to obtain estimates. The Brooks, Gelman & Rubin convergence statistic was 
used to assess model convergence and only properly converged models were further 
considered. Model selection proceeded on grounds of identifiability of the model and 
through minimisation of the deviance information criterion (DIC) while ensuring a 
positive number of parameters (pD) estimated in the model (Spiegelhalter et al., 2002) 
and, on the other hand, on a Bayesian p-value (Gelman et al., 2004). The latter is a 
measure for the goodness-of-fit of the model (a comparison of the data to the posterior 
predictive distribution) and essentially represents the proportion of positive 
differences at consecutive iterations between the deviance for ‘cell’ counts, sampled 
from the model, and the deviance calculated for the data. A model, based on a 
multinomial distribution and including all possible interactions between the three 
individual tests requires 15 parameters to be estimated. These are the prevalence, the 
sensitivity and specificity of the first test, two conditional sensitivities and two 
conditional specificities for the second test, and finally four conditional sensitivities 
and four conditional specificities for the third test (Figure 2.1).  
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Figure 2.1: Conditional probabilities for Bayesian models up to six tests 
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This model is in fact inestimable since the data only allow 7 parameters to be 
estimated. Therefore, the model building strategy consists of incorporating extraneous 
prior information in an attempt to reduce the number of parameters to be estimated. 
This can be done by stating, for example, that the specificity of one of the tests is 1, 
leading to the exclusion of all parameters pertaining to false positives for this test: e.g. 
in Appendix A, equating the specificity of test 1 to 1 ([3] = 1) implicates that [7] must 
not be estimated, since Pr D T1+( ) = 0. Probabilistic prior information can also be 
applied to reduce the possible range of values for a specific parameter. This reduction 
may affect the possible range of values for other parameters as well. Because of the 
complexity of the model, it is impossible to predict or calculate what level of 
reduction in the number of parameters to be estimated will result from this prior 
information. Therefore DIC is used to evaluate the model fit. DIC is an information 
criterion and consists of two components: first an equivalent of a likelihood measure 
(transformed in such a way that a lower value means a better fit) and secondly a 
penalty for the complexity of the model (the lower the value, the simpler the model). 
This DIC is to be minimised during the model building process, attempting to find the 
best fit with the simplest possible model. The pD that was effectively estimated in the 
model also represents the complexity of the model and is an indication of the final 
reduction in the number of parameters that had to be estimated. This approach is 
described in more detail by Berkvens et al. (2006). 
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2.1.3 Results 
In total 499 dairy calves and 333 beef calves were examined for the presence of 
Giardia. The mean age of the dairy calves was 26.43 ±0.93 (mean±standard error) 
days ranging from 1 to 70 days, with 59% younger than 4 weeks. Seventy-four 
percent of the dairy calves were female and 26% were male. There was an average 
number of 5 calves on these dairy farms, ranging from 1 to 19. The mean age of the 
beef calves was 32.7 ±1.1 days ranging from 1 to 70 days, with 47% younger than 4 
weeks. Fifty-two percent of the animals were female and 48% were male. There was 
an average number of 7 calves on the farms, ranging from 1 to 17. The mean age of 
the calves on beef farms was significantly (P<0.001) higher than on dairy farms. The 
cross-classified test results obtained by the three individual tests for the detection of 
Giardia are presented in table 2.1. 
 
Table 2.1: The cross-classified test results obtained by the three different tests for the detection of 
Giardia in dairy calves.  
 
ME = Microscopical examination; IFA = Immunofluorescence Assay; ELISA = Enzyme-linked immunosorbent 
assay; # samples= number of test results  
 
Of the 235 dairy calves examined by the three different diagnostic assays, 49 were 
positive for ME, 41 for IFA and 58 for ELISA (table 2.2). In 163 (69%) calves there 
was full agreement among test results, either positive or negative. A full conditional 
model was run, but did not reach convergence. Prior knowledge on the prevalence 
(constraint between 0 and 0.50) had to be included into the model. Adding 
information on specificity of both IFA (0.9-1) and ELISA (0.9-1) did not improve the 
model parameters Bayes-p, DIC and pD. The prevalence, the sensitivity and 
specificity of each test was estimated based on the parameters obtained by the first 
model. The estimated prevalence was 19% (95% probability interval (PI): 11-28%). 
The sensitivity and specificity of each test is presented in table 2.2.  
ME IFA ELISA # samples
1 1 1 18
1 1 0 2
1 0 0 22
1 0 1 7
0 1 1 13
0 0 1 20
0 1 0 8
0 0 0 145
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Table 2.2: The apparent prevalence (AP: in percentage) of Giardia, and the test properties of 
microscopical examination (ME), imunofluorescence assay (IFA) and ELISA as estimated by the three-
test Bayesian analysis. (Se=sensitivity; Sp= specificity, with 95% Probability Interval) 
 
 
 
 
 
 
Based on the sensitivity and specificity estimates of IFA, as presented in table 2.1, 
and on the IFA results of the samples collected on 100 dairy and 50 beef farms, the 
true prevalence of Giardia was estimated (table 2.3). 
 
Table 2.3: The true Giardia prevalence (in percentage), with the 95% Probability Interval, for different 
age categories (w=weeks) in dairy and beef farms, and the farm prevalence (Farm) 
 
  <4w 4-10w <10w Farm 
Dairy 9 (2-19) 41 (25-61) 22 (12-34) 48 
Beef 34 (19-53) 55 (36-80) 45 (30-64) 64 
 
On dairy farms the cyst excretion ranged from 100 to 1,040,000 CPG, with a 
geometric mean of 3516 CPG. As shown in figure 2.2, the highest geometric mean 
cyst excretion was observed among calves 4 weeks old and remained high among 
calves up to the age of 8 weeks, but decreased afterwards. In calves before the age of 
2 weeks the geometric mean CPG was low, although the highest individual count was 
detected in a 12 days old calf. The calf prevalence was highest in dairy calves aged 5 
weeks and stayed high among older animals up to 10 weeks, but was low among 
calves before the age of 2 weeks. On beef farms the cyst excretion ranged from 50 to 
246,000 CPG, with a geometric mean of 1841 CPG. The geometric mean cyst 
excretion was highest among calves between 4 and 10 weeks (figure 2.2). The highest 
calf prevalence was observed in 7 week old calves, and prevalence was generally high 
in calves older than 4 weeks. Similar to dairy farms the geometric mean CPG before 
the age of 2 weeks was low compared to older calves.  
 
 
 
 
 AP      Se Sp 
ME 22 56 (39-73)    87 (81-91) 
IFA 17 77 (53-97)    95 (91-99) 
ELISA 25 89 (70-99)    90 (83-97) 
84  Chapter 2 
____________________________________________________________________________________________ 
Figure 2.2: Prevalence and geometric mean cyst excretion (CPG) of Giardia in different age categories 
(1-10 weeks) on dairy and beef farms, as diagnosed by immunofluorescence assay. The primary Y-axis 
indicates the geometric CPG (value x100). The secondary Y-axis indicates the prevalence in 
percentage. 
 
 
 
2.1.4. Discussion 
This is the first study to use a Bayesian approach to evaluate three different test 
procedures for the detection of Giardia in calves. The lack of diagnostic test 
evaluations for Giardia in dairy calves prior to this study, would have rendered the 
estimation of the prevalence based on the results of a single diagnostic technique 
unreliable (Greiner and Gardner, 2000). The apparent prevalence ranged from 17 to 
25%, depending on the technique of choice. It has been demonstrated that a Bayesian 
approach can be used to obtain better estimates of both the prevalence and the test 
characteristics when the test results of three or four independent assays are available 
(Pouedet et al., 2002; Basanez et al., 2004; Dorny et al., 2004). In the present study, 
three diagnostic techniques were performed on 235 samples coming from 50 dairy 
farms to obtain a more reliable estimate of the test characteristics. ELISA was 
evaluated as the most sensitive (89%) and IFA as the most specific (95%). The higher 
sensitivity of the ELISA compared to the IFA may be attributed to the detection of 
Cyst Wall Protein 1 by ELISA, which is secreted in large amounts by encysting 
trophozoites, whereas the IFA probably only detects cysts and not trophozoites 
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(Boone et al., 1999). Despite a lower sensitivity compared to ELISA, the highly 
specific IFA was preferred as diagnostic assay in the present study because IFA can 
be used quantitatively. The ME has a low sensitivity compared to ELISA and IFA. 
Xiao and Herd (1993) also described low recovery rates using the sucrose gradient 
flotation technique.  
The prevalence estimated in the initial 235 dairy samples using the three test Bayesian 
approach was later confirmed by the 1 test approach with the results of the additional 
screening of 264 dairy samples using only IFA as diagnostic technique. The 
prevalence estimate found in the dairy calves is comparable to other studies based on 
a large number of farms (Wade et al., 2000). In studies with a smaller number of 
farms (Quilez et al., 1996; Olson et al., 1997 a, b; Hunt et al., 2000), higher 
prevalence estimates were reported. The prevalence found in the beef farms is 
comparable to previous prevalence estimates reported in beef farms (Appelbee et al., 
2003; Gow and Waldner, 2006). Both the individual calf prevalence and the farm 
prevalence was high on beef farms compared to dairy farms, possibly due to 
differences in farm management such as the more frequent use of group housing and 
the higher stocking rate in beef farms. Next to substantial differences in farm 
management, the higher average age of beef calves in the present study might account 
for the higher prevalence, since Giardia tends to be more prevalent in calves older 
than one month. Both on dairy and beef farms the highest proportion of positive 
calves was found between 4 and 10 weeks. In calves before the age of two weeks the 
prevalence was low. A similar age distribution was described by Xiao et al. (1994) 
and Quilez et al. (1996), while others reported that giardiasis is more prevalent in 
calves older than 10 weeks (O’Handley et al., 1999; Huetinck et al., 2001), although 
these results could either be attributed to particular management practices on that farm 
(Huetinck et al., 2001) or to a slow immune response to a Giardia infection 
(O’Handley et al., 2003) in that calf population.  
In accordance with results published by Xiao et al. (1994) and Nydam et al. (2001), 
the intensity of cyst excretion exceeded 10
6
 cysts per gram of faeces in some calves. 
The highest cyst excretion in both dairy and beef calves was recorded among calves 
aged 3 to 10 weeks. In dairy calves excretion peaked at the age of one month, but not 
in beef calves. The low prevalence and intensity of cyst excretion before the age of 
two weeks may be due to maternal immunity, as bovine colostrum contains a high 
level of anti-Giardia antibodies. After the maternal antibodies become depleted, 
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calves become more susceptible to infection with Giardia, as they fail to develop a 
strong and fast specific humoral immunity against infection (O’Handley et al., 2003).  
The present study indicates that Giardia is highly prevalent in calves from the age of 
three weeks onwards, and that the prevalence is higher in beef compared to dairy 
calves. IFA and ELISA were both sensitive and specific diagnostic techniques, 
whereas ME was less sensitive for use in epidemiological studies. 
 
  
 
 
 
 
 
 
 
Chapter 2.2 
A Bayesian approach for the evaluation 
of six diagnostic assays and the 
estimation of Cryptosporidium 
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Based on: 
Geurden, T., Berkvens, D., Geldhof, P., Vercruysse, J., Claerebout, E., 2006, A 
Bayesian approach for the evaluation of six diagnostic assays and the estimation of 
Cryptosporidium prevalence in dairy calves. Vet Res 37, 1-12. 
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2.2.1. Introduction 
Cryptosporidium has been associated with diarrhoea in cattle, especially in young 
calves (de Graaf et al., 1999). The prevalence of Cryptosporidium in calves aged less 
than 6 months varies from 1% (Kvac et al., 2006) to 59% (Olson et al., 1997a). 
Similar to Giardia, this variation is not only due to substantial differences in 
climatological or management conditions, but also to differences in study design, such 
as the diagnostic technique used in the study. Although there is no gold standard 
reference test, several conventional diagnostic assays have been widely used for the 
diagnosis of Cryptosporidium in calves, such as ME of a faecal smear after Kinyoun 
acid fast, modified Ziehl-Neelsen staining or carbolfuchsine staining, and 
immunological assays, such as IFA and ELISA. More recently, PCR has been shown 
to be a very sensitive and specific alternative (Morgan et al., 1998). Accuracy 
assessment of diagnostic assays is traditionally performed by the frequentist approach 
using contingency tables with the test results of one assay or a combination of assays 
as the gold standard reference. However, due to a lack of knowledge of the true 
disease status of the tested animals, diagnostic test evaluation is frequently rendered 
ineffective leading to an over-or underestimation of the performance of the new test. 
The test evaluation for the diagnosis of Cryptosporidium is illustrative for the 
problem. In some studies ME was used as gold standard, overrating the ME 
sensitivity and specificity values compared to ELISA or IFA (Newman et al., 1993; 
Ignatius et al., 1997) whereas in other studies IFA (Quilez et al., 1996) or PCR 
(Morgan et al., 1998) was used as gold standard, underestimating the ME test 
characteristics. Similar reflections can be made for the evaluation of ELISA using 
IFA as gold standard (Rosenblatt and Sloan, 1993; Garcia and Shimizu, 1997).  
The gold standard problem can be circumvented by using spiked samples to evaluate 
the sensitivity and specificity of diagnostic test methods. A higher recovery rate for 
IFA compared to ME was described (Weber et al., 1991; Webster et al., 1996), 
although recovery of Cryptosporidium oocysts from spiked specimens is known to be 
low (Weber et al., 1991). Furthermore, this procedure can only be used in a controlled 
evaluation protocol and not for evaluation of diagnostic tests in an epidemiological 
study where the true disease status of the subject is unknown. Recently, Bayesian 
analysis has proven its value in circumventing the gold standard problem. In the 
present study, different Bayesian approaches are presented for the evaluation of the 
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Cryptosporidium prevalence in calves in the province of East Flanders, Belgium, and 
for the evaluation of diagnostic tests.  
 
2.2.2 Material and methods 
Study design  
The study design is the same as for the prevalence estimation of Giardia (chapter 
2.1.2). The samples from the first fifty dairy farms were used for the Bayesian test 
evaluation. These samples were examined within 48 hours after collection with ME 
and IFA, preserved at –20°C and later examined with two ELISAs and 2 PCR assays. 
The ME, IFA and the 2 ELISAs are from hereon referred to as the conventional 
assays. The samples from the remaining fifty dairy farms and from the fifty beef 
farms were examined only with IFA. The complete dataset of the 100 dairy and 50 
beef farms was used in order to estimate farm and calf prevalence, the intensity of 
oocyst excretion and the average prevalence in each age category. The farm 
prevalence was calculated as the number of farms with at least one positive calf, 
compared to the total number of farms in the study. The apparent prevalence was 
calculated as the number of Cryptosporidium positive calves, as diagnosed by the 
respective technique, compared to the total number of animals. 
 
Detection of Cryptosporidium oocysts  
Carbolfuchsine smear method followed by microscopical examination (ME) 
A direct faecal smear followed by carbolfuchsine staining (Heine, 1982) was used to 
demonstrate Cryptosporidium oocysts in fresh faecal material. Approximately 2cm
2
 of 
each slide was examined at a 1000x magnification. A sample was considered positive 
as soon as an oocyst with the correct morphology (4.6-5.6μm x 4-4.8μm) was 
identified. 
 
Direct Immunofluorescence Assay (IFA) 
The commercial Merifluor Cryptosporidium/Giardia immunofluorescence assay 
(Meridian Diagnostics, Inc., Cincinnati, Ohio) was used for the quantitative detection 
to obtain the number of Cryptosporidium oocysts per gram of faeces (OPG), 
following the same procedure as described for Giardia.  
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Enzyme-linked immunosorbent assay  
The TechLab (Techlab) Cryptosporidium test (Techlab, Inc., Blacksburg, Va.) and the 
Tetrakit (Tetra) or Bio-X Digestive ELISA Kit (Bio-X diagnostics, Marche-en-
Famenne, Belgium) were used to demonstrate the prevalence of Cryptosporidium 
antigen in frozen samples. Both assays were used as instructed by the manufacturer.  
 
PCR diagnosis 
DNA was extracted from faecal samples using the QIAamp Stool Mini Kit (Qiagen). 
The first PCR (C-PCR) was performed as previously described using the 
oligonucleotide primers CP-CR and O21F (Morgan et al., 1997) for the amplification 
of a 312 bp product from the rDNA gene. The second PCR (COWP-PCR) was 
performed as previously described using the oligonucleotide primers cry-15 and cry-9 
(Spano et al., 1997). They were designed to amplify a 550 bp product from the gene 
encoding for the Cryptosporidium oocyst wall protein (COWP). Amplification 
products were subsequently vizualized on 1.5 % agarose gels with ethidium bromide. 
A positive and negative control sample was included in each PCR reaction. The 
positive control consisted of a plasmid originally cloned from a Cryptosporidium 
DNA sample isolated from a calf (kindly provided by Simone Caccio). The negative 
control was purified water. Amplification products of both PCR assays were randomly 
selected and sequenced throughout the study to confirm the specificity of both PCR 
assays. 
 
Statistical analysis 
Similar to Giardia, a one-test approach (Appendix A) was used to estimate the true 
prevalence, based on the number of negative and positive samples found in the 100 
dairy and 50 beef farms, and on the sensitivity and specificity of the IFA, estimated in 
the six-test approach. DIC and pD were used for model evaluation (Spiegelhalter et 
al., 2002; Berkvens et al., 2006). 
A Bayesian analysis framework with only full conditional models was used to draw 
inferences about the sensitivity and specificity of different assays for the detection of 
of Cryptosporidium. Two different approaches were used to estimate the test 
characteristics. In a previously described four-test approach (Dorny et al., 2004), a 
model (Appendix C) based on a multinomial distribution and including all possible 
interactions between the ME, IFA, Techlab and Tetra was used, requiring 31 
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parameters to be estimated (figure 2.1). Furthermore, a new six-test approach 
(Appendix D) was developed, requiring 127 parameters (figure 2.1) to be estimated: 
the prevalence, the sensitivity and specificity of the first test, two conditional 
sensitivities and two conditional specificities for the second test, four conditional 
sensitivities and four conditional specificities for the third test, eight conditional 
sensitivities and eight conditional specificities for the fourth test, sixteen conditional 
sensitivities and sixteen conditional specificities for the fifth test and finally thirty-two 
conditional sensitivities and thirty-two conditional specificities for the sixth test. 
Since the data only allow 63 parameters to be estimated (64 ‘classes’ of test results 
with probabilities summing to unity), this model is in fact not identifiable. Therefore, 
the model building strategy consists of incorporating extraneous prior information, 
such as expert opinion (Suess et al., 2002), in an attempt to reduce the number of 
parameters to be estimated. This prior information can be either deterministic or 
probabilistic. Probabilistic prior information is applied to reduce the possible range of 
values for a specific parameter (Dunson, 2001; Dorny et al., 2004; Berkvens et al., 
2006), which may affect the possible range of values for other parameters as well. 
Model evaluation was performed as previously described (Spiegelhalter et al., 2003; 
Gelman et al., 2004). For some parameters no objective prior information can be 
formulated. Therefore it is necessary to leave prior information on these parameters 
non-informative, if one wants to maintain a minimum degree of honesty (Gelman et 
al., 2004; Berkvens et al., 2006).  
 
2.2.3 Results 
A total of 499 dairy and 333 beef calves were examined by IFA for the presence of 
Cryptosporidium. Mean age and average number of calves on the farms were 
described in chapter 2.1.3. A subset of 234 dairy calves were examined for the 
presence of Cryptosporidium using six different assays. The apparent calf prevalence 
as estimated by the different diagnostic assays, is presented in table 2.5 and ranged 
from 14% in the Tetra up to 46% in the C-PCR.  
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Four-test approach  
The cross-classified test results obtained by the four tests for the detection of 
Cryptosporidium are presented in table 2.4. In the four-test approach, 150 (64%) 
calves were in full agreement, either positive or negative.  
 
Table 2.4: The cross-classified test results obtained by the four tests for the detection of 
Cryptosporidium in dairy calves. 
 
ME = Microscopical examination; IFA=Immunofluorescence; Techlab=Techlab Elisa; Tetra= Tetrakit Elisa; # 
samples= number of test results  
 
A conditionally dependent test model was used. Prior information on prevalence 
(prevalence constrained between 0.1-0.8) and on the specificity of the IFA, Techlab 
and Tetra (0.7-1) had to be included into the model to reach convergence. Adding 
information on the sensitivity of the IFA (0.4-1) further improved the model but 
additional constraints did not. Therefore, this model was used to estimate prevalence 
and test characteristics of the 4 assays. The estimated prevalence was 17% (95% 
Probability Interval (PI): 10-28%). The estimated sensitivity and specificity of each 
test are presented in table 2.5.  
 
 
 
 
ME IFA Techlab Tetra # samples
1 1 1 1 18
1 1 1 0 5
1 1 0 1 1
1 1 0 0 3
1 0 1 1 1
1 0 1 0 6
1 0 0 1 2
1 0 0 0 34
0 1 1 1 1
0 1 1 0 4
0 1 0 1 0
0 1 0 0 6
0 0 1 1 2
0 0 1 0 13
0 0 0 1 7
0 0 0 0 132
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Table 2.5: The apparent prevalence (AP) of Cryptosporidium and the test properties of the diagnostic 
tests (95% PI) as estimated by the four test approach and the six test approach 
 
Se= sensitivity; Sp= specificity; ND= not done 
 
Six-test approach  
In the six-test approach the results for 83 (35%) calf samples were in full agreement, 
either positive or negative (data not shown). Prior information on the specificity of 
both PCR assays (sp=1) was included in the model, based on previously published 
specificity estimates (Spano et al., 1997; Morgan et al., 1998). Furthermore, the 
specificity of both PCR assays was confirmed by the sequencing of amplification 
products of randomly chosen samples throughout the study (n=25) and all sequences 
proved to be Cryptosporidium parvum. The specificity constraints made the model 
converge, whereas widening the constraints on the specificity of both PCR assays to a 
range between 0.8 and 1 prohibited model convergence. Therefore the model with the 
constraints on PCR specificity (sp=1) was used to estimate the test characteristics of 
all diagnostic assays (table 2.5). The animal prevalence estimated using this six-test 
model was 58% (95% PI: 50-66%).  
 
One-test approach 
Based on the sensitivity and specificity estimates of IFA obtained in the six-test 
approach, as presented in table 2.5, and on the IFA results of the samples collected on 
100 dairy and 50 beef farms, the true prevalence of Cryptosporidium was estimated 
using the one-test model (table 2.6). 
 
  4 test approach  6 test approach  
 AP Se (%) Sp (%) Se (%) Sp (%) 
C-PCR 46 ND ND 79 (69-87) 100 
COWP PCR 35 ND ND 59 (50-67) 100 
ME 30 78 (56-95) 79 (72-87) 40 (31-49) 84 (75-97) 
IFA 16 78 (54-95) 95 (91-99) 26 (19-34) 94 (88-99) 
Techlab 21 76 (54-92) 89 (84-94) 37 (28-46) 84 (76-92) 
Tetra 14 59 (39-77) 93 (89-96) 30 (21-42) 88 (81-94) 
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Table 2.6: The true Cryptosporidium prevalence (in percentage), with the 95% Probability Interval, for 
different age categories (w=weeks) in dairy and beef farms, and the farm prevalence (Farm) 
 
 
 
 
Within the first 234 dairy samples, a high number of positive calves was found 
between the age of 1 and 4 weeks by all six tests performed. However, in calves older 
than one month the number of positive calves decreased when using the conventional 
diagnostic techniques. With the PCR assays a high number of positive test results was  
not only demonstrated until the age of 4 weeks, but also in calves up to the age of 10 
weeks: the apparent prevalence in calves younger and older than one month as 
estimated by the C-PCR was 45% and 49% respectively. For the COWP the 
prevalence was 34% and 41% respectively for calves younger and older than one 
month. In figure 2.3, the proportion of Cryptosporodium positive calves, as diagnosed 
by IFA and C-PCR in the 234 dairy calves are presented along with the oocyst 
excretion. Since the prevalence for the different age categories estimated by ME, IFA 
and ELISA were similar, only the data obtained with IFA are presented, in 
comparison with the data of the C-PCR assay, which were similar to those of the 
COWP. The number of excreted oocysts by these 234 calves was determined using 
IFA and ranged from 200 to 24,000,000 OPG. The OPG was highest in calves 
between the age of 1 to 3 weeks. The highest individual OPG was observed in a 12 
days old calf. The data obtained by IFA on the remaining 50 dairy farms confirmed 
the findings on age dependent prevalence and mean oocyst excretion. The overall 
geometric mean oocyst excretion in the 499 dairy calves was 29,425 OPG, ranging 
from 100 to 71,376,000 OPG. On the beef farms the number of positive samples was 
too low to calculate prevalence and mean oocyst excretion for each age category. The 
overall geometric mean oocyst excretion in beef calves was 780 OPG, ranging from 
50 to 32,400 OPG. 
 
 
 
 
 
             <4w            4-10w          <10w       Farm  
    Dairy          68 (17-97)         10 (1-27)        37 (7-70)         32 
    Beef          17 (1-44)         11 (1-30)        12 (1-30)         24 
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Figure 2.3: Prevalence and mean oocyst excretion (oocysts per gram faeces: OPG) of Cryptosporidium 
in different age categories (1-10 weeks), as diagnosed by IFA and the C-PCR assay. 
 
 
2.2.4 Discussion 
The present study was the first to use a Bayesian approach to evaluate diagnostic 
assays for the detection of Cryptosporidium in calves, and to estimate parasite 
prevalence. Since there is no gold standard for the diagnosis of Cryptosporidium 
infection, a prevalence estimate based on the results of a single diagnostic assay 
would have been unreliable: in this study the apparent calf prevalence ranged from 
13% to 46 % depending on the technique of choice. Previously a Bayesian approach 
has proven its potential to circumvent this gold standard problem when 3 (Pouedet et 
al., 2002) or 4 (Dorny et al., 2004) diagnostic tests are applied. The four-test approach 
estimated a Cryptosporidium calf prevalence of 17%. When the test results of 2 
additional PCR assays were combined with the results of the 4 conventional assays 
and used to develop the six-test Bayesian approach, the prevalence estimate however 
increased to 58%. The overall true prevalence was estimated by the one-test model 
based on the IFA results in the 100 dairy farms and the 50 beef farms, taking the six-
test model sensitivity and specificity estimates of the IFA into account. The true 
prevalence was comparable to the six-test model prevalence estimate and is 
considerably higher than most other prevalence reports. The higher prevalence is 
largely due to the detection by both PCR assays of positive calves older than one 
month which the conventional techniques failed to identify. The additional detection 
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by PCR is probably due to the combined effect of the lower oocyst excretion in older 
calves and the higher sensitivity of PCR compared to the conventional techniques 
(Webster et al., 1996). Similar to previous reports (Xiao and Herd, 1994; O’Handley 
et al., 1999; Nydam et al., 2001), the peak in oocyst excretion was observed in calves 
between 1 to 4 weeks of age. Although the oocyst excretion decreases in calves older 
than one month, the prevalence estimated by both PCR assays remained high in calves 
older than one month, contrary to other studies with a decrease in prevalence found in 
calves in the age category of 4 to 10 weeks (Quilez et al., 1996; Olson et al., 1997). 
Calves between the age of 4 to 10 weeks should therefore be considered as an 
possible source of infection for susceptible animals, although there appears to be a 
shift in Cryptosporidium species with age in calves (Santin et al., 2004). The 
Cryptosporidium prevalence in dairy calves was higher than in beef calves, which is 
partially due to several risk factors, such as seasonal calvings and farm management 
(Atwill et al., 1999; Geurden et al., 2006; Gow and Waldner, 2006; Kvac et al., 
2006). Furthermore, the dairy calves were younger than the beef calves, and age of 
the calf is an important risk factor for infection (O'Handley et al., 1999), with a 
maximum risk for infection between 9 and 12 days of age (Maldonado-Camargo et 
al., 1998; Castro-Hermida et al., 2002). 
The evaluation of the conventional techniques in the four-test approach yielded 
comparable sensitivity estimates for the ME and two out of the three immunological 
techniques, confirming previous reports that immunological detection methods are not 
significantly more sensitive than ME (Rodriguez-Hernandez et al., 1994). The 
specificity of the immunological techniques however was higher than the specificity 
of ME. The higher sensitivity of the PCR assays reported by Morgan et al. (1998) and 
Spano et al. (1997) was confirmed by the six-test approach. The difference in test 
characteristics estimates of the conventional assays determined in the four-test and the 
six-test approach, is due to the inclusion of two diagnostic techniques with a high 
sensitivity: both PCR assays not only confirmed most samples positive by the four 
conventional assays, but also detected additional positive samples, resulting in a 
decrease in sensitivity estimates for the conventional techniques, whereas the 
specificity estimates for the 4 conventional assays were comparable in both 
approaches. The results of the six-test approach demonstrate that PCR assays can 
provide additional epidemiological information compared to the conventional 
diagnostic tools. 
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2.4 Appendices 
2.4.1 Appendix A: One test Bayesian model 
 
model 
{ 
r[1:2] ~ dmulti(p[1:2], n) 
  
p[1] <- prev*(1-se)+(1-prev)*sp 
p[2] <- prev*se + (1-prev)*(1-sp) 
  
prev  ~ dbeta(1,1) 
se ~ dbeta(1,1) 
sp ~ dbeta(1,1) 
  
for (i in 1:2) 
{ 
     d[i] <- r[i]*log(max(r[i],1)/(p[i]*n)) 
} 
G0 <- sum(d[]) 
r2[1:2] ~ dmulti(p[1:2], n) 
 
for (i in 1:2) 
{ 
     d2[i] <- r2[i]*log(max(r2[i],1)/(p[i]*n)) 
} 
Gt <- sum(d2[]) 
bayesp <- step(G0 - Gt) 
  
} 
  
list(r=c(#neg,#pos), n = 000) 
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2.4.2 Appendix B: Three test Bayesian model 
model 
{ 
 
r[1:8] ~ dmulti(pr[1:8], n) 
 
pr[1]<-p[1]*p[2]*p[4]*p[8]+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15]) 
pr[2]<-p[1]*p[2]*p[4]*(1-p[8])+(1-p[1])*(1-p[3])*(1-p[7])*p[15] 
pr[3]<-p[1]*p[2]*(1-p[4])*p[9]+(1-p[1])*(1-p[3])*p[7]*(1-p[14]) 
pr[4]<-p[1]*p[2]*(1-p[4])*(1-p[9])+(1-p[1])*(1-p[3])*p[7]*p[14] 
pr[5]<-p[1]*(1-p[2])*p[5]*p[10]+(1-p[1])*p[3]*(1-p[6])*(1-p[13]) 
pr[6]<-p[1]*(1-p[2])*p[5]*(1-p[10])+(1-p[1])*p[3]*(1-p[6])*p[13] 
pr[7]<-p[1]*(1-p[2])*(1-p[5])*p[11]+(1-p[1])*p[3]*p[6]*(1-p[12]) 
pr[8]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])+(1-p[1])*p[3]*p[6]*p[12] 
 
for (i in 1:8) 
{ 
 d[i] <- r[i]*log(max(r[i],1)/(pr[i]*n)) 
} 
G0 <- 2* sum(d[]) 
 
r2[1:8] ~ dmulti(pr[1:8],n) 
for (i in 1:8) 
{ 
 d2[i] <- r2[i]*log(max(r2[i],1)/(pr[i]*n)) 
} 
Gt <- 2* sum(d2[]) 
 
bayesp <- step(G0 - Gt) 
 
p[1]  ~ dbeta(1,1) 
p[2]  ~ dbeta(1,1) 
p[3]  ~ dbeta(1,1) 
p[4]  ~ dbeta(1,1) 
p[5]  ~ dbeta(1,1) 
p[6]  ~ dbeta(1,1) 
p[7]  ~ dbeta(1,1) 
p[8]  ~ dbeta(1,1) 
p[9]  ~ dbeta(1,1) 
p[10]  ~ dbeta(1,1) 
p[11]  ~ dbeta(1,1) 
p[12]  ~ dbeta(1,1) 
p[13]  ~ dbeta(1,1) 
p[14]  ~ dbeta(1,1) 
p[15]  ~ dbeta(1,1) 
 
se[1] <- p[2] 
sp[1] <- p[3] 
se[2] <- p[2]*p[4]+(1-p[2])*p[5] 
sp[2] <- p[3]*p[6]+(1-p[3])*p[7] 
se[3] <- p[2]*(p[4]*p[8]+(1-p[4])*p[9])+(1-p[2])*(p[5]*p[10]+(1-p[5])*p[11]) 
sp[3] <- p[3]*(p[6]*p[12]+(1-p[6])*p[13])+(1-p[3])*(p[7]*p[14]+(1-p[7])*p[15]) 
 
} 
 
list(r= c(#neg,#pos), n = 000) 
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2.4.3 Appendix C: Four test Bayesian model 
model 
{ 
r[1:16] ~ dmulti( pr[1:16], n ) 
  
pr[1] <- p[1]*(1-p[2])*(1-p[5])*(1-p[11])*(1-p[23])+(1-p[1])*p[3]*p[6]*p[12]*p[24] 
pr[2] <- p[1]*(1-p[2])*(1-p[5])*(1-p[11])*p[23]+(1-p[1])*p[3]*p[6]*p[12]*(1-p[24]) 
pr[3] <- p[1]*(1-p[2])*(1-p[5])*p[11]*(1-p[22])+(1-p[1])*p[3]*p[6]*(1-p[12])*p[25] 
pr[4] <- p[1]*(1-p[2])*(1-p[5])*p[11]*p[22]+(1-p[1])*p[3]*p[6]*(1-p[12])*(1-p[25]) 
pr[5] <- p[1]*(1-p[2])*p[5]*(1-p[10])*(1-p[21])+(1-p[1])*p[3]*(1-p[6])*p[13]*p[26] 
pr[6] <- p[1]*(1-p[2])*p[5]*(1-p[10])*p[21]+(1-p[1])*p[3]*(1-p[6])*p[13]*(1-p[26]) 
pr[7] <- p[1]*(1-p[2])*p[5]*p[10]*(1-p[20])+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*p[27] 
pr[8] <- p[1]*(1-p[2])*p[5]*p[10]*p[20]+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*(1-p[27]) 
pr[9] <- p[1]*p[2]*(1-p[4])*(1-p[9])*(1-p[19])+(1-p[1])*(1-p[3])*p[7]*p[14]*p[28] 
pr[10]<- p[1]*p[2]*(1-p[4])*(1-p[9])*p[19]+(1-p[1])*(1-p[3])*p[7]*p[14]*(1-p[28]) 
pr[11]<- p[1]*p[2]*(1-p[4])*p[9]*(1-p[18])+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*p[29] 
pr[12]<- p[1]*p[2]*(1-p[4])*p[9]*p[18]+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*(1-p[29]) 
pr[13]<- p[1]*p[2]*p[4]*(1-p[8])*(1-p[17])+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*p[30] 
pr[14]<- p[1]*p[2]*p[4]*(1-p[8])*p[17]+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*(1-p[30]) 
pr[15]<- p[1]*p[2]*p[4]*p[8]*(1-p[16])+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*p[31] 
pr[16]<- p[1]*p[2]*p[4]*p[8]*p[16]+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*(1-p[31]) 
   
for( i in 1:16) { 
d[i] <- r[i]*log(max(r[i],1)/(pr[i]*n)) 
  } 
G0 <- 2* sum(d[]) 
   
r2[1:16] ~ dmulti(pr[1:16], n) 
 
for( i in 1:16) { 
d2[i] <- r2[i]*log(max(r2[i],1)/(pr[i]*n)) 
  } 
Gt <- 2* sum(d2[]) 
bayesp <- step(Gt - G0) 
  
p[1]  ~ dbeta(1,1)I(0,0.5) 
p[2]  ~ dbeta(1,1) 
p[3]  ~ dbeta(1,1) 
p[4]  ~ dbeta(1,1) 
p[5]  ~ dbeta(1,1) 
p[6]  ~ dbeta(1,1) 
p[7]  ~ dbeta(1,1) 
p[8]  ~ dbeta(1,1) 
p[9]  ~ dbeta(1,1) 
p[10] ~ dbeta(1,1) 
p[11] ~ dbeta(1,1) 
p[12] ~ dbeta(1,1) 
p[13]  ~ dbeta(1,1) 
p[14]  ~ dbeta(1,1) 
p[15]  ~ dbeta(1,1) 
p[16] ~ dbeta(1,1) 
p[17] ~ dbeta(1,1) 
p[18] ~ dbeta(1,1) 
p[19] ~ dbeta(1,1) 
p[20] ~ dbeta(1,1) 
p[21] ~ dbeta(1,1) 
p[22] ~ dbeta(1,1) 
p[23] ~ dbeta(1,1) 
p[24] ~ dbeta(1,1) 
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p[25] ~ dbeta(1,1) 
p[26]  ~ dbeta(1,1) 
p[27]  ~ dbeta(1,1) 
p[28]  ~ dbeta(1,1) 
p[29]  ~ dbeta(1,1) 
p[30]  ~ dbeta(1,1) 
p[31]  ~ dbeta(1,1) 
 
} 
list(r=c(#neg,#pos), n = 000) 
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2.4.4 Appendix D: Six test Bayesian model 
model 
{ 
r[1:64] ~ dmulti(Pr[1:64], n) 
 
Pr[1] <-p[1]*p[2]*p[4]*p[8]*p[16]*p[32]*p[64]+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*(1-p[31])*(1-p[63])*(1-p[127]) 
Pr[2] <-p[1]*p[2]*p[4]*p[8]*p[16]*p[32]*(1-p[64])+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*(1-p[31])*(1-p[63])*p[127] 
Pr[3] <-p[1]*p[2]*p[4]*p[8]*p[16]*(1-p[32])*p[65]+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*(1-p[31])*p[63]*(1-p[126]) 
Pr[4] <-p[1]*p[2]*p[4]*p[8]*p[16]*(1-p[32])*(1-p[65])+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*(1-p[31])*p[63]*p[126] 
Pr[5] <-p[1]*p[2]*p[4]*p[8]*(1-p[16])*p[33]*p[66]+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*p[31]*(1-p[62])*(1-p[125]) 
Pr[6] <-p[1]*p[2]*p[4]*p[8]*(1-p[16])*p[33]*(1-p[66])+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*p[31]*(1-p[62])*p[125] 
Pr[7] <-p[1]*p[2]*p[4]*p[8]*(1-p[16])*(1-p[33])*p[67]+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*p[31]*p[62]*(1-p[124]) 
Pr[8] <-p[1]*p[2]*p[4]*p[8]*(1-p[16])*(1-p[33])*(1-p[67])+(1-p[1])*(1-p[3])*(1-p[7])*(1-p[15])*p[31]*p[62]*p[124] 
Pr[9] <-p[1]*p[2]*p[4]*(1-p[8])*p[17]*p[35]*p[68]+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*(1-p[30])*(1-p[61])*(1-p[123]) 
Pr[10]<-p[1]*p[2]*p[4]*(1-p[8])*p[17]*p[35]*(1-p[68])+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*(1-p[30])*(1-p[61])*p[123] 
Pr[11]<-p[1]*p[2]*p[4]*(1-p[8])*p[17]*(1-p[35])*p[69]+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*(1-p[30])*p[61]*(1-p[122]) 
Pr[12]<-p[1]*p[2]*p[4]*(1-p[8])*p[17]*(1-p[35])*(1-p[69])+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*(1-p[30])*p[61]*p[122] 
Pr[13]<-p[1]*p[2]*p[4]*(1-p[8])*(1-p[17])*p[36]*p[70]+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*p[30]*(1-p[60])*(1-p[121]) 
Pr[14]<-p[1]*p[2]*p[4]*(1-p[8])*(1-p[17])*p[36]*(1-p[70])+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*p[30]*(1-p[60])*p[121] 
Pr[15]<-p[1]*p[2]*p[4]*(1-p[8])*(1-p[17])*(1-p[36])*p[71]+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*p[30]*p[60]*(1-p[120]) 
Pr[16]<-p[1]*p[2]*p[4]*(1-p[8])*(1-p[17])*(1-p[36])*(1-p[71])+(1-p[1])*(1-p[3])*(1-p[7])*p[15]*p[30]*p[60]*p[120] 
Pr[17]<-p[1]*p[2]*(1-p[4])*p[9]*p[18]*p[36]*p[72]+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*(1-p[29])*(1-p[59])*(1-p[119]) 
Pr[18]<-p[1]*p[2]*(1-p[4])*p[9]*p[18]*p[36]*(1-p[72])+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*(1-p[29])*(1-p[59])*p[119] 
Pr[19]<-p[1]*p[2]*(1-p[4])*p[9]*p[18]*(1-p[36])*p[73]+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*(1-p[29])*p[59]*(1-p[118]) 
Pr[20]<-p[1]*p[2]*(1-p[4])*p[9]*p[18]*(1-p[36])*(1-p[73])+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*(1-p[29])*p[59]*p[118] 
Pr[21]<-p[1]*p[2]*(1-p[4])*p[9]*(1-p[18])*p[37]*p[74]+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*p[29]*(1-p[58])*(1-p[117]) 
Pr[22]<-p[1]*p[2]*(1-p[4])*p[9]*(1-p[18])*p[37]*(1-p[74])+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*p[29]*(1-p[58])*p[117] 
Pr[23]<-p[1]*p[2]*(1-p[4])*p[9]*(1-p[18])*(1-p[37])*p[75]+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*p[29]*p[58]*(1-p[116]) 
Pr[24]<-p[1]*p[2]*(1-p[4])*p[9]*(1-p[18])*(1-p[37])*(1-p[75])+(1-p[1])*(1-p[3])*p[7]*(1-p[14])*p[29]*p[58]*p[116] 
Pr[25]<-p[1]*p[2]*(1-p[4])*(1-p[9])*p[19]*p[38]*p[76]+(1-p[1])*(1-p[3])*p[7]*p[14]*(1-p[28])*(1-p[57])*(1-p[115]) 
Pr[26]<-p[1]*p[2]*(1-p[4])*(1-p[9])*p[19]*p[38]*(1-p[76])+(1-p[1])*(1-p[3])*p[7]*p[14]*(1-p[28])*(1-p[57])*p[115] 
Pr[27]<-p[1]*p[2]*(1-p[4])*(1-p[9])*p[19]*(1-p[38])*p[77]+(1-p[1])*(1-p[3])*p[7]*p[14]*(1-p[28])*p[57]*(1-p[114]) 
Pr[28]<-p[1]*p[2]*(1-p[4])*(1-p[9])*p[19]*(1-p[38])*(1-p[77])+(1-p[1])*(1-p[3])*p[7]*p[14]*(1-p[28])*p[57]*p[114] 
Pr[29]<-p[1]*p[2]*(1-p[4])*(1-p[9])*(1-p[19])*p[39]*p[78]+(1-p[1])*(1-p[3])*p[7]*p[14]*p[28]*(1-p[56])*(1-p[113]) 
Pr[30]<-p[1]*p[2]*(1-p[4])*(1-p[9])*(1-p[19])*p[39]*(1-p[78])+(1-p[1])*(1-p[3])*p[7]*p[14]*p[28]*(1-p[56])*p[113] 
Pr[31]<-p[1]*p[2]*(1-p[4])*(1-p[9])*(1-p[19])*(1-p[39])*p[79]+(1-p[1])*(1-p[3])*p[7]*p[14]*p[28]*p[56]*(1-p[112]) 
Pr[32]<-p[1]*p[2]*(1-p[4])*(1-p[9])*(1-p[19])*(1-p[39])*(1-p[79])+(1-p[1])*(1-p[3])*p[7]*p[14]*p[28]*p[56]*p[112] 
Pr[33]<-p[1]*(1-p[2])*p[5]*p[10]*p[20]*p[40]*p[80]+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*(1-p[27])*(1-p[55])*(1-p[111]) 
Pr[34]<-p[1]*(1-p[2])*p[5]*p[10]*p[20]*p[40]*(1-p[80])+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*(1-p[27])*(1-p[55])*p[111] 
Pr[35]<-p[1]*(1-p[2])*p[5]*p[10]*p[20]*(1-p[40])*p[81]+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*(1-p[27])*p[55]*(1-p[110]) 
Pr[36]<-p[1]*(1-p[2])*p[5]*p[10]*p[20]*(1-p[40])*(1-p[81])+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*(1-p[27])*p[55]*p[110] 
Pr[37]<-p[1]*(1-p[2])*p[5]*p[10]*(1-p[20])*p[41]*p[82]+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*p[27]*(1-p[54])*(1-p[109]) 
Pr[38]<-p[1]*(1-p[2])*p[5]*p[10]*(1-p[20])*p[41]*(1-p[82])+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*p[27]*(1-p[54])*p[109] 
Pr[39]<-p[1]*(1-p[2])*p[5]*p[10]*(1-p[20])*(1-p[41])*p[83]+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*p[27]*p[54]*(1-p[108]) 
Pr[40]<-p[1]*(1-p[2])*p[5]*p[10]*(1-p[20])*(1-p[41])*(1-p[83])+(1-p[1])*p[3]*(1-p[6])*(1-p[13])*p[27]*p[54]*p[108] 
Pr[41]<-p[1]*(1-p[2])*p[5]*(1-p[10])*p[21]*p[42]*p[84]+(1-p[1])*p[3]*(1-p[6])*p[13]*(1-p[26])*(1-p[53])*(1-p[107]) 
Pr[42]<-p[1]*(1-p[2])*p[5]*(1-p[10])*p[21]*p[42]*(1-p[84])+(1-p[1])*p[3]*(1-p[6])*p[13]*(1-p[26])*(1-p[53])*p[107] 
Pr[43]<-p[1]*(1-p[2])*p[5]*(1-p[10])*p[21]*(1-p[42])*p[85]+(1-p[1])*p[3]*(1-p[6])*p[13]*(1-p[26])*p[53]*(1-p[106]) 
Pr[44]<-p[1]*(1-p[2])*p[5]*(1-p[10])*p[21]*(1-p[42])*(1-p[85])+(1-p[1])*p[3]*(1-p[6])*p[13]*(1-p[26])*p[53]*p[106] 
Pr[45]<-p[1]*(1-p[2])*p[5]*(1-p[10])*(1-p[21])*p[43]*p[86]+(1-p[1])*p[3]*(1-p[6])*p[13]*p[26]*(1-p[52])*(1-p[105]) 
Pr[46]<-p[1]*(1-p[2])*p[5]*(1-p[10])*(1-p[21])*p[43]*(1-p[86])+(1-p[1])*p[3]*(1-p[6])*p[13]*p[26]*(1-p[52])*p[105] 
Pr[47]<-p[1]*(1-p[2])*p[5]*(1-p[10])*(1-p[21])*(1-p[43])*p[87]+(1-p[1])*p[3]*(1-p[6])*p[13]*p[26]*p[52]*(1-p[104]) 
Pr[48]<-p[1]*(1-p[2])*p[5]*(1-p[10])*(1-p[21])*(1-p[43])*(1-p[87])+(1-p[1])*p[3]*(1-p[6])*p[13]*p[26]*p[52]*p[104] 
Pr[49]<-p[1]*(1-p[2])*(1-p[5])*p[11]*p[22]*p[44]*p[88]+(1-p[1])*p[3]*p[6]*(1-p[12])*(1-p[25])*(1-p[51])*(1-p[103]) 
Pr[50]<-p[1]*(1-p[2])*(1-p[5])*p[11]*p[22]*p[44]*(1-p[88])+(1-p[1])*p[3]*p[6]*(1-p[12])*(1-p[25])*(1-p[51])*p[103] 
Pr[51]<-p[1]*(1-p[2])*(1-p[5])*p[11]*p[22]*(1-p[44])*p[89]+(1-p[1])*p[3]*p[6]*(1-p[12])*(1-p[25])*p[51]*(1-p[102]) 
Pr[52]<-p[1]*(1-p[2])*(1-p[5])*p[11]*p[22]*(1-p[44])*(1-p[89])+(1-p[1])*p[3]*p[6]*(1-p[12])*(1-p[25])*p[51]*p[102] 
Pr[53]<-p[1]*(1-p[2])*(1-p[5])*p[11]*(1-p[22])*p[45]*p[90]+(1-p[1])*p[3]*p[6]*(1-p[12])*p[25]*(1-p[50])*(1-p[101]) 
Pr[54]<-p[1]*(1-p[2])*(1-p[5])*p[11]*(1-p[22])*p[45]*(1-p[90])+(1-p[1])*p[3]*p[6]*(1-p[12])*p[25]*(1-p[50])*p[101] 
Pr[55]<-p[1]*(1-p[2])*(1-p[5])*p[11]*(1-p[22])*(1-p[45])*p[91]+(1-p[1])*p[3]*p[6]*(1-p[12])*p[25]*p[50]*(1-p[100]) 
Pr[56]<-p[1]*(1-p[2])*(1-p[5])*p[11]*(1-p[22])*(1-p[45])*(1-p[91])+(1-p[1])*p[3]*p[6]*(1-p[12])*p[25]*p[50]*p[100] 
Pr[57]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])*p[23]*p[46]*p[92]+(1-p[1])*p[3]*p[6]*p[12]*(1-p[24])*(1-p[49])*(1-p[99]) 
Pr[58]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])*p[23]*p[46]*(1-p[92])+(1-p[1])*p[3]*p[6]*p[12]*(1-p[24])*(1-p[49])*p[99] 
Pr[59]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])*p[23]*(1-p[46])*p[93]+(1-p[1])*p[3]*p[6]*p[12]*(1-p[24])*p[49]*(1-p[98]) 
Pr[60]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])*p[23]*(1-p[46])*(1-p[93])+(1-p[1])*p[3]*p[6]*p[12]*(1-p[24])*p[49]*p[98] 
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Pr[61]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])*(1-p[23])*p[47]*p[94]+(1-p[1])*p[3]*p[6]*p[12]*p[24]*(1-p[48])*(1-p[97]) 
Pr[62]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])*(1-p[23])*p[47]*(1-p[94])+(1-p[1])*p[3]*p[6]*p[12]*p[24]*(1-p[48])*p[97] 
Pr[63]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])*(1-p[23])*(1-p[47])*p[95]+(1-p[1])*p[3]*p[6]*p[12]*p[24]*p[48]*(1-p[96]) 
Pr[64]<-p[1]*(1-p[2])*(1-p[5])*(1-p[11])*(1-p[23])*(1-p[47])*(1-p[95])+(1-p[1])*p[3]*p[6]*p[12]*p[24]*p[48]*p[96] 
 
for (i in 1:64) 
{ 
 d[i] <- r[i]*log(max(r[i],1)/(Pr[i]*n)) 
} 
G0 <- 2* sum(d[]) 
 
r2[1:64] ~ dmulti(Pr[1:64],n) 
for (i in 1:64) 
{ 
 d2[i] <- r2[i]*log(max(r2[i],1)/(Pr[i]*n)) 
} 
Gt <- 2* sum(d2[]) 
bayesp <- step(G0 - Gt) 
 
p[1] ~ dbeta(1,1) 
... 
p[127] ~ dbeta(1,1) 
 
se[1] <- p[2] 
sp[1] <- p[3] 
 
se[2] <- p[2]*p[4]+(1-p[2])*p[5] 
sp[2] <- p[3]*p[6]+(1-p[3])*p[7] 
 
se[3] <- p[2]*(p[4]*p[8]+(1-p[4])*p[9])+(1-p[2])*(p[5]*p[10]+(1-p[5])*p[11]) 
sp[3] <- p[3]*(p[6]*p[12]+(1-p[6])*p[13])+(1-p[3])*(p[7]*p[14]+(1-p[7])*p[15]) 
 
se[4] <- p[2]*(p[4]*(p[8]*p[16]+(1-p[8])*p[17])+(1-p[4])*(p[9]*p[18]+(1-p[9])*p[19])) 
+(1-p[2])*(p[5]*(p[10]*p[20]+(1-p[10])*p[21])+(1-p[5])*(p[11]*p[22]+(1-p[11])*p[23])) 
sp[4] <- p[3]*(p[6]*(p[12]*p[24]+(1-p[12])*p[25])+(1-p[6])*(p[13]*p[26]+(1-p[13])*p[27])) 
+(1-p[3])*(p[7]*(p[14]*p[28]+(1-p[14])*p[29])+(1-p[7])*(p[15]*p[30]+(1-p[15])*p[31])) 
 
se[5] <- p[2]*(p[4]*(p[8]*(p[16]*p[32]+(1-p[16])*p[33])+(1-p[8])*(p[17]*p[34]+(1-p[17])*p[35])) 
+(1-p[4])*(p[9]*(p[18]*p[36]+(1-p[18])*p[37])+(1-p[9])*(p[19]*p[38]+(1-p[19])*p[39]))) 
+(1-p[2])*(p[5]*(p[10]*(p[20]*p[40]+(1-p[20])*p[41])+(1-p[10])*(p[21]*p[42]+(1-p[21])*p[43])) 
+(1-p[5])*(p[11]*(p[22]*p[44]+(1-p[22])*p[45])+(1-p[11])*(p[23]*p[46]+(1-p[23])*p[47])))  
 
sp[5] <- p[3]*(p[6]*(p[12]*(p[24]*p[48]+(1-p[24])*p[49])+(1-p[12])*(p[25]*p[50]+(1-p[25])*p[51])) 
+(1-p[6])*(p[13]*(p[26]*p[52]+(1-p[26])*p[53])+(1-p[13])*(p[27]*p[54]+(1-p[27])*p[55]))) 
+(1-p[3])*(p[7]*(p[14]*(p[28]*p[56]+(1-p[28])*p[57])+(1-p[14])*(p[29]*p[58]+(1-p[29])*p[59])) 
+(1-p[7])*(p[15]*(p[30]*p[60]+(1-p[30])*p[61])+(1-p[15])*(p[31]*p[62]+(1-p[31])*p[63])))  
 
 
se[6]<- p[2]*(p[4]*(p[8]*(p[16]*(p[32]*p[64]+(1-p[32])*p[65])+(1-p[16])*(p[33]*p[66]+(1-p[33])*p[67])) 
+(1-p[8])*(p[17]*(p[34]*p[68]+(1-p[34])*p[69])+(1-p[17])*(p[35]*p[70]+(1-p[35])*p[71]))) 
+(1-p[4])*(p[9]*(p[18]*(p[36]*p[72]+(1-p[36])*p[73])+(1-p[18])*(p[37]*p[74]+(1-p[37])*p[75])) 
+(1-p[9])*(p[19]*(p[38]*p[76]+(1-p[38])*p[77])+(1-p[19])*(p[39]*p[78]+(1-p[39])*p[79])))) 
+(1-p[2])* (p[5]*(p[10]*(p[20]*(p[40]*p[80]+(1-p[40])*p[81])+(1-p[20])*(p[41]*p[82]+ 
(1-p[41])*p[83]))+(1-p[10])*(p[21]*(p[42]*p[84]+(1-p[42])*p[85])+(1-p[21])*(p[43]*p[86]+(1-
p[43])*p[87]))) 
+(1-p[5])*(p[11]*(p[22]*(p[44]*p[88]+(1-p[44])*p[89])+(1-p[22])*(p[45]*p[90]+(1-p[45])*p[91])) 
+(1-p[11])*(p[23]*(p[46]*p[92]+(1-p[46])*p[93])+(1-p[23])*(p[47]*p[94]+(1-p[47])*p[95])))) 
 
 
sp[6] <- p[3]*(p[6]*(p[12]*(p[24]*(p[48]*p[96]+(1-p[48])*p[97])+(1-p[24])*(p[49]*p[98]+(1-p[49])*p[99])) 
+(1-p[12])*(p[25]*(p[50]*p[100]+(1-p[50])*p[101]) +(1-p[25])*(p[51]*p[102]+(1-p[51])*p[102]))) 
+(1-p[6])*(p[13]*(p[26]*(p[52]*p[104]+(1-p[52])*p[105])+(1-p[26])*(p[53]*p[106]+(1-p[53])*p[107]))  
+(1-p[13])*(p[27]*(p[54]*p[108]+(1-p[54])*p[109])+(1-p[27])*(p[55]*p[110]+(1-p[55])*p[111])))) 
+(1-p[3])*(p[7]*(p[14]*(p[28]*(p[56]*p[112]+(1-p[56])*p[113])+(1-p[28])*(p[57]*p[114]+(1-
p[57])*p[115])) 
+(1-p[14])*(p[29]*(p[58]*p[116]+(1-p[58])*p[117])+(1-p[29])*(p[59]*p[118]+(1-p[59])*p[119]))) 
+(1-p[7])*(p[15]*(p[30]*(p[60]*p[120]+(1-p[60])*p[121])+(1-p[30])*(p[61]*p[122]+(1-p[61])*p[123])) 
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+(1-p[15])*(p[31]*(p[62]*p[124]+(1-p[62])*p[125])+(1-p[31])*(p[63]*p[126]+(1-p[63])*p[127])))) 
 
} 
 
list(r= c(#neg,#pos), n = 000) 
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3.1.1 Introduction 
Several Cryptosporidium species and genotypes have been described in cattle: apart 
from the ubiquitous and zoonotic C. parvum, the ruminant specific species C. bovis 
and C. andersoni, and the Cryptosporidium cervine genotype are reported on a regular 
basis in cattle (Caccio et al., 2005; Fayer et al., 2006a). Occasionally C. suis (Fayer et 
al., 2006b), C. felis (Bornay-Llinares et al., 1999), C. canis (Fayer et al., 2001) and C. 
hominis (Smith et al., 2005) are diagnosed, but the contribution of the latter species to 
the development of clinical symptoms in cattle is probably limited. Since C. parvum 
is most prevalent and clinical cryptosporidiosis mainly occurs in calves younger than 
1 month, C. parvum is believed to be the most pathogenic species in calves, although 
comparative studies with related species have not yet been conducted. Human 
cryptosporidiosis can be due to infections with either the human specific C. hominis 
or the zoonotic C. parvum, and in a more limited number of cases with C. 
meleagridis, which is also zoonotic (Pedraza-Diaz et al., 2001). Probably due to the 
more intensified contact between human activity and livestock industry, C. parvum is 
the main cause (57% on average) of human cryptosporidiosis in Europe, while in 
America, Africa and Australia C. hominis is most prevalent (62% on average) (Caccio 
et al., 2005). At least part of the human C. parvum infections can be ascribed to 
contact with livestock, either direct or indirectly through contaminated water or food. 
However, the identification of C. parvum in human stool samples does not 
conclusively implicate farm animals as a source of infection. Subgenotype analysis at 
the 60kDa glycoprotein locus (gp60) (Peng et al., 2001; Alves et al., 2003; Sulaiman 
et al., 2005; Trotz-Williams et al., 2006) and multilocus microsatellite genotyping 
(Caccio et al., 2000; Mallon et al., 2003), revealed both human specific and zoonotic 
subgenotypes within C. parvum. In most waterborne outbreaks, including the large 
Milwaukee outbreak in 1993, human sources of infection were identified (Peng et al., 
1997). Only in one Canadian waterborne outbreak could livestock be conclusively 
identified as the source of infection (Fayer et al., 2000). Most of the isolates included 
in molecular characterisation studies are obtained from outbreaks. In sporadic cases of 
cryptosporidiosis the source of infection is often hard to trace, yet direct contact with 
infected livestock has repeatedly been associated with infection (Hunter and 
Thompson, 2005). Since the majority of human cryptosporidial infections are sporadic 
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cases (Feltus et al., 2006), the relevance of zoonotic transmission might be 
underestimated based on the data obtained from outbreaks.  
The objective of the present study was to identify the Cryptosporidium species in 
dairy and beef calves in East Flanders, Belgium. Furthermore, samples from clinically 
affected calves were included to study the association between diarrhea and species or 
genotype. By subgenotyping of the C. parvum positive samples the potential of calves 
as a zoonotic reservoir for human infection was investigated. 
 
3.1.2 Materials and methods 
In order to have a representative view of the different Cryptosporidium species and 
subgenotypes in the calf population of East Flanders, Cryptosporidium positive 
isolates from dairy and beef calves from a cross-sectional epidemiological study 
(chapter 2) were selected for genotyping. Furthermore, samples from calves younger 
than 6 weeks with clinical cryptosporidiosis, sent to the diagnostic laboratory by 
practicing veterinarians, were withheld. DNA was extracted using the QIAamp 
Stool Mini Kit (Qiagen) according to the manufacturer’s instructions, although an 
initial step of 3 freeze-thaw cycles (freezing in liquid nitrogen for 5 minutes and 
heating at 95˚C for 5 minutes) was incorporated in the protocol to maximise oocyst 
lesion. The eluted DNA was dissolved in 15 μl ultra-pure water.  
 
The primers used in the present study are presented in table 3.1. For the amplification 
of the Cryptosporidium 70 kDa heat shock protein (HSP-70) gene the primer pair 
HSP-F4 and HSP-R4 was used in the primary PCR, and HSP-F3 and HSP-R3 in the 
nested reaction. The PCR protocol was performed as previously described (Morgan et 
al., 2001). For the Cryptosporidium 18S ribosomal DNA gene (18S rDNA) the primer 
pair 18SiCF2 and 18SiCR2 was used in the primary reaction, and 18SiCF1 and 
18SiCR1 in the nested PCR reaction. Reactions were performed as described by Ryan 
et al. (2003). For the subgenotyping of C. parvum positive samples, the 60kDa 
glycoprotein (gp60) was targeted, using the primers AL 3531 and AL 3534 for the 
primary and AL 3532 and AL 3533 for the nested PCR. The reaction was performed 
as described by Peng et al. (2001). In all the above-mentioned reactions bovine serum 
albumin (BSA) was added to a final concentration of 0.1μg BSA/μl reaction mixture. 
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Table 3.1: Primers used for the molecular characteristation of Cryptosporidium isolates. 
Forward (5-3) Reverse (5-3) 
HSP-F4 (GGT GGT GGT ACT TTT GAT GTA TC) HSP-R4 (GCC TGA ACC TTT GGA ATA CG) 
HSP-F3 (GCT GST GAT ACT CAC TTG GGT GG) HSP-R3 (CTC TTG TCC ATA CCA GCA TCC) 
18SiCF2 (GAC ATA TCA TTC AAG TTT CTG ACC) 18SiCR2 (CTG AAG GAG TAA GGA ACA ACC) 
18SiCF1 (CCT ATC AGC TTT AGA CGG TAG G) 18SiCR1 (TCT AAG AAT TTC ACC TCT GAC TG) 
AL 3531 (ATA GTC TCC GCT GTA TCC) AL 3534 (GCA GAG GAA CCA GCA TC) 
AL 3532 (TCC GCT GTA TTC TCA GCC) AL 3533 (GAG ATA TAT CTT GGT GCG) 
  
Amplification products were visualized on 1.5 % agarose gels with ethidium bromide. 
A positive (Plasmid DNA) and negative (PCR water) control sample was included in 
each PCR reaction. PCR products were purified using the Qiaquick purification kit 
(Qiagen) and fully sequenced using the Big Dye Terminator V3.1 Cycle sequencing 
Kit (Applied Biosystems). Sequencing reactions were analysed on a 3100 Genetic 
Analyzer (Applied Biosystems) and assembled with Seqman II (DNASTAR, Madison 
WI, USA).  
 
Figure 3.1: Subgenotyping within Cryptosporidium parvum allele IIa based on the number of TCA (A), 
TCG (G) or rare (R) repeats in the 60kDa glycoprotein sequence 
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  51  G G C T C A T C A T C G T C A T C G T C A T C G T C -   -   -  -  - - A T C A T C A T C A T C A T C A T C  IIaA18G3R1
  51  G G C T C A T C A T C G T C A T C  -  -  -   -  -  -   -  -  -  -   -  -  -  -  -  -   -  - G T C A T C A T C A T C A T C  IIaA15G2R1
  51  G G C T C A T C A T C G T C A T C G T C A T C  -  -  -  -   -  -  -  -  -  -   -  - A T C A T C A T C A T C A T C  IIaA15G2R2
  51  G G C T C A T C A T C G T C A T C  -  -  -  -   -  -  -  -  -  -   -  -  -  -  -  -   -   - A T C A T C A T C A T C A T C  IIaA16G1R1
  51  G G C T C A T C A T C G T C A T C G T C -   -  -  -  -  -  -   -  -  -  -  -  -   -   - A T C A T C A T C A T C A T C  IIaA16G2R1
  51  G G C T C A T C A T C G T C A T C G T C A T C -  -  -  -   -   -  -  -  -  -  -   - G T C A T C A T C A T C A T C  IIaA16G3R1
  51  G G C T C A T C A T C G T C A T C G T C A T C -   -  -  -   -   -  -  -  -  -  -   - A T C A T C A T C A T C A T C  IIaA17G2R1
   3   G G C T C A T C A T C G T C A T C G T C A T C A T C  -  -   -  -   -  - A T C A T C A T C A T C A T C A T C  IIaA17G2R2
   7   G G C T C A T C A T C G T C A T C G T C A T C G T C A T C G T C A T C A T C A T C A T C A T C A T C  IIaA17G4R2
 13   G G C T C A T C A T C G T C A T C G T C A T C -   -  -  -  -   -  -  -   -  A T C A T C A T C A T C A T C A T C  IIaA18G2R1
                                     110                            120                             130                              140                             150
 95  A T C A T C A T C A T C A T C A T C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA18G3R1
 83  A T C A T C A T C A T C A T C A T C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA15G2R1
 89  A T C A T C A T C A T C A T C A A C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA15G2R2
 83  A T C A T C A T C A T C A T C A T C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA16G1R1
 86  A T C A T C A T C A T C A T C A T C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA16G2R1
 89  A T C A T C A T C A T C A T C A T C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA16G3R1
 89  A T C A T C A T C A T C A T C A T C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA17G2R1
 47  A T C A T C A T C A T C A T C A A C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA17G2R2
 57  A T C A T C A T C A T C A T C A A C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA17G4R2
 54  A T C A T C A T C A T C A T C A T C A T C A A C A T C A A C C G T C G C A C C A G C A A A T A A G G  IIaA18G2R1
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Sequences were compared with known sequences by blasting against the NCBI 
databank. Furthermore, phylogenetic analysis was performed on more conserved 
positions of the nucleotide alignment created with Muscle (Edgar, 2004). Editing of 
the alignment was performed with BioEdit (Hall, 1999). Distance matrices were 
calculated based on Poisson correction and trees were constructed with the neighbor-
joining algorithm using the software packages TREECON (Van de Peer and De 
Wachter, 1994). Bootstrap analysis with 100 replicates was performed to test the 
significance of nodes. The nomenclature of the gp60 subgenotyping within allele IIa 
was based on the number of TCA (A), TCG (G) or rare (R) repeats (figure 3.1) within 
the amplified region containing the mini or microsatellite motifs (Chalmers et al., 
2005) 
The age of the C. parvum and the C. bovis positive calves was compared with a two-
way Mann-Withney U test. Probability (P) values <0.05 were considered to indicate a 
significant difference. 
 
3.1.3 Results 
The number of samples and the results of the molecular characterisation are presented 
in Table 3.2. At least one isolate from the 32 Cryptosporidium positive dairy farms 
was included. Isolates from 9 of the 12 positive beef farms were included, since no 
amplification product could be obtained from isolates of the three remaining farms. 
Both in beef and in dairy farms C. parvum was predominantly identified, next to the 
cattle specific C. bovis. In the samples from the calves with clinical cryptosporidiosis 
only C. parvum was identified. In all C. parvum positive samples the subgenotype IIa 
(IIaA13G2R1 (n=1), IIaA14G2R1 (n=1), IIaA15G2R1 (n=81), IIaA16G2R1 (n=3)) 
was identified, except in one sample from a clinically affected calf, with the IId 
subgenotype (IIdA22G1). All but one of the calves infected with C. bovis were older 
than 4 weeks and the average age of the C. bovis positive calves was higher (P<0.001) 
than the age of the C. parvum positive calves. In one beef calf, the porcine specific C. 
suis was identified.  
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Table 3.2: Results of the molecular characterisation for Cryptosporidium in the dairy, beef, clinically 
affected calves and overall, with the age and age range (in days) for each species (n=total number of 
samples; HSP-70=70kDa Heat shock Protein; 18S=18S ribosomal DNA; gp60=60kDa glycoprotein; 
NA=No Amplification; nd=not done) 
 
  n   HSP 70 18S GP60 age (range) 
Dairy 73 C. parvum 67 67 53 IIa 24.8 (3-68) 
  C. bovis 6 6 nd 53.8 (22-69) 
    NA 0 0 14   
Beef 11 C. parvum 7 6 5 IIa 18.4 (3-46) 
  C. bovis 2 3 nd 51.3 (36-70) 
  C. suis 1 1 nd 27 
    NA 1 1 2   
Clinical 31 C. parvum 31 31 28 IIa+ 1 IId <42 
    NA 0 0 2   
Overall 115 C. parvum 105 104 86 IIa +1IId   
  C. bovis 8 9 nd  
  C. suis 1 1 nd  
    NA 1 1 18   
 
 
3.1.4 Discussion 
Although human sources of infection are most often implicated in waterborne 
Cryptosporidium outbreaks, livestock and in particular young calves have to be 
considered as a potential source of human cryptosporidiosis, in outbreak related 
(Fayer et al., 2000) and in sporadic cases (Goh et al., 2004; Feltus et al., 2006). Since 
not all Cryptosporidium species in cattle have zoonotic potential, molecular 
identification should be included in epidemiological studies to further elucidate the 
relevance of cattle in the epidemiology of human cryptosporidiosis (Traub et al., 
2005). However, only a limited number of studies did combine prevalence estimation 
and molecular identification, both in the United States (Santin et al., 2004; Fayer et 
al., 2006a) and in Australia (Becher et al., 2004). In other studies molecular 
characterisation was performed on a limited (Hajdusek et al., 2004) or large number 
(McLauchlin et al., 2000; Peng et al., 2003) of Cryptosporidium isolates from calves, 
but not within the framework of a cross-sectional epidemiological study, which might 
lead to a selection bias towards clinical samples. The samples in the present study 
were collected within a cross-sectional epidemiological framework. 
The guidelines proposed by Caccio et al. (2005) were taken into account, emphasizing 
that the genetic characterisation of Cryptosporidium isolates should be based on 2 
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genetic loci, of which at least one is the conserved 18S rDNA gene. For further 
subgenotyping the gp60 locus was targeted. The genotyping results of the HSP-70 and 
18S rDNA gene concurred in all but two samples, in which one of the two genes did 
not amplify. The majority of the Cryptosporidium positive samples from the dairy and 
beef calves was identified as C. parvum. Since the calves included in the 
epidemiological study were all youger than 70 days, the current results are in 
accordance with previous findings that C. parvum is the most prevalent species in pre-
weaned calves (Santin et al., 2004). The 70-days age limit also accounts for the 
limited number of C. bovis infections, and for the absence of C. andersoni or the 
Cryptosporidium cervine genotype in the present study. All but one of the C. bovis 
infections were identified in calves older than 1 month, confirming that C. bovis is 
more prevalent in older calves compared to neonatal calves (Santin et al., 2004). In 1 
beef calf C. suis was found, indicating a rather erratic parasitism of this 
Cryptosporidium species in cattle (Fayer et al., 2006b). In the clinically affected 
calves which were all under 6 weeks of age, solely C. parvum was identified, 
confirming that neonatal cryptosporidial diarrhea in calves is primarily caused by C. 
parvum (de Graaf et al., 1999; Santin et al., 2004).  
Unlike previous reports (Tanriverdi et al., 2003; Santin et al., 2004), no mixed 
infections were found in the present study. The lack of mixed infections could be 
attributed to the exponential nature of PCR and the tendency of C. parvum to outgrow 
other Cryptosporidium species. To detect small Cryptosporidium subpopulations, a 
species-specific multiplex PCR or real-time PCR assay is preferred (Tanriverdi et al., 
2003). 
Of the Cryptosporidium species commonly found in calves, only C. parvum is known 
to infect human patients. Within C. parvum anthroponotic and zoonotic subgenotypes 
have been described. The molecular analysis on the gp60 gene identified all but one 
of the C. parvum positive calf isolates as the zoonotic IIa allele, with predominantly 
subtype IIaA15G2R1. This allele subtype has previously been reported as most 
prevalent in calves in Portugal (Alves et al., 2006), in the UK (Chalmers et al., 2005), 
and in Northern America (Peng et al., 2003; Trotz-Williams et al., 2006; Xiao et al., 
2007). Furthermore, this subtype is known to frequently infect human patients 
(Chalmers et al., 2005; Sulaiman et al., 2005; Feltus et al., 2006), indicating the 
zoonotic reservoir function for these calves. In total, 4 different allele IIa subtypes 
have been identified in the present study. When the IIaA15G2R1 subtype is not found 
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other subtypes are more frequently identified (Trotz-Williams et al., 2006). The 
predominant occurrence of the IIaA15G2R1 subtype in humans raises some concerns 
about the selection of highly infectious strains by intensive animal husbandry systems 
(Xiao et al., 2007). The occurrence of subgenotype IId in calves is rare, but has 
previously been reported (Alves et al., 2003, 2006). As expected, the anthroponotic C. 
parvum allele IIc was not found in any of the calves. 
The present study therefore demonstrates a high prevalence of zoonotic C. parvum 
infections in calves in Belgium, and confirms that calves should be considered as a 
potential zoonotic reservoir for human infections.  
 
  
 
 
 
 
 
 
 
 
 
 
Chapter 3.2 
Molecular characterisation of Giardia in 
calves in Belgium 
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3.2.1 Introduction 
The livestock specific assemblage E is the most prevalent Giardia species in cattle. 
However, the zoonotic assemblage A has been reported in up to 20% of either pre-
weaned calves (O'Handley et al., 2000; Appelbee et al., 2003; Becher et al., 2004; 
Berrilli et al., 2004; Trout et al., 2004; Itagaki et al., 2005), post-weaned calves 
(Trout et al., 2005), or adult cattle (Trout et al., 2006; Uehlinger et al., 2006). 
Occassionally, assemblage B was identified in calves (van Keulen et al., 2002; Lalle 
et al., 2005). In human patients both assemblage A and B are commonly identified, 
with assemblage B as most prevalent (Amar et al., 2002; Read et al., 2002; Traub et 
al., 2004; van der Giessen et al., 2006). A species-specific pathogenicity has been 
observed in human patients (Homan and Mank, 2001; Read et al., 2002), but not in 
calves.  
Although little is known about the frequency of transmission between cattle and man, 
zoonotic infections either occur by direct contact or indirectly, by the ingestion of 
contaminated water or food (Caccio et al., 2005). Most studies seem to suggest that 
the public health risk from cattle is minimal, at least in Northern America and in 
Australia (Sulaiman et al., 2004; Caccio et al., 2005). Similar to Cryptosporidium, 
anthropozoonotic transmission is more likely to occur in endemic locations with 
closer contact between human and livestock sources of infection (Graczyk et al., 
2002; Uehlinger et al., 2006). Transmission from cattle to man may therefore be more 
frequent in North-Western Europe, given the intensified cattle industry and close 
contact between agricultural and human activity. Studies from Europe indeed indicate 
a high prevalence of the zoonotic assemblage A in cattle, although the available data 
are scarce and were not collected within an epidemiological study (Berrilli et al., 
2004; Lalle et al., 2005). Furthermore, the occurrence of mixed assemblage A/E 
infections in calves might be underestimated, since the exponential nature of PCR 
favours the amplification of the most abundant gene present in a sample. Due to the 
high frequency of transmission in calves, the host-specific assemblage E is likely to 
out-compete underlying assemblage A infections, as is described in dogs (Hopkins et 
al., 1997).  
Therefore, the different Giardia assemblages in calf samples collected in an 
epidemiological study in East Flanders (Belgium), were identified using the -giardin 
gene, as described by Caccio et al. (2005). A novel assemblage-specific PCR was 
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developed based on the triose phosphate isomerase (tpi) gene, to study the occurrence 
of mixed infections in calves. 
 
3.2.2 Materials and methods 
In order to have a representative view of the different Giardia species or assemblages 
in the calf population of East Flanders, Giardia positive isolates from dairy and beef 
calves from a cross-sectional epidemiological study (chapter 2) were selected for 
genotyping. Furthermore, samples from calves younger than 1 year with clinical 
giardiosis were collected on farms with a Giardia outbreak (chapter 4.2), or sent to 
the laboratory by veterinarians in practice. DNA was extracted using the QIAamp 
Stool Mini Kit (Qiagen) according to the manufacturer’s instructions, although an 
initial step of 3 freeze-thaw cycles (freezing in liquid nitrogen for 5 minutes and 
heating at 95˚C for 5 minutes) was incorporated in the protocol to maximise cyst 
lesion. The eluted DNA was dissolved in 15 μl ultra-pure water. 
 
Amplification of the -giardin gene 
For the amplification of the Giardia -giardin gene the primer pair G7 and G759 was 
used in the primary PCR reaction, and G7n and G759n in the nested PCR reaction 
(Table 3.3). The PCR protocol was performed as previously described (Lalle et al., 
2005), with BSA added to a final concentration of 0.1μg BSA/μl reaction mixture. 
Amplification products were subsequently visualized on 1.5 % agarose gels with 
ethidium bromide. A positive (Plasmid DNA) and negative (PCR water) control 
sample was included in each PCR reaction. PCR products were purified using the 
Qiaquick purification kit (Qiagen) and fully sequenced using the Big Dye 
Terminator V3.1 Cycle sequencing Kit (Applied Biosystems). Sequencing reactions 
were analysed on a 3100 Genetic Analyzer (Applied Biosystems) and assembled with 
Seqman II (DNASTAR, Madison WI, USA). Sequences were compared to previously 
published sequences by blasting against the NCBI databank. The subgenotype 
analysis was based on alignment by ClustalW and comparison to the substitutions 
described by Lalle et al. (2005). Furthermore, phylogenetic analysis was performed 
on more conserved positions of the nucleotide alignment created with Muscle (Edgar, 
2004). Editing of the alignment was performed with BioEdit (Hall, 1999). Distance 
matrices were calculated based on Poisson correction and trees were constructed with 
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the neighbor-joining algorithm using the software packages TREECON (Van de Peer 
and De Wachter, 1994). Bootstrap analysis with 100 replicates was performed to test 
the significance of nodes. 
 
Table 3.3: Primers used for the molecular characteristation of Giardia isolates. 
Forward (5-3) Reverse (5-3) 
 G7 (AAG CCC GAC CTC ACC CGC AGT GC) G759 (GAG GCC GCC CTG GAT CTT CGA GAC GAC) 
 G7n (GAA CGA ACG AGA TCG AGG TCC G) G759n (CTC GAC GAG CTT CGT GTT) 
AL 3543 (AAA TIA TGC CTG CTC GTC G) AL 3546 (CAA ACC TTI TCC GCA AAC C) 
Af (CGC CGT ACA CCT GTC A) Ar (AGC AAT GAC AAC CTC CTT CC) 
Ef2 (CCC CTT CTG CCG TAC ATT TAT) Er (GGC TCG TAA GCA ATA ACG ACT T) 
 
Amplification of the triose phosphate isomerase (tpi) gene 
For the amplification of the Giardia tpi gene the primer pair AL 3543 and AL 3546 
was used in the primary PCR. The PCR reaction was performed as described in 
Sulaiman et al. (2003), with BSA added to a final concentration of 0.1μg BSA/μl 
reaction mixture. In the nested PCR reaction new species-specific primers were used 
(figure 3.2). Assemblage A specific primers (Af and Ar: table 3.3) were designed 
based on Genbank sequences (AY368157 to AY368161; GIU57897 and AY655704), 
to amplify a 332 bp PCR product. Assemblage E specific primers (Ef2 and Er: table 
3.3) were designed based on Genbank deposited sequences (AY228645 to 
AY228647; AY655705 to AY655706), for the amplification a 388 bp PCR product. 
The reaction mixture for the secondary species-specific tpi PCR consisted of a master 
mix containing 0.25μl Taq DNA polymerase, 0.5μl dNTP mixture, BSA a to a final 
concentration of 0.1μg BSA/μl reaction mixture, 2.5 μl standard Taq buffer, 10 pM of 
each primer and 2,5 μl of template DNA in total volume of 25 μl. Subsequent steps 
were initial denaturation for 10 min at 94°C, followed by 35 cycles of denaturation for 
45s at 94°C, annealing for 45s at 60°C and an extension for 45s at 72°C. 
Amplification products were subsequently visualized on 1.5 % agarose gels with 
ethidium bromide. A positive (Plasmid DNA) and negative (PCR water) control 
sample was included in each PCR reaction.  
To verify the specificity of the species-specific primers, a subset of the samples was 
selected for sequencing, both from the assemblage A and E positive samples. The 
PCR products were purified using the Qiaquick purification kit (Qiagen) and fully 
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sequenced with the Big Dye Terminator V3.1 Cycle sequencing Kit (Applied 
Biosystems). Sequencing reactions were analysed on a 3100 Genetic Analyzer 
(Applied Biosystems) and assembled with Seqman II (DNASTAR, Madison WI, 
USA). Sequences were identified by blasting against the NCBI databank. 
 
Figure 3.2: Selection of the species-specific primers based on the alignment of the triose phosphate 
isomerase nucleotide sequences (a) forward primers (b) reverse primers 
 
(a) 
 
(b) 
 
The age of the calves positive for the different Giardia assemblages was compared 
with a two-way Mann-Withney U test. Probability (P) values <0.05 were considered 
to indicate a significant difference. 
 
 
 
 
 
 
 
                                        450                               460                             470                             480
 441  A A G A T G  C T C T  G G A A G G A G G T T G T C A T T G C T T A C G A G C C C G               ass A
 441  A A G A A G  T T A T  G G G A G A A C G  T T G T A A T T G C C T A T  G A G C C G G              ass B
 441  A A G G C G C T C T  G G A A G A G T  G T C G T C A T C G C C T A C  G A G C C C                 ass C
 441  A A G A A G  C T T T  G G A A G A A C  G T T G T T A T C  G C A T A T  G A A C C T G              ass D
 441  A A G C T G  C T A T  G G A A  A A A A G T C G T T A T T  G  C T T A C G A G C C C G             ass E
                                     90                               100                             110                            120
 81  G T C G T C A T T G C C C C C T C C G C C G T A C A C C T G T C A A C A G C C A    ass A
 81  G T T G T T G T T G C T  C C C T C C T T T G T  G C A C C T T  T C T A C A G C T A    ass B
 81  G T G A T C A T C G C C C C C T C G T C C G T G C A T C T G  T C T A C G G C C A   ass C
 81  G T G A T T A T T G C T  C C T T C G T C G G T  G C A T C T A  T C T A C G G C T A   ass D
 81  G T T G T T G T T G C C C C T T C T  G C C G T A C A T T T A  T C A A C A G C T A    ass E
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3.2.3 Results 
At least one isolate from 32 out of 48 Giardia positive dairy farms was included in the 
molecular study. For the beef farms, isolates from 21 of the 32 positive farms were 
included. From the isolates of the remaining farms, there was either not enough faeces 
from the positive samples to extract DNA or no amplification product could be 
obtained from the sample(s). The number of samples included and the results of the 
molecular characterisation on the -giardin gene are presented in Table 3.4.  
 
Table 3.4: Results of the molecular characterisation from the -giardin gene for Giardia in the dairy, 
beef, clinically affected calves and overall, with the age and age range in days (n=total number of 
samples; %= percentage of samples identified as the respective Assemblage) 
 
  n Ass A Ass E age (range) 
Dairy 49 29   (59%) 20 (41%) 39 (11-70) 
Beef 44 7   (16%) 37 (84%)      39 (6-70) 
Clinical 27 7   (26%) 20 (74%)      < 352 
Overall 120 43  (36%) 77 (64%)  
 
Overall, the livestock specific assemblage E (64%) was predominantly identified by 
the -giardin gene. In beef calves (84%) and in calves with clinical giardiosis (74%) 
the livestock specific assemblage E was most prevalent, whereas in dairy calves the 
zoonotic assemblage A (59%) was identified in the majority of the samples. In 25 of 
the 32 dairy farms (78%) and in 12 of the 21 beef farms (57%) assemblage A was 
identified in at least one isolate. Within assemblage A the subgenotypes A2 and A3 
were identified, and within assemblage E the subgenotypes E2 and E3. There was no 
difference in the age of the calves infected with assemblage A or E (P>0.05). 
 
The results of the species-specific tpi PCR are presented in table 3.5. For 19 samples 
amplified with the -giardin gene no result could be obtained using the tpi PCR 
protocol, due to the absence of faecal material or lack of amplification. In the majority 
of the samples the identification of the -giardin gene was confirmed by the 
identification of the tpi gene, either as mono-infection or as mixed assemblage A/E 
infection. In 3 dairy samples, assemblage A was found on the -giardin gene, and 
assemblage E on the tpi gene (no mixed infection could be detected in these samples). 
In total, 69% of the samples identified as assemblage A and 20% of the samples 
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identified as assemblage E by the -giardin gene, were diagnosed as a mixed infection 
by the tpi gene.  
  
Table 3.5: Results of the molecular characterisation from the triose phosphate isomerase gene for 
Giardia in the dairy, beef, clinically affected calves and overall with the age and age range in days  
(n=total number of samples; %= percentage of samples identified as the respective Assemblage) 
 
 
 
The specificity of the species-specific PCR was confirmed by the sequencing of 
species-specific PCR products from dairy, beef and clinical samples. Eighteen of the 
47 samples (38%) yielding a positive amplification for the assemblage A specific 
PCR and 33 of the 85 samples (39%) yielding a positive amplification for the 
assemblage E specific PCR, were selected for sequencing. All assemblage A positive 
samples were confirmed as assemblage A, and all assemblage E positive samples 
were confirmed as assemblage E. 
 
3.2.4 Discussion 
Since not all Giardia species found in cattle are relevant in a public health 
perspective, molecular identification of calf isolates should be included in 
epidemiological studies to elucidate the zoonotic potential (Traub et al., 2005). In 
general, cattle are not considered as an important source for human giardiasis (Caccio 
et al., 2003; Sulaiman et al., 2004), due to the high prevalence of the livestock 
specific assemblage E in cattle, observed in the United States (Trout et al., 2004, 2005 
and 2006), Canada (Applebee et al., 2003), New Zealand (Hunt et al., 2000) and in 
Australia (O’Handley et al., 2000; Becher et al., 2004). In Europe, either parasite 
prevalence was estimated without molecular characterisation (Castro-Hermida et al., 
2006; Hamnes et al., 2006; Maddox-Hyttel et al., 2006), or molecular characterisation 
  n Ass A Ass E Mixed Ass A/E age (range) 
Dairy 45 11   (24%) 17 (38%) 17 (38%) 39 (11-70) 
Beef 31 2   (6%) 22 (71%) 7 (22%) 37 (6-64) 
Clinical 25 3   (12%) 15 (60%) 7 (28%) < 352 
Overall 101 16   (16%) 54 (53%) 31 (31%)  
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was performed on samples not collected within a cross-sectional epidemiological 
study design (Berelli et al., 2004; Lalle et al., 2005). This is the first molecular 
epidemiological study for Giardia in calves in Europe.  
Whether the use of a single locus for the identification of Giardia is sufficient for 
epidemiological research, remains uncertain (Caccio et al., 2005). Therefore, two 
different genetic loci were targetted in the present study. The genotyping results of the 
–giardin and the tpi gene agreed in all samples, except in 3 dairy calves. Overall, the 
majority of the Giardia positive samples was identified as assemblage E of G. bovis, 
confirming previous reports in the United States (Trout et al., 2004, 2005, 2006), 
Canada (Applebee et al., 2003), New Zealand (Hunt et al., 2000) and in Australia 
(O’Handley et al., 2000; Becher et al., 2004). However, a substantial part of the 
isolates was identified as the zoonotic assemblage A, especially in the dairy calves, 
which confirms the scarce European data indicating that assemblage A is prevalent in 
calves (Berrilli et al., 2004; Lalle et al., 2005). Furthermore, assemblage A was 
identified in 78% of the dairy farms and 57% of the beef farms included in the 
genotyping study, indicating a wide distribution of the zoonotic assemblage A. 
Similar to the present study, a wide distribution of assemblage A among farms was 
also reported in the United States (Trout et al., 2004). Contrary to previous reports 
(Lalle et al., 2005; van Keulen et al., 2002), assemblage B was not found in the 
present study. Furthermore, mixed assemblage A/E infections were detected with the 
species-specific tpi PCR. Most (69%) of the assemblage A infections found with the 
-giardin gene were found to be a mixed A/E infection with the tpi gene whereas only 
20% of the -giardin diagnosed assemblage E infections were identified as a mixed 
A/E infection with tpi, confirming that the livestock specific assemblage E is the most 
prevalent in calves. The absence of mixed infections in previous reports can be 
attributed to the exponential nature of PCR and the subsequent failure to detect small 
Giardia subpopulations. Hence, this is the first report of mixed Giardia assemblage 
A/E infections in calves.  
The high prevalence of the zoonotic Giardia assemblage A infections in calves in 
East Flanders might be due to the proximity of intensified livestock industry to human 
activity, facilitating interaction between the human and livestock transmission cycle. 
The higher likelihood of anthropozoonotic transmission in an endemic focus has been 
described between the companion animal and the human transmission cycle. Dogs in 
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frequent contact with their owners tend to be infected with the zoonotic assemblage 
A, while dogs staying in packs are more likely to be infected with the dog specific 
assemblage D (Hopkins et al., 1997; Traub et al., 2004). Similarly, the more frequent 
occurrence of the zoonotic assemblage A in dairy calves compared to beef calves, 
both in the present study and in previous reports (O’Handley et al., 2000; Appelbee et 
al., 2003; Trout et al., 2004, 2005 and 2006), might be due to the seperation of dairy 
calves from the dam shortly after birth and the more frequent contact with human 
caretakers, whereas beef calves tend to stay with the dam. Contrary to 
Cryptosporidium, there was no correlation between infection with either assemblage 
and the age of the calf. Although post-weaned calves and adult cattle were not 
included in the present study, this seems to confirm previous findings (Trout et al., 
2004, 2005, 2006).  
Once introduced, assemblage A is able to maintain itself in a bovine population. 
Moreover, the occurrence of assemblage A infections in clinically affected calves 
seems to suggest that infections with assemblage A are not only transient infections 
(Caccio et al., 2005), but contribute to the development of clinical giardiasis in calves. 
Although mixed infections were not considered, a difference in clinical outcome has 
been described in human patients (Homan and Mank, 2001; Read et al., 2002). 
Whether there is a difference in clinical outcome between assemblage A and 
assemblage E infections in calves, remains uncertain.  
The present study demonstrates a high prevalence and wide distribution among farms 
of Giardia assemblage A infections, and the occurrence of mixed assemblage A/E 
infections in calves. The results suggest that calves, although primarily infected with 
the livestock specific assemblage E, are also infected to a large extent with the 
zoonotic assemblage A, and that calves should therefore be considered as a potential 
zoonotic reservoir for human infections. The occurrence of mixed infections also 
illustrates the hazard of evaluating the zoonotic potential of Giardia isolates from 
animal origin using molecular identification based on a single gene. 
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4.1.1 Introduction 
Infection with Giardia leads to villus atrophy and crypt hyperplasia mainly in the 
duodenum, resulting in an intermittent and mucous diarrhea (Ruest et al., 1997). 
Although the detrimental effects of giardiosis have never been experimentally 
examined in calves, in a lamb model a Giardia infection caused a decreased weight 
gain, impaired feed efficiency and reduced carcass weight (Olson et al., 1995). 
Furthermore, there is clinical evidence that infection in calves is associated with 
diarrhea and ill thrift and therefore has a negative impact on growth performance (St. 
Jean et al. 1987; Xiao et al., 1993; O’Handley et al., 1999). Giardia infections in 
calves might also constitute a possible reservoir for human infection (chapter 3.2), 
although the non zoonotic assemblage E appears to be more prevalent in calves than 
the zoonotic assemblage A (Thompson and Monis, 2004; Trout et al., 2004). 
Several compounds like metronidazole (St. Jean et al., 1987; Xiao et al., 1993), 
dimetridazole (St Jean et al., 1987), fenbendazole and albendazole (Xiao et al., 1996; 
O’Handley et al., 1997, 2000) have been used in the treatment of giardiasis in calves, 
achieving symptomatic improvement in all treated animals. Data on reduction in cyst 
excretion are only available for treatment with fenbendazole and albendazole. Both 
albendazole (20 mg/kg during three consecutive days) and fenbendazole (5-20 mg/kg 
during three consecutive days) were effective in significantly reducing the cyst 
excretion after treatment (Xiao et al., 1996; O’Handley et al., 1997, 2000). 
A promising alternative for treatment is paromomycin, since it is poorly absorbed 
from the gastrointestinal tract and therefore well tolerated by calves (Grinberg et al., 
2002). Paromomycin or aminosidin is a broad-spectrum amino-glycoside antibiotic, 
with well-known efficacy against several protozoan parasites like Cryptosporidium in 
calves (Fayer and Ellis, 1993; Mancassola et al., 1995; Chartier et al., 1996; Viu et 
al., 2000; Grinberg et al., 2002), Histomonas in chickens (Hu and McDougland, 
2004) and Giardia in rats (Awadalla et al., 1995) and in humans (Wright et al., 2003). 
Paromomycin binds to the small subunit rRNA and inhibits protein synthesis, which 
has either a direct effect on Giardia or an indirect effect of nutrient withdrawal caused 
by the inhibition of bacterial protein synthesis and destruction of the bacterial flora 
(Edlind, 1989; Harder et al., 2001; Harris et al., 2001).  
In the present study the efficacy of a five-day treatment with three different dosages 
of paromomycin against an experimental infection with Giardia was evaluated. 
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4.1.2 Materials and methods 
Study design 
Twenty-four male Holstein calves aged 3 to 5 weeks were screened upon arrival for 
the presence of Bovine Viral Diarrhea antigen in blood samples and in faecal samples 
for the presence of Giardia cysts using IFA, and Eimeria oocysts using the McMaster 
technique. Only healthy calves without diarrhea and negative for all pathogens were 
included in the study. All animals were individually housed in pens with concrete 
floors and walls, which prevented contact between neighbouring calves. The calves 
remained in the same pen from the day of arrival up to the end of the study. They 
received a commercial calf feed and milk. Straw bedding was added to the pens daily. 
This study was conducted in accordance with the VICH Guidelines for Good Clinical 
Practice and the E.U. Animal Welfare Directives. 
Giardia cysts were purified from the faeces of a calf experimentally infected with a 
field strain. These cysts were confirmed by PCR (Caccio et al., 2002) to be 
Assemblage E. The cysts in the inoculum were enumerated based on multiple counts 
using IFA and diluted in water to obtain the same infection dose as described in a 
previous infection study (O’Handley et al., 2000). Eleven days before the start of the 
treatment (D-11), all calves were orally inoculated twice with a 12h interval, with a 
total infection dose of 10
5 
Giardia cysts. From 5 days (D-6) after infection until D-2, 
faeces were collected daily from all calves to confirm the presence of cysts. Calves 
were blocked by descending order of D-2 cyst excretion and within each block calves 
were randomly assigned to one of the treatment groups or the control group (6 
calves/group). The calves in the three treatment groups received an oral treatment 
with paromomycin sulfate (Gabbrovet CEVA Animal Health) at a dose rate of 25, 
50 or 75 mg/kg body weight (BW) respectively during 5 consecutive days (D0-D4). 
The paromomycin sulfate was diluted in water and given orally before the meal using 
a syringe. The control group received a placebo (water).  
All animals were examined three times a week during three consecutive weeks after 
the start of the treatment for the presence of Giardia cysts in their faeces. Data on 
faecal consistency and general health were recorded during the entire duration of the 
study on a daily basis. The general health was described as either normal or abnormal. 
The faecal consistency was scored as either normal (1), pasty (2) or watery (3) and an 
average faecal consistency score was calculated on D6, D13 and D20. All calves were 
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weighed prior to treatment (D-1) and at the end of the study (D20) using a cattle-
weighing scale with a calibration of 1kg. Calibrated weights were used to confirm the 
accuracy of the scale prior and after weighing. 
 
Detection and enumeration of Giardia cysts 
A quantitative direct IFA (Merifluor Cryptosporidium/Giardia kit; Meridian 
Diagnostics Inc., Cincinnati, Ohio) was developed by modifying the method of Xiao 
and Herd (1993). In short, one gram of the faecal sample was suspended in distilled 
water and strained through a layer of surgical gauze. After sedimentation for 1 hour 
and subsequent centrifugation of this sediment at 3000 g for 5 minutes, the obtained 
pellet was resuspended in distilled water up to a volume of 1 ml. After thorough 
vortexing, an aliquot of 20 μl was pippeted onto a treated IFA-slide. After staining the 
slide, as instructed by the manufacturer, the entire smear was examined at a 400x 
magnification under a fluorescence microscope. The number of cysts per gram faeces 
(CPG) was obtained by multiplying the total number of cysts on the smear by 50. 
 
Assessment of efficacy 
The treatment efficacy in this study was measured based on the reduction in cyst 
excretion for each treatment group compared to the control group and on differences 
in cumulative cyst excretion. The reduction in cyst excretion was calculated using the 
Henderson-Tilton formula (Henderson and Tilton, 1955):  
  
100 X 1 Ta X Cb
Tb X Ca
 
  
 
   
Tb & Ta being the geometric mean cyst count in the treated group before and after 
treatment, and Cb & Ca being the geometric mean cyst count in the control animals 
before and after treatment (Presidente, 1985). The Henderson-Tilton formula is 
considered to be the most appropriate when counts in the control group tend to 
decrease. Cumulative cyst counts (cysts per gram of faeces; CPG) were calculated for 
each animal using the trapezium rule, i.e. the average CPG of two sequential sampling 
days was multiplied by the number of days in between the sampling days. The 
cumulative CPG from the start of the experiment to each sampling day for each 
animal was then calculated by adding together the period cyst counts and used to 
calculate the geometric mean cumulative cyst excretion per group.  
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Differences in cyst excretion, faecal consistency and weight gain between groups 
were analysed using a Kruskal-Wallis test, followed by a Mann-Whitney test for 
pairwise comparison of each treated group with the control group. Probability (P) 
values <0.05 were considered to indicate significant differences. 
 
4.1.3 Results 
During and after treatment no adverse reactions were observed. All calves were 
negative for Giardia before the start of the study. The number of animals excreting 
cysts in the faeces prior and after treatment is presented in Table 4.1, along with the 
geometric mean (GM) and the range of the faecal cyst counts.  
 
Table 4.1: The geometric mean (mean) and range of the faecal Giardia cyst excretion, and the number of animals  
(#) excreting cysts on each sampling day before and after treatment with paromomycin 
 
Prior to treatment all animals were excreting Giardia cysts and there was no 
significant difference in cyst excretion between groups. In the group treated with 75 
mg/kg, there was no cyst excretion until D11. In the groups treated with 25 and 50 
mg/kg, two and one animal respectively excreted cysts during and shortly after 
treatment. In the final week of the observation period all animals, except 1 animal in 
the group treated with 75 mg/kg, were intermittently excreting cysts in the faeces. 
The reduction in cyst excretion calculated with the Henderson-Tilton formula, based 
on the GM cyst counts, is presented in Table 4.2. For the group treated with 75mg/kg 
there was a 100% reduction in cyst excretion until D9 and a 98% reduction until 
D13. For the group treated with 50 mg/kg, there was a 93% reduction until D13. In 
the group treated with 25 mg/kg there was a 94% until D9. From D16 onwards, the 
reduction in all treatment groups was low and discontinuous. 
 
  control     
25 
mg/kg     
50 
mg/kg     
75 
mg/kg     
  mean range # mean range # mean range # mean range #
D-1 1828 100-30,550 6 2049 200-35,000 6 1660 50-29,700 6 1572 50-12,450 6
D2 205 0-43,350 4 11 0-3,000 2 8 0-50 3 0 0 0
D4 1270 100-39,300 6 7 0-1,200 2 3 0-50 1 0 0 0
D6 281 0-56,100 4 17 0-8,700 2 3 0-50 1 0 0 0
D9 530 0-35,000 5 21 0-19,000 2 5 0-5,400 1 0 0 0
D11 326 50-16,600 6 168 0-43,850 4 20 0-2,750 3 4 0-350 1
D13 476 50-8,700 6 353 0-17,200 4 13 0-4,150 2 7 0-250 2
D16 142 0-12,550 5 635 0-50,350 5 440 0-19,950 5 291 0-105,000 5
D18 738 0-2,450 6 648 0-44,200 5 188 0-2,850 5 142 0-24,750 4
D20 91 0-3,300 5 1225 0-27,600 5 15 0-3,200 2 372 0-14,700 5
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Table 4.2: Percentage reduction in geometric mean Giardia cyst counts calculated by the  
Henderson-Tilton formula in all treatment groups after treatment with paromomycin 
  
The GM cumulative cyst excretion for each group was calculated based on the 
individual cumulative cyst excretions and is presented in Figure 4.1. The total 
cumulative cyst excretion over the three-week period was highest in the control 
group. In the group treated with 25 mg/kg, the cumulative cyst count increased from 
D6 onwards. In the groups treated with 50 and 75 mg/kg, the cumulative cyst count 
increased from D13 onwards. The cumulative cyst excretion until D13 was 
significantly lower (P<0.05) in the groups treated with 50 (GM: 634 CPG; range: 0-
23.350 CPG) and 75 mg/kg (GM: 9 CPG; range: 0-850 CPG) compared to the control 
group (GM: 22.652 CPG; range: 3.550-394.500 CPG). In the group treated with 25 
mg/kg (GM: 991 CPG; range: 0-152.900 CPG), the cumulative cyst excretion was not 
significantly lower than in the control group. 
 
Figure 4.1: The geometric mean cumulative Giardia cyst excretion after treatment with paromomycin at 
25mg/kg (25), 50 mg/kg (50=), 75 mg/kg (75) and in the control group. 
 
 
The general health was normal for all animals during the entire extent of the study. 
The faecal consistency scores were higher in the control group compared to the treated 
treatment D2 D4 D6 D9 D11 D13 D16 D18 D20 
25 mg/kg 95.4 99.4 94.6 96.4 53.9 33.8 0.0 0.0 0.0 
50 mg/kg 95.6 99.7 98.8 98.9 93.3 96.9 0.0 71.9 82.3 
75 mg/kg 100 100 100 100 98.7 98.3 0.0 77.6 0.0 
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groups, although there was no significant difference on D6, D13 and D20 (Table 4.3). 
The arithmetric mean weight gain was 8.2kg (± standard deviation: 3.4kg) for the 
control group and 8.9kg (±3.4kg), 9.0kg (±2.3kg) and 10.8kg (±2.6kg) for the groups 
treated with 25, 50 and 75 mg/kg respectively. However, there was no significant 
difference in weight gain between the treated and the control animals.  
 
Table 4.3: The arithmetic mean (±standard deviation) of the faecal consistency scores on D0, D6, D13 
and D20 for all groups (25= 25mg/kg; 50= 50 mg/kg; 75= 75 mg/kg; control= control group) 
 
 
4.1.4 Discussion 
All animals in this trial were excreting cysts within 10 days after infection with 10
5 
Giardia cysts, confirming previous experimental infection results using this infection 
dose (O’Handley et al., 2000). In other studies the efficacy was evaluated based on 
reduction of the geometric mean cyst counts and on clinical improvement (Xiao et al., 
1996; O’Handley et al., 1997; 2000). However, since there are no official guidelines 
for efficacy assessment of treatment against protozoal infections in cattle, contrary to 
nematode infections (Vercruysse et al., 2001), we used the Henderson-Tilton formula, 
which takes the natural course of infection into account, and the reduction in 
cumulative cyst excretion, as a measure of the reduction in contamination of the 
environment. Furthermore, faecal consistency and weight gain were monitored as a 
measure of clinical improvement.  
In the highest dosage groups (75 and 50 mg/kg) there was a very high reduction in cyst 
excretion until D13, which resulted in a significantly (P<0.05) lower cumulative cyst 
excretion in these treatment groups compared to the control group. All animals, except 
one animal in the group treated with 75 mg/kg, were re-excreting cysts within 2 to 3 
weeks after treatment. A similar efficacy and post treatment infection pattern was 
observed for treatments with fenbendazole and albendazole (Xiao et al., 1996; 
O’Handley et al., 1997; 2000). The re-occurrence of cyst-excretion within two weeks 
after treatment may be due to reinfection from the contaminated environment shortly 
DO  D6  D13  D20
control 1.3 (±0.54) 1.27 (±0.29) 1.36 (±0.37) 1.35 (±0.29)
25 1.17 (±0.41) 1.22 (±0.47) 1.24 (±0.37) 1.21 (±0.25)
50 1.5 (±0.51) 1.17 (±0.19)      1.09 (±0.07) 1.19 (±0.16)
75 1.18 (±0.41) 1.06 (±0.15) 1.1 (±0.17) 1.11 (±0.12)
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after treatment. Giardia has a prepatent period of only 4 to 10 days (Xiao and Herd, 
1994; Olson et al., 1995) and, contrary to other studies (Xiao et al., 1996; O’Handley 
et al., 1997), housing in this trial was not disinfected. Alternatively some Giardia 
trophozoites may have survived treatment (Xiao et al., 1996; O’Handley et al., 1997) 
resulting in a continuous passing of a limited number of cysts in the faeces shortly 
after treatment. This low cyst excretion might not have been diagnosed in the faeces, 
since the sensitivity of the IFA used in this study is not 100%.  
Due to the high variation within the groups and to the limited number of animals per 
group, the short term cyst-suppressing effect of treatment did not result in a 
significantly better faecal consistency score or weight gain, although the animals in all 
treatment groups had an average weight that was between 0.7 and 2.6kg higher than in 
the control group. Furthermore, the short term cyst-suppressing effect of both 
paromomycin and benzimidazole products in a contaminated environment (Xiao et al., 
1996; O’Handley et al., 2000) further emphasises the need for an integrated control 
program combining cleaning and disinfection of the environment with treatment, 
although even that might not guarantee total elimination of infection (Xiao et al., 
1996). The higher efficacy at the end of the treatment (D4; >99%) in the groups 
treated with 25 and 50 mg/kg compared to efficacy on D2 (>95%) suggests that 
cleaning and disinfection should be performed at the end of the treatment period to 
further minimise risk of reinfection after treatment, rather than at the start of the 
treatment.  
The present study demonstrates the efficacy and safety of a five-day treatment with 
paromomycin against an experimental Giardia infection in calves. The efficacy of a 
paromomycin treatment is comparable to the efficacy of both fenbendazole and 
albendazole treatments, although a dose confirmation study and field efficacy studies 
need to be conducted to further confirm these results.  
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treatment combined with hygienic and management measures against a natural 
Giardia infection in calves. Vet Parasitol 142, 367-371. 
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4.2.1 Introduction 
Several compounds such as fenbendazole and albendazole (Xiao et al., 1996; 
O’Handley et al., 1997, 2000), and paromomycin (chapter 4.1) can be used for 
treatment of giardiasis in calves. Fenbendazole (5-20 mg/kg bodyweight during 3 
consecutive days) and paromomycin (50 or 75 mg/kg bodyweight during 5 
consecutive days) resulted in a 100% reduction of the cyst excretion after treatment, 
although calves were re-excreting cysts within 2 to 3 weeks after treatment. Since 
Giardia cysts can survive for 1 week in cattle faeces and up to 7 weeks in soil (Olson 
et al., 1999), the effective treatment period of most treatment protocols (3-5 days) 
may be too short to prevent reinfection from a contaminated environment shortly after 
treatment. Furthermore, a high environmental infection pressure can result in an 
efficacy less than 100% from 1 week after treatment onwards, as in the albendazole 
trial of Xiao et al. (1996). Although in the fenbendazole trials of Xiao et al. (1996) 
and O’Handley et al. (1997) calves were housed in a clean and disinfected 
environment, leading to a 100% efficacy until at least 13 days after treatment, calves 
were re-excreting cysts after treatment, suggesting failure of disinfection, reinfection 
through faecal material on limbs or other parts of the calf or survival of Giardia 
trophozoites in the intestine (Xiao et al., 1996; O’Handley et al., 1997, 2000). The 
short term cyst-suppressing effect of treatment in a contaminated environment (Xiao 
et al., 1996; O’Handley et al., 2000) emphasises the need for an integrated control 
program combining treatment with cleaning and disinfection of the environment at the 
end of the treatment period to further minimise risk of reinfection after treatment. 
Giardia cysts are known to be resistant to commonly used desinfectants, such as 
chlorine. Alternative desinfectants, including chlorine dioxide, ozone and ultra violet 
irradiation have been the focus of research in drinking water treatment processes 
(Betancourt and Rose, 2004), although there are practical objections against most of 
these disinfection procedures for use in calf facilities. Alternatively, heat or 
desiccation (Olson et al., 1999) and disinfection with quaternary ammonium (Xiao et 
al., 1996; O’Handley et al., 1997) can be used in calf facilities. In the present study, 
the efficacy of a combination of animal treatment with fenbendazole and 
environmental cleaning and disinfection with ammonia 10% or relocation was 
evaluated on ten commercial farms with a total of 94 animals.  
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4.2.2 Materials and Methods 
Study design  
Two studies were performed on 10 commercial farms, with a total of 94 animals. The 
farms were selected based on a history of chronic diarrhea, dull hair coat, ill thriving 
and impaired growth in calves between the age of 1 to 6 months (Figure 4.2).  
 
Figure 4.2: Calves clinically affected by Giardia: (a) impaired growth and dirty hind quarters due to 
chronic diarrhea; (b) rough haircoat 
a           
       
b 
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The diagnosis of giardiasis was confirmed through identification of Giardia cysts in at 
least 50% of the animals. Coccidiosis was excluded on all these farms as a possible 
pathogen. The first study (study 1), which included 5 farms (farms 1 to 5) was 
performed during the winter of 2004-2005. In the second study (study 2) another 5 
farms (farms 6 to 10) were visited during the winter of 2005-2006. On all farms 
animals were housed together in pens with concrete floor and bedding. Management 
consisted of adding straw to the bedding on a regular basis (2-3x/week), but the 
bedding was removed only once, twice or thrice a year, depending on the farm. 
Disinfection was not performed or with chlorine. Although treatment dosages as low 
as 5 mg fenbendazole per kg bodyweight are 100% effective in reducing Giardia cyst 
excretion in natural infections (O’Handley et al., 1997), a higher fenbendazole dosage 
(15 mg/kg during 3 consecutive days; Panacur® Intervet, Boxmeer, the Netherlands) 
was preferred in the present studies because the environmental infection pressure on 
these farms was considered to be high. One of two possible environmental measure 
protocols were implemented on the last day of treatment. The choice of the final day 
of the treatment period for the application of the environmental measures was inspired 
by observations that the reduction in cyst excretion is maximised at the end of the 
treatment period (chapter 4.1). The first protocol consisted of transfering the animals 
to a clean environment which had not been used for animal housing for at least 1 year 
(transfer protocol). The second protocol was removal of all bedding material, 
thourough high pressure cleaning with water, followed by complete drying of the 
housing and disinfection with an ammonia 10% solution (ammonia protocol). A 
previously described and evaluated immunofluorescence assay (IFA: Merifluor 
Cryptosporidium/Giardia; Meridian Diagnostics Inc., Cincinnati, Ohio) was used for 
detection of Giardia cysts (chapter 4.1). The IFA was used qualitatively in the first 
study and quantitatively in the second study, to calculate the percentage reduction. 
Clinical symptoms (diarrhea) and general appearance were evaluated at each sampling 
date and 4 months after the end of the treatment.  
 
Study 1 
On farms 2 and 3 animals were moved to a clean environment on the third day of 
treatment. No calves had been kept in these clean calf facilities at all (farm 2) or for at 
least one year prior to the treatment (farm 3). On farms 1, 4 and 5 the ammonia 
protocol was applied on the third day of treatment. Individual faecal samples were 
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collected from all animals prior to treatment (D-1) and weekly thereafter, until 
positive animals were identified or until four weeks after treatment (D7, D14, D21 
and D28). 
 
Study 2 
On farm 6 animals were moved to a clean environment where no calves had been 
housed for at least one year prior to the treatment. On farms 7, 8 and 9 the ammonia 
protocol was applied. On farm 10 the treatment was not combined with environmental 
measures, and the animals remained in the contaminated environment. Based on the 
results of the first study faecal sampling in study 2 was limited to D21 and D28 after 
treatment. On the other hand, cyst excretion in study 2 was determined quantitatively 
instead of qualitatively. Geometric mean (GM) cyst counts were calculated at each 
sampling date and a percent reduction was calculated as following: 
  
  
%Reduction =  GMbefore - GMafter       x100
                                GMbefore
 
with GMbefore being the geometric mean cyst count before treatment and GMafter being 
the geometric mean cyst count after treatment. The geometric mean cyst counts before 
(D-1) and after treatment (D21 and D28) were compared on each farm, using the 
Mann-Whitney test. Probability (P) values <0.05 were considered to indicate 
significant differences. 
 
4.2.3 Results 
Study 1 
The results of study 1 are presented in table 4.4. Prior to treatment the percentage of 
positive animals present in the group housing varied between 50% and 85%. No cysts 
were detected during week 1 or 2 after treatment. Furthermore, no cysts were 
identified after treatment on farm 2 where animals were moved to a housing which 
was previously not used for calves. In the remaining farms cysts were detected within 
3 weeks after treatment, although not in all animals excreting cysts prior to treatment. 
There was a noticable improvement in diarrhea towards D28 and at four months after 
treatment in all farms (data not shown).  
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Table 4.4: The total number of animals (n) on farms 1 to 10 and the number of animals excreting 
Giardia cysts before treatment (D-1) and on day 7 (D7), day 14 (D14), day 21 (D21) and day 28 (D28) 
after treatment, along with the treatment and environmental measures (ammonia or transfer protocol).  
     nd = not done 
 
Study 2 
The results of farms 6 to 10 are presented in table 4.4 and 4.5. Since in the first study 
in none of the animals Giardia cysts were identified on D7 or D14 after treatment, it 
was concluded that D21 and D28 could be considered as adequate sampling days to 
identify cyst re-appearance after treatment. The percentage of positive animals varied 
between 64% and 100% prior to treatment (Table 4.4). Furthermore, the intensity of 
cyst excretion varied between animals of the same farm (Table 4.5).  
 
Table 4.5: The geometric mean and range of the Giardia faecal cyst count (cyst per gram of faeces) on 
D-1 (GM D-1), D21 (GM D21) and D28 (GM D28) and the percent reduction (%) are presented, along 
with the treatment and environmental measures (ammonia or transfer protocol). 
nd = not done; *significant (P<0.05) reduction 
 
On farms 6 to 9 Giardia cysts were detected within 3 to 4 weeks after treatment in a 
limited number of animals (Table 4.4). The reduction in geometric mean cyst counts 
after treatment (D21 and D28) was very high on these farms (98.0%; P<0.05; Table 
4.5). In contrast, on farm 10 a majority of the animals (7 out of 9) was excreting high 
numbers of cysts 3 weeks after treatment (Table 4.5) and excretion was not 
significantly lower (P>0.05) after treatment. Similar to the first study, diarrhea 
Farm n D-1 D7 D14 D21 D28 treatment
1 5 4 0 0 0 2 15 mg/kg 3d + ammonia 
2 10 5 0 0 0 0 15mg/kg 3d + transfer
3 7 4 0 0 3 3 15 mg/kg 3d + transfer
4 8 5 0 0 2 3 15 mg/kg 3d + ammonia 
5 14 12 0 0 3 8 15 mg/kg 3d + ammonia 
6 11 7 nd nd 1 1 15mg/kg 3d + transfer
7 14 9 nd nd 0 1 15 mg/kg 3d + ammonia 
8 8 8 nd nd 1 0 15 mg/kg 3d + ammonia 
9 8 7 nd nd 1 1 15 mg/kg 3d + ammonia 
10 9 9 nd nd 7 nd 15mg/kg 3d
Farm GM D-1 GM D21 GM D28 red D21 red D28 treatment
6 28.4 (0-4,750) 0.4  (0-50) 0.4 (0-50) 98.0%* 98.0%* 15mg/kg 3d + transfer
7 109.5 (0-31,000) 0 0.5 (0-300) 100.0%* 99.5%* 15 mg/kg 3d + ammonia 
8 2988 (150-40,200) 1 (0-300) 0 99.9%* 100.0%* 15 mg/kg 3d + ammonia 
9 5074 (0-250,000) 0.9 (0-200) 0.9 (0-150) 99.9%* 99.9%* 15 mg/kg 3d + ammonia 
10 1229 (50-17,050) 1122 (0-66,150) nd 8.7% nd 15mg/kg 3d
Chapter 4: Treatment and control        151 
__________________________________________________________________________________________ 
improved in all farms towards D28 and at four months after treatment (data not 
shown), except in farm 10. 
 
4.2.4 Discussion 
These results illustrate the clinical importance of a natural Giardia infection in calves 
between the age of 1 to 6 months, since all farms reported problems of chronic and 
often mucous diarrhea, reduced weight gain and ill thrift. On Giardia positive farms 
most calves are infected when introduced into a contaminated housing (Xiao et al., 
1994) and start excreting up to 10
6
 cysts per gram of faeces (Xiao et al., 1994), 
resulting in a rapid increase of the environmental infection pressure. Because only a 
low number of Giardia cysts is needed for infection (Caccio et al., 2005) and a 
specific immune response against Giardia infection develops slowly in ruminants 
(Yanke et al., 1998; O’Handley et al., 2003), it has been suggested that environmental 
disinfection in combination with animal treatment is necessary (Xiao et al., 1996; 
O’Handley et al., 1997, 2000). This was confirmed by the results of farm 10 where 
housing was not disinfected after treatment. Calves were re-excreting high numbers of 
cysts within three weeks after treatment and there was no effect of treatment on 
clinical symptoms.  
Both in the first and in the second study the combination of treatment with 15mg 
fenbendazole per kg bodyweight and the ammonia protocol on the third day of 
treatment resulted in a total suppression of cyst excretion during at least 2 weeks. An 
alternative way of coping with the high environmental infection pressure was to move 
the calves to a Giardia free environment, as suggested in the albendazole trial of Xiao 
et al. (1996) where the high efficacy 6 weeks after treatment was probably due to the 
transfer of the calves to pasture 2 weeks after treatment. The relocation of the calves 
to a clean environment resulted in a similar cyst excretion pattern compared to 
ammonia protocol. Moreover, the relocation of the animals on farm 2 to pens which 
were never used before to house ruminants, resulted in a 100% reduction of excretion 
for 4 weeks, indicating that the environment should be considered as the most 
important source for reinfection. Both environmental protocols resulted in a 
significant (P<0.05) reduction of the cyst excretion during at least 4 weeks after 
treatment, leading to a low environmental infection pressure and preventing clinical 
symptoms for at least four months after treatment.  
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The need for a combination of animal treatment and environmental measures against a 
natural Giardia infection in calves between the age of 1 to 6 months is emphasized by 
the present results. Treatment with fenbendazole at 15mg/kg during 3 consecutive 
days combined with the ammonia protocol or relocation of the animals on the third 
day of treatment did result in a significant (P<0.05) reduction of cyst excretion until at 
least 4 weeks after treatment and in a noticable improvement of clinical symptoms. 
Although there are no scientific data on the cost-effectiveness of a treatment against 
Giardia in calves, the results of the present study indicate that treatment leads to a 
noticable improvement of the clinical symptoms caused by a Giardia infection, and 
hence contribute to an improved general health and production parameters. 
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5.1 Introduction 
The main objective of the present thesis was to obtain better insight in the molecular 
epidemiology of Cryptosporidium and Giardia in calves in Belgium, and to optimize 
the treatment of clinical giardiosis in calves. More specifically, the aim in chapter 2 
was to obtain a reliable estimate of the parasite prevalence in both dairy and beef 
calves, based on a Bayesian estimation of test characteristics. In chapter 3, existing 
and novel tools for molecular characterisation were applied on a selection of parasite 
positive calf samples to elucidate the distribution of species, genotypes and 
subgenotypes of Cryptosporidium and Giardia in the dairy and beef calf population. 
Finally in chapter 4, the efficacy of a treatment with paromomycin was evaluated in 
an experimental study design, and of fenbendazole in combination with additional 
environmental measures under natural conditions.  
In the present chapter, the advantages and disadvantages of the applied methodology 
are discussed. Last but not least, the general conclusions and future perspectives are 
presented. 
 
5.2 Prevalence estimation 
In chapter 2, the prevalence of Cryptosporidium and Giardia in calves was studied in 
the province of East Flanders. To estimate the parasite prevalence in a population, a 
cross-sectional study design is preferred (Greiner and Gardner, 2000), although this 
methodology can underestimate the parasite prevalence under specific conditions, 
such as intermittent or seasonal variations in (oo)cyst excretion (O’Handley et al., 
1999). Prevalence estimates are not only affected by parasite or host factors, but also 
by the characteristics of the diagnostic tests applied in the study (Greiner and Gardner, 
2000; Basanez et al., 2004). Although some of the assays used in the present study 
were previously evaluated for use in human medicine, for clinical diagnosis or in 
experimental validation studies, general scepticism is appropriate when extrapolating 
test parameters beyond the limits of the validation study. Furthermore, test evaluation 
in experimental settings typically results in an overestimation of the test 
characteristics (Greiner and Gardner, 2000). Therefore, the sensitivity and specificity 
of the different assays was evaluated for the diagnosis of infection in calf samples 
collected within an epidemiological study design.  
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Test are traditionally evaluated by a frequentist approach using contingency tables. In 
the frequentist approach, test characteristics are estimated based on the ‘true disease’ 
status of the animals, as determined by one or a combination of gold standard 
reference assays. Since even widely accepted gold standards are subject to human or 
other sources of misclassification errors, the results might be biased in favour of the 
gold standard reference test. In the present study, a Bayesian approach was preferred 
over a frequentist approach, since it proved its value in circumventing the gold 
standard problem (Dorny et al., 2004). A further advantage is that full posterior 
distributions for the parameters of interest (i.e. prevalence and test characteristics) are 
generated, while a frequentist approach only provides the best estimate of the 
parameter and a standard error. Further differences between the frequentist and a 
Bayesian statistical approach are reviewed in more detail by Basanez et al. (2004). 
 
In a Bayesian analysis, inferences on prevalence and test characteristics are based on 
the data, being the cross-classified test results of at least three diagnostic assays, and 
on prior information, which comprises previously published estimates or expert 
opinion on model parameters (Suess et al., 2002; Branscum et al., 2005). Since the 
data at hand are established in the experiment and are hence fixed values, the prior 
information does influence to a large extent the posterior distributions. The 
incorporation of prior information has therefore been the most controversial element 
of Bayesian analysis, although there is no alternative to constrain the space on certain 
parameters, allowing estimation of remaining parameters. A good Bayesian analysis 
should therefore include a judgement on the importance of the prior information 
(Dunson, 2001; Basanez et al., 2004; Toft et al., 2005).  
The prior information included in a Bayesian model can be either deterministic or 
probabilistic. A deterministic constraint sets the parameter at a particular value, 
whereas a probabilistic constraint specifies a prior distribution for that parameter 
(Berkvens et al., 2006). Some authors advocate the use of sensitivity analysis based 
on expert opinion to verify the validity of the prior information. A disadvantage of 
this approach is the bias of the prior information, since the sensitivity analysis is 
solely based on information previously obtained in contingency studies or on 
subjective expert opinion (Enoe et al., 2000). More recently, an alternative approach 
was introduced, using the DIC, pD and the Bayes-p to verify whether the prior 
information is in conflict with the data, and to quantify the effect of these prior 
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constraints on the number of effectively estimated parameters (Berkvens et al., 2006). 
The latter approach was used in the present study. 
 
In chapter 2, the use of wide range constraints (Dunson, 2001) was sufficient to 
reduce the number of parameters to be estimated, and did not influence the posterior 
distributions in the 3-test model for Giardia and the 4-test model for 
Cryptosporidium. In the Cryptosporidium 6-test model however, the use of more 
stringent constraints was necessary to reduce the high number of parameters. The use 
of stringent parameters in the six test model directed the Bayesian model and the 
parameter estimates towards the results of the PCR assays. In the present study, the 
validity of the previously published prior information on the specificity of both PCR 
assays (Morgan et al., 1997; Spano et al., 1997) was verified and confirmed by 
sequencing randomly selected PCR amplification products. Although the posterior 
distributions in the six-test approach were largely driven by the rigid prior 
information, these results still illustrate the major advantage of the Bayesian approach 
over the frequentist approach: the ability to include previously tested assumptions 
(=prior information) on certain, but not all parameters, while in the frequentist 
approach, all parameters describing the sensitivity and specificity of the gold standard 
reference test are inherently set at value 1.  
Since the posterior estimates are not rigid parameters, but best-possible estimates 
based on the observations and the prior information (Dorny et al., 2004), 
inconsiderate extrapolation of results beyond the limits of the study cannot be made. 
Since the data at hand resulted from an epidemiological study including both calves 
with and without clinical symptoms, and depended to a large extent on the choice of 
diagnostic test, the posterior estimates of the test characteristics must be interpreted 
taking these limits into account. The low sensitivity estimates of the conventional 
techniques in the six-test model are mostly due to the low excretion of 
Cryptosporidium oocysts in calves older than one month and to the higher sensitivity 
of PCR compared to more conventional techniques. It does however not imply that 
these conventional techniques are not reliable for clinical diagnosis, since clinical 
symptoms are mostly diagnosed in calves younger than one month and correlate with 
an increased oocyst excretion. The usefulness of different conventional diagnostic 
assays was confirmed in a recent study to evaluate test characteristics for the detection 
of Cryptosporidium in faeces of clinically affected calves (Geurden et al., 
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unpublished results). Sensitivity and specificity should therefore not be considered as 
values intrinsic to the diagnostic test (i.e. constant and universally applicable), but as 
variables dependent on parasite prevalence and intensity of excretion (Berkvens et al., 
2006).  
 
5.3 Molecular characterisation and the zoonotic reservoir function of calves 
A substantial part of the Cryptosporidium and Giardia research in the last decade 
focussed on taxonomy and on the development of molecular genotyping tools. As 
reviewed by Caccio et al. (2005), molecular tools are now available for both parasites 
at different levels of specificity, and the application of these tools in epidemiological 
research has been advocated to obtain better insight into the transmission dynamics 
(Traub et al., 2005). Most molecular studies in calves were however not conducted 
within the limits of an epidemiological study, possibly biasing the genotyping results 
towards a clinical perspective. In an epidemiological context and from a public health 
perspective, a representative sample of the calf population is preferred for genotyping, 
including both clinically affected and asymptomatic carrier animals, in order to obtain 
a reliable estimate of the prevalence and the distribution of the respective isolates. 
Therefore, positive samples from the epidemiological study (chapter 2) were selected 
to ensure a wide spectrum of farms and isolates. Furthermore, previously described 
primers and PCR protocols were selected for genotyping, based on their reliability 
and specificity as genotyping tools (Caccio et al., 2005), and on the availability of a 
sufficient number of reference sequences in the NCBI Genbank. By doing so, the 
results of the present molecular study could be compared with previous studies in 
Northern America, Australia and New Zealand, and viewed in a broader perspective. 
For Giardia, 2 new primer pairs were developed for the species-specific amplification 
of assemblage A and assemblage E isolates. A similar approach has been described 
for the identification of assemblage A and B in human samples (Bertrand et al., 
2005). 
 
The molecular identification of Cryptosporidium confirmed that calves are a potential 
zoonotic reservoir for human cryptosporidiosis. Despite the frequent identification of 
zoonotic species and subgenotypes, calves are considered to be less important than 
human sources in the epidemiology of human cryptosporidiosis (Caccio et al., 2005; 
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Smith et al., 2006). However, several important epidemiological factors have possibly 
been neglected. Although approximately 90% of the human cases of cryptosporidiosis 
are not outbreak related (Feltus et al., 2006), most molecular information from human 
isolates originates from outbreaks, in which human sources of infection are known to 
be most important (Peng et al., 1997). The continuous selection of outbreak related 
isolates might bias the results of molecular characterisation studies towards C. 
hominis or human specific C. parvum subgenotypes. Furthermore, in most human 
outbreaks of cryptosporidiosis, infections are due to a limited number of infection 
sources, again biasing the results towards an epidemic population structure (Mallon et 
al., 2003). Therefore, the relevance of zoonotic subgenotypes of C. parvum in the 
aetiology of sporadic cases of human cryptosporidiosis is possibly underestimated. In 
sporadic cases of human cryptosporidiosis, which are often not identified as such 
(hence the limited number of reports in the medical literature), it is less clear which 
subgenotypes are prevalent, and to what extent calves contribute to these sporadic 
infections. Despite the overall bias towards outbreak related samples, C. parvum and 
not C. hominis has been shown to be the major cause of human cryptosporidiosis in 
Europe (Caccio et al., 2005). Although it is not clear if zoonotic subgenotypes of C. 
parvum contribute to sporadic cases of human cryptosporidiosis in Belgium, the 
results of the present study indicate that young calves mainly harbour isolates with a 
zoonotic potential and are a possible reservoir for human infection. 
 
The high Giardia prevalence in calves, the wide distribution among farms of 
infections with the zoonotic assemblage A, and the occurrence of mixed assemblage 
A/E infections in calves were not expected, taking previous reports in the United 
States (Trout et al., 2004, 2005, 2006), Canada (Appelbee et al., 2003), New Zealand 
(Hunt et al., 2000) and in Australia (O’Handley et al., 2000; Becher et al., 2004) into 
account. The results seem therefore to suggest that geographical differences in the 
prevalence of Assemblage A in calves might occur. Geographical differences were 
also observed in pre-weaned calves in the United States (Trout et al., 2004), although 
not confirmed in post-weaned (Trout et al., 2005) and adult cattle (Trout et al., 2006). 
The current results seem therefore to renew the zoonotic relevance of calves in the 
epidemiology of giardiosis, which is in contradiction with previous opinions based on 
data from Northern America and Australia (Olson et al., 2004; Caccio et al., 2005).  
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The identification of zoonotic lineages in the majority (for Cryptosporidium) or in a 
substantial part (for Giardia) of their parasite population indicates that dairy and beef 
calves are a potential reservoir for human infections. The relevance of calves in the 
epidemiology of human infections is however mainly determined by the frequency of 
transmission to humans. The opportunity for interaction between the livestock and the 
human transmission cycles is probably less in scarcely populated compared to densely 
populated agricultural areas with intensified cattle industry, such as East Flanders. 
Such a densely populated rural region can be considered as a large endemic focus, in 
which transmission between different reservoirs is likely to occur. Zoonotic 
transmission of Cryptosporidium between different reservoir populations in endemic 
foci, such as farms, has been described (Miron et al., 1991; Lengerich et al., 1993; 
Evans and Gardner, 1996; Sayers et al., 1996). Similarly for Giardia, transmission of 
zoonotic assemblages is likely to occur more frequently between dogs and their 
owners in urban areas than in rural areas (Traub et al., 2004). In cattle a high 
prevalence of the zoonotic assemblage A has been reported in Uganda, due to contact 
with park rangers (Graczyk et al., 2002), and in a bovine teaching herd (Uehlinger et 
al., 2006a).  
Most of these reports consider rather small endemic foci (e.g. farms or dog loving 
households). However, the same assumptions of facilitated transmission might be 
valid on a larger scale, on condition that appropriate vehicles for transmission are at 
hand. In the UK, the spring peak in human cryptosporidiosis coincides with the 
lambing and calving season and is almost exclusively due to C. parvum (McLaughlin 
et al., 2000); in Scotland the foot and mouth disease outbreak in 2001 resulted in a 
decrease in the number of human cryptosporidiosis cases (Strachan et al., 2003); and 
in New Zealand the proportion of human C. parvum infections in rural areas was 
found to be higher than in urban areas (Learmonth et al., 2004). For Giardia a 
significant association was observed between human giardiosis and both livestock 
density and manure use on agricultural land (Odoi et al., 2004). 
 
The facilitated transmission in a large endemic focus occurs when an appropriate 
vehicle for infection is present, such as water. The (oo)cysts of both parasites are 
extremely resistant in water, and are not retained by the commonly used disinfection 
and filtration procedures (Caccio et al., 2005). Furthermore, pasture run-off from 
livestock is known to be an important source of contamination of drinking water 
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resources (Sischo et al., 2000), especially in the calving season (Bodley-Tickell et al., 
2002). Studies attempting to correlate (oo)cyst prevalence in drinking water to the 
prevalence of disease in man do however not reveal a clear relationship, although the 
lack of correlation could be masked by several other factors, such as differences in 
host immunity (Savioli et al., 2006).  
 
Next to water, food is an important vector for infection with Cryptosporidium or 
Giardia, given the all-year round demand of soft fruit and salad vegetables from 
around the world, including agricultural production areas with more limited resources 
for manure management or water treatment. The rapid and cooled transport increases 
the likelihood of (oo)cyst survival on the food surface, and the subsequent foodborne 
transmission. In contrast, a negative association between consumption of raw 
vegetables and infection has been reported and is ascribed to repeated exposure to low 
infection doses and the subsequent acquisition of immunity (Hunter et al., 2004). In 
community settings with infrequent exposure to infection and hence limited 
immunity, foodborne transmission through consumption of raw vegetables might 
however be succesfull, given the limited number of (oo)cysts required for infection.  
Fresh-water and marine shellfish are also well known vehicles for transmission, since 
shellfish concentrate (oo)cysts from contaminated water. Hence, they are good 
indicators of the infection load in water, but also an important foodborne source for 
infection (Smith et al., 2006). Livestock might contribute to this foodborne and 
waterborne transmission through spreading of manure onto the fields, and the 
subsequent direct contamination of crops, or the indirect contamination of surface 
water through water run-off from manure-laden fields (Olson et al., 2004). 
Although the potential of calves as zoonotic reservoir for human infection is clear, the 
frequency and the routes of zoonotic transmission still require further 
epdidemiological research, preferably in longitudinal studies in well defined endemic 
foci, using state of the art genotyping and subgenotyping tools (Caccio et al., 2005; 
Smith et al., 2006).  
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5.4 Treatment and prevention of giardiosis in calves 
Therapeutic treatment 
In Europe, there are no chemotherapeutic compounds registered for the treatment of a 
Giardia infection in calves. From a public health point of view, treatment prevents 
environmental contamination and possible zoonotic transmission, and from a 
veterinary perspective treatment can prevent diarrhea and retarded growth. Although 
the pathogenicity of Giardia was reported almost 20 years ago (St. Jean, 1987) and 
the results of chapter 4 confirm the clinical relevance, Giardia is often ignored as a 
pathogen and as a differential diagnosis for coccidiosis in calves older than 1 month. 
The study of the treatment with fenbendazole against a natural Giardia infection in 
calves (chapter 4.2), emphasized the need for a combination of animal treatment and 
environmental measures, but also illustrates the increasing awareness of the 
pathogenic importance of Giardia, since the farms included in the study were visited 
on demand of the practicing veterinarians. 
 
The experimental study in chapter 4 indicated that treatment with an intermediate or a 
high dosage of paromomycin is effective against an experimental infection with 
Giardia in calves. The efficacy of paromomycin is comparable to fenbendazole and 
albendazole under similar experimental conditions (Xiao et al., 1996; O’Handley et 
al., 1997, 2000). However, a positive control group treated with BZD was not 
included in the present dose determination study, and efficacy studies should be 
compared with caution, since there are no official guidelines for the evaluation of 
anti-protozoal drugs in cattle, contrary to the evaluation of anthelmintic treatment 
(Vercruysse et al., 2001).  
Cyst excretion re-occurred within 13 days in the experimental study (chapter 4.1), and 
within 4 weeks in the study under natural conditions (chapter 4.2). Although some 
Giardia trophozoites may survive treatment (Xiao et al., 1996; O’Handley et al., 
1997), the excretion after treatment is mainly due to re-infection with cysts from the 
environment. Since both paromomycin and fenbendazole lack persistent efficacy, 
calves are re-infected shortly after drug withdrawal. A curative treatment should 
therefore include hygienic measures to minimize exposure after treatment to infective 
oocysts from the environment. Since the environmental infection pressure is generally 
high on farms with a clinical outbreak of giardiosis, re-infection post treatment often 
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results in the re-occurrence of clinical symptoms. In the study with naturally infected 
calves, the hygienic measures resulted in a decrease of the environmental infection 
pressure, to the extent that clinical symptoms were no longer observed after treatment.  
 
In human medicine several chemotherapeutic compounds are commonly used, such as 
tinidazole, metronidazole, mebendazole and quinacrine. Furthermore, nitazoxanide is 
proving to be usefull and promising in the treatment of both cryptosporidiosis and 
giardiosis (Fox and Saravolatz, 2005; Fung and Doan, 2005). However, treatment 
failures have been reported with all commonly used antigiardial drugs (Whright et al., 
2003), and none of these compounds have been or are being registered for use in 
calves. Recently, the antigiardial activity of several plant extracts and spices, such as 
peppermint and curcumin, was reported both in vitro and in vivo in mice (Barbosa et 
al., 2006, 2007; Perez-Arriaga et al., 2006; Vidal et al., 2007). Although they may be 
promising alternatives for chemoterapeutic treatment, the efficacy of these 
compounds in calves was however never studied.  
 
Prevention 
For the prevention of clinical outbreaks on Giardia positive farms, prophylaxis based 
on treatment is probably not effective. Contrary to the prevention of cryptosporidiosis, 
the strategic treatment time is unpredictable, due to the prolonged susceptibility of 
calves to infection with Giardia (O’Handley et al., 2003). Prevention therefore relies 
on hygienic and management measures. Since the epidemiology of Cryptosporidium, 
Giardia and Eimeria spp. is similar, the prevention of giardiosis should fit in a farm 
based approach to reduce the occurrence of protozoal diarrhea in calves. Despite the 
lack of well-defined risk factors triggering a clinical outbreak of giardiosis, the 
general principles of the environmental and management measures are reviewed in 
table 1.3. 
 
Vaccination could provide an alternative for chemotherapeutic treatment. The efficacy 
of vaccination is defined by multiple factors, such as the antigen presentation, the 
ability of the host to mount a protective immune response, the environmental 
infection pressure, and the route and time of vaccine administration (Olson et al., 
2000). For Cryptosporidium, the efficacy of an active vaccination is limited due to the 
blocking effect of maternal antibodies, and to the difficulty of mediating a significant 
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protection against clinical cryptosporidiosis within a month after parturition. 
Therefore, passive immunisation through transfer of colostral antibodies was found to 
be more effective. Due to the rapid development of a specific cellular immune 
response against Cryptosporidium in calves, the colostral immunity is sufficient to 
protect the susceptible calf during the first weeks of life (de Graaf et al., 1999).  
In contrast, immunity against Giardia is mainly humoral (Faubert, 2000) and 
develops slowly in ruminants (O’Handley et al., 2003). Although colostrum contains 
specific antibodies against Giardia, they are depleted within 2 weeks after parturition, 
whereas clinical symptoms mainly occur in calves older than 1 month. Active 
immunisation seems therefore more appropriate for the prevention of giardiosis. In the 
United States a Giardia vaccine is commercially available for use in cats and dogs, 
but the efficacy of a preventive (Olson et al., 1996) or curative (Olson et al., 2001; 
Payne et al., 2002; Stein et al., 2003; Anderson et al., 2004) vaccination was found to 
be variable. In calves, a preventive vaccination against an experimental infection with 
Giardia did not result in a significant protective immune response (Uehlinger et al., 
2006b). This might be due to the antigenic variation in Giardia, the high infection 
dose used in the experiment (10
5
 cysts) or the slow immune response in ruminants. 
Although studies in mice and naturally infected human patients indicate that humoral 
immunity, mainly IgG and IgA antibodies, contribute to the elimination of Giardia 
trophozoites from the intestine, both calves and lambs did not mount a significant 
humoral immune response against infection with Giardia (Yanke et al., 1998; 
O’Handley et al., 2003). Further research into the immune response against Giardia 
in ruminants is therefore required to elucidate the possibility of mediating a protective 
immune response by vaccination. 
 
5.5 Future perspectives 
In chapters 2 and 3 we have clearly demonstrated that Cryptosporidium is highly 
prevalent in dairy and to a lesser extent in beef calves. Most of the isolates found in 
these calves were identified as zoonotic subgenotypes of C. parvum. Similarly, a high 
Giardia prevalence was found both in the dairy and beef calves. Although the 
majority of the isolates was livestock specific, the zoonotic assemblage A constitutes 
a considerable proportion of the parasite population in calves, either as a single or as a 
mixed infection. To further elucidate the transmission between cattle and man, a 
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longitudinal study in one or more endemic foci is required, based on molecular 
identification of bovine and human isolates. Since water is a major vehicle for 
infection, raw and treated surface water, and drinking water should be monitored. The 
environmental risk factors contributing to the transmission dynamics in an endemic 
focus can be studied using the Geographic Information System (GIS) technology, 
which enables to incorporate both geographically referenced information and 
information on weather patterns into a risk factor analysis (Odoi et al., 2004). 
Furthermore, the relevance of other farm animals and companion animals in the 
epidemiology of human infections, and the prevalence and distribution of the 
respective isolates in sporadic cases of human cryptosporidiosis and giardiosis, needs 
to be determined. 
 
Since chemotherapeutic treatment is not suitable, prevention of clinical giardiosis 
should rely on management and environmental measures. Several studies have 
identified multiple, but often contradictory risk factors for infection (Garber et al., 
1994; Mohammed et al., 1999; Castro-Hermida et al., 2002), possibly due to the 
rather small number of farms in relation to the high number of risk factors included in 
those studies. Therefore, longitudinal studies on infected farms should be conducted 
to identify these factors contributing to outbreaks of clinical infection. Given the large 
number of possible risk factors and the interaction between risk factors, a large 
number of farms should be monitored.  
 
For the prevention of infection, vaccination constitutes a valid alternative. The 
efficacy of vaccination is, among other factors, defined by the ability of the host to 
mount a protective immune response. Due to the luminal localization of the parasite, 
the adaptive immune response against Giardia requires the effector molecules to 
reach the lumen in sufficient quantities to be effective, and is believed to be locally 
generated by the mucosa-associated lymphoid tissue. The immune response against 
Giardia is mostly studied in in vitro studies, in murine animal models and in a small 
number of ruminant models. In these ruminant models Giardia specific serum IgG 
and IgM antibody titres in infected animals did not significantly differ from control 
animals (Yanke et al., 1998; O'Handley et al., 2003), although serum IgM antibodies 
did rise in the early stage of infection. Similar to murine models an elevated serum 
IgA response was observed in infected lambs (Yanke et al., 1998). The authors 
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concluded that ruminants did not mount a rapid humoral immune response against 
Giardia infection, ignoring that serum and local IgA responses are not always well 
correlated. A ruminant-based infection model could therefore help in further 
elucidating the adaptive immune response against Giardia, and to finetune the 
vaccination strategy. 
 
5.6 General conclusions  
The results of the present study indicate that both Cryptosporidium and Giardia occur 
frequently in calves, and that calves should be considered as a reservoir for human 
cryptosporidiosis and giardiosis. For the control of giardiosis in calves several 
compounds are effective, although in natural conditions control solely based on 
animal treatment is not sufficient, but should be combined with environmental 
hygienic measures. 
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Summary 
 
Cryptosporidiosis mainly occurs in calves younger than 1 month, and causes a mild to 
profuse diarrhea, leading to weight loss and dehydration. Sometimes infection results 
in mortality, especially in combination with other intestinal pathogens. In contrast, an 
infection with Giardia is most frequently diagnosed in calves older than 1 month and 
clinical symptoms comprise a chronical and intermittent diarrhea, and ill thriving. 
Both Cryptosporidum and Giardia are also frequently diagnosed pathogens in human 
cases of diarrhea, weight loss and impaired development. Cattle and in particular 
young calves are considered as a possible reservoir for zoonotic transmission, 
although the relevance of cattle in the epidemiology of human infections remains 
unclear. 
 
In chapter 1, the most recent findings on Cryptosporidium and Giardia are reviewed, 
with emphasis on prevalence, molecular epidemiology, diagnosis and treatment. In 
the review conclusions, some remaining questions are highlighted, leading to the 
specific objectives of the present thesis.  
Previously published studies indicate that both parasites occur frequently in cattle 
worldwide, although the reported prevalences vary considerably. The variability can 
partially be ascribed to differences in study design, such as the technique used for 
parasite diagnosis. Although prevalence estimation and the comprehension of the 
parasite epidemiology depend on a reliable diagnosis, both for Cryptosporidium and 
Giardia there is no gold standard reference test and most diagnostic techniques have 
never been evaluated for use in cattle. The first objective of this thesis was therefore 
to estimate the prevalence of Cryptosporidium and Giardia in dairy and beef calves in 
the province of East Flanders (Belgium), based on a reliable Bayesian estimate of the 
test characteristics (objective 1). 
The inclusion of molecular identification in epidemiological research has been 
advocated to assess the role of cattle in the epidemiology of human infections, since 
not all Cryptosporidium and Giardia species, genotypes or subgenotypes have 
zoonotic potential. In Northern America and in Australia, molecular epidemiological 
studies and subgenotype analysis suggest a limited contribution of cattle to human 
infections. Similar molecular epidemiological studies have not yet been conducted in 
Europe, but the higher population density and closer contact between agriculture and 
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human population might result in a more frequent transmission between cattle and 
humans. Moreover, in the molecular epidemiological studies the possible occurrence 
of mixed Giardia infections in cattle with both non-zoonotic and zoonotic 
assemblages has not been taken into account. Therefore, the second objective was to 
evaluate the zoonotic potential of bovine Cryptosporidium and Giardia isolates by 
molecular identification, with emphasis on subgenotype analysis for   
Cryptosporidium and on mixed assemblage A/E infections for Giardia (objective 2). 
For the treatment of Giardia in calves, several benzimidazole compounds have shown 
to be highly efficacious in experimental conditions. In natural conditions the efficacy 
was less, possibly due to re-infection of the calves from the environment. Additional 
environmental and management measures are needed for the control of infection in 
natural conditions. Next to BZ, paromomycin is a potential chemotherapeutic 
compound for treatment of giardiosis. Hence, the third objective of the present work 
was to evaluate the efficacy of different dosages of paromomycin against an 
experimental Giardia infection in calves, and to determine the efficacy of a 
combination of fenbendazole treatment and hygienic measures against a natural 
infection in calves (objective 3). 
 
In chapter 2, the prevalence of Cryptosporidium and Giardia in both dairy and beef 
calves, and the test properties of three diagnostic assays for Giardia and six diagnostic 
assays for Cryptosporidium were estimated using Bayesian analysis. The prevalence 
of Giardia in dairy calves was 22% (95% CI: 12-34%) and in beef calves 45% (95% 
CI: 30-64%). Furthermore, 48% of the dairy and 64% of the beef farms had at least 
one Giardia positive calf. The test evaluation indicated that ELISA and IFA were 
both sensitive and specific diagnostic techniques for use in epidemiological studies, 
whereas ME was less sensitive. The Cryptosporidium prevalence was estimated to be 
37% (95% CI: 7-70%) in dairy and 12% (95% CI: 1-30%) in beef calves. 
Furthermore, 32% of the dairy and 24% of the beef farms had at least one 
Cryptosporidium positive calf. A 4-test Bayesian approach included the test results of 
the four conventional assays (ME, IFA, Tetra and Techlab ELISA), and indicated that 
the specificity estimates of the IFA and both ELISAs were high compared to ME. The 
IFA and the Techlab were found to be most sensitive. In the six-test Bayesian model, 
the sensitivity estimates of the conventional techniques decreased, due to the inclusion 
of 2 PCR assays with a higher sensitivity compared to the conventional techniques. 
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The specificity estimates of these conventional assays were comparable in the four-
test and in the six-test approach. The results in chapter 2 illustrate the potential of a 
Bayesian analysis in estimating prevalence and test characteristics in the abscence of a 
gold standard, but they also indicate that estimates of test characteristics should be 
used within the limits of the original study design. The need for sensitive diagnostic 
assays in epidemiological studies for Cryptosporidium is emphasized, especially for 
the identification of subclinicaly infected animals as the PCR assays identify these 
animals with reduced oocyst excretion, which the conventional techniques fail to 
identify.  
 
In chapter 3, the molecular identification of 115 Cryptosporidium positive samples, 
based on the 18S rDNA and the HSP-70 gene, revealed that the majority of the 
isolates from dairy and beef calves was C. parvum, probably due to the age of the 
calves which was limited to a maximum of 10 weeks. The age limit also accounts for 
the low number of C. bovis infections, and for the absence of C. andersoni or the 
Cryptosporidium cervine genotype in the present study. In 1 beef calf C. suis was 
retrieved. In clinically affected calves, all under 6 weeks of age, solely C. parvum was 
identified, confirming that neonatal cryptosporidial diarrhea in calves is primarily 
caused by C. parvum. The subgenotype analysis on the gp60 gene identified all but 
one of the C. parvum positive calf isolates as the zoonotic IIa allele (mainly 
IIaA15G2R1), indicating the zoonotic reservoir function of calves. In 1 clinically 
affected calf, subgenotype IId was identified. In the 120 Giardia positive calf samples 
selected for genotyping, a high prevalence and wide distribution among farms of 
infections with the zoonotic assemblage A was found using the -giardin gene. 
Furthermore, mixed assemblage A/E infections were identified using a new species 
specific PCR, based on the triose phosphate isomerase gene. The identification of 
zoonotic lineages in the majority (for Cryptosporidium) or in a substantial part (for 
Giardia) of their parasite population indicate that dairy and beef calves are a potential 
zoonotic reservoir for human infections.  
 
In chapter 4, the treatment and control of clinical giardiosis was studied. In chapter 
4.1, a controlled and blinded study was conducted to evaluate the efficacy and safety 
of a treatment with paromomycin sulphate against an experimental Giardia infection 
in calves. Animals were infected with 10
5 
Giardia assemblage E cysts and were either 
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treated eleven days later with 25, 50 or 75 mg paromomycin /kg body weight /day 
during 5 consecutive days or not treated (control group). Efficacy was evaluated 
based on reduction in cyst excretion. Furthermore weight gain and diarrhea scores 
were monitored. In the group treated with 75 mg/kg there was a 100% reduction in 
cyst excretion until 9 days after the start of the treatment (D9) and a very high 
reduction (98%) until D13. There was a high reduction (93%) until D9 and D13 in 
the groups treated with 25 and 50 mg/kg respectively. The cumulative cyst excretion 
on D13 was significantly (P<0.05) lower in the groups treated with 75 and 50 mg/kg 
compared to the control group. Although there was a trend towards higher weight gain 
and less diarrhea in the treated groups, differences between groups were not 
significant. No adverse reactions to the paromomycin treatment were recorded.  
In chapter 4.2, the efficacy of a combination of animal treatment and environmental 
measures against a natural Giardia infection in calves between the age of 1 and 6 
months was evaluated. Ten commercial farms with a total of 94 calves suffering from 
chronic diarrhea, ill thriving and impaired growth, were included in 2 subsequent 
studies. The first study indicated that treatment of all animals with fenbendazole at 
15mg/kg/day during three consecutive days combined with environmental measures 
on the final day of treatment, which were either removal of bedding, thorough 
cleaning and ammonia 10% disinfection or relocation of the treated animals to a 
Giardia free environment, resulted in a total reduction in cyst excretion for at least 2 
weeks. In the second study the IFA was used quantitatively and confirmed that the 
combination of treatment and environmental measures resulted in a total reduction of 
cyst excretion during 2 weeks and in a significant (98.0%; P<0.05) reduction of the 
cyst excretion until at least 4 weeks after treatment. Furthermore there was a noticable 
improvement of the clinical symptoms in all animals towards D28 after treatment and 
4 months after treatment health in all calves was normal. 
 
Finally in chapter 5, the main difficulties encountered in the present thesis, and the 
advantages and disadvantages of the applied methodology are discussed. The general 
conclusions and future perspectives are presented.  
The results of the present thesis revealed that Cryptosporidium and Giardia are highly 
prevalent in both dairy and beef calves in East Flanders (Belgium). Furthermore, 
calves should be considered as a reservoir for human cryptosporidiosis and giardiosis. 
To further elucidate the importance of the calf reservoir to zoonotic transmission and 
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the transmission dynamics, longitudinal studies in well defined endemic foci should 
be conducted using specific genotyping tools. For the treatment of giardiosis in calves 
several compounds are effective, although in natural conditions control solely based 
on animal treatment is not sufficient, but should be combined with environmental 
hygienic measures. Vaccination could provide an alternative to chemotherapeutic 
treatment but preliminary results show that vaccination did not result in a protective 
immune response in calves. Therefore, the immune respons against a Giardia 
infection in calves is in need of further research. 
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Samenvatting 
 
Cryptosporidiosis is een protozoaire infectie die vooral voorkomt bij kalveren jonger 
dan 1 maand, en een milde tot uitgesproken diarree veroorzaakt met eventueel 
gewichtsverlies en deshydratatie tot gevolg. In combinatie met andere, vooral virale 
infecties wordt mortaliteit beschreven. De klinische symptomen veroorzaakt door een 
infectie met Giardia worden meestal waargenomen bij dieren die ouder zijn dan 1 
maand. Giardiosis wordt gekenmerkt door een chronische en intermitterende diarree, 
en door slechte groei. Zowel Cryptosporidium als Giardia komen ook vaak voor bij 
de mens, met als belangrijkste symptoom diarree. Chronische infecties bij kinderen 
kunnen leiden tot verminderde lichamelijke en intellectuele ontwikkeling. Ofschoon 
vooral jonge kalveren worden beschouwd als een belangrijk zoönotisch reservoir, is 
de rol van kalveren in de epidemiologie van humane infecties nog helemaal niet 
duidelijk. 
 
In de literatuurstudie (hoofdstuk 1), worden de meest recente ontwikkelingen in het 
wetenschappelijk onderzoek naar Cryptosporidium en Giardia besproken, met nadruk 
op de prevalentie, de moleculaire epidemiologie, de diagnose en de behandeling. In de 
conclusies van hoofdstuk 1 worden enkele lacunes aangehaald, die leiden tot het 
formuleren van de objectieven van deze thesis. 
Door eerdere prevalentiestudies werd duidelijk dat zowel Cryptosporidium als 
Giardia veel voorkomen bij kalveren, hoewel de prevalentiecijfers sterk verschillen 
naargelang de studie. Die grote variatie in prevalentie is onder meer te wijten aan 
verschillen in de studieopzet, zoals de diagnosetechniek die wordt gebruikt. Hoewel 
de schatting van de prevalentie en een goed inzicht in de epidemiologie afhangen van 
een betrouwbare diagnose, zijn er geen referentie-of gouden standaard testen gekend 
voor Cryptosporidium en Giardia. Bovendien zijn de meeste testen nooit gevalideerd 
voor de diagnose van boviene infecties. De eerste doelstelling was dan ook een 
betrouwbare schatting te bekomen van de sensitiviteit en specificiteit van de gebruikte 
diagnosetechnieken, en van de prevalentie van Cryptosporidium en Giardia bij 
kalveren in Oost-Vlaanderen, door middel van Bayesiaanse analyse (doelstelling 1).  
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Recent werd het gebruik van moleculaire technieken in epidemiologische studies 
bepleit om de rol van runderen en andere dieren in de epidemiologie van humane 
infecties te bestuderen, daar niet alle species van Cryptosporidium of Giardia een 
zoönotisch belang hebben. In Noord-Amerika en in Australië wijzen moleculaire 
epidemiologische studies erop dat runderen een beperkte rol spelen in de humane 
epidemiologie. In Europa zijn geen gelijkaardige studies gekend, maar de hogere 
bevolkingsdichtheid en de intensieve veeteelt zou kunnen leiden tot een meer 
frequente overdracht tussen mens en dier. Voorts werd voor Giardia het voorkomen 
van gemengde infecties met zoönotische en diersoortspecifieke species bij het rund 
nog niet onderzocht. De tweede doelstelling betracht dan ook het zoönotisch 
potentieel van Cryptosporidium en Giardia in een selectie van kalverstalen na te gaan, 
waarbij aandacht wordt besteed aan identificatie tot op het niveau van subgenotypes 
voor Cryptosporidium en aan het voorkomen van gemengde infecties bij Giardia 
(doelstelling 2).  
 
Verschillende benzimidazole preparaten hebben een goede efficaciteit voor de 
behandeling van Giardia infecties bij kalveren, vooral onder experimentele 
omstandigheden. In natuurlijke condities was de efficaciteit minder, hetgeen te wijten 
is aan de herinfectie van de dieren kort na de behandeling. Daarom zijn voor de 
controle van giardiosis in natuurlijke omstandigheden bijkomende managements-en 
omgevingsmaatregelen noodzakelijk. Daarnaast werd de werkzaamheid van een 
combinatie van behandeling met febendazole en omgevingsmaatregelen tegen een 
natuurlijke infectie met Giardia onderzocht. Naast benzimidazoles wordt 
paromomycine gezien als een efficiënt geneesmiddel voor de behandeling van 
giardiose bij kalveren. De derde doelstelling was het nagaan van de efficaciteit van 
verschillende doseringen van paromomycine tegen een experimentele besmetting met 
Giardia bij kalveren (doelstelling 3).  
 
In hoofdstuk 2 werd de prevalentie van Cryptosporidium en Giardia in melkvee-en 
vleesveekalveren onderzocht, en werden de sensitiviteit en de specificiteit van 3 
diagnostische testen voor Giardia en van 6 technieken voor Cryptosporidium geschat 
aan de hand van een Bayesiaanse analyse. De prevalentie van Giardia was 22% (95% 
CI: 12-34%) in melkveekalveren en 45% (95% CI: 30-64%) in vleesveekalveren. In 
48% van de melkveebedrijven en in 64% van de vleesveebedrijven werd minstens 1 
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Giardia positief kalf gevonden. De evaluatie van de testen toonde aan dat zowel 
ELISA als IFA gevoelige en specifieke diagnosetechnieken zijn voor gebruik in 
epidemiologische studies. De ME was minder gevoelig.  
De prevalentie van Cryptosporidium werd geschat op 37% (95% CI: 7-70%) in 
melkveekalveren en op 12% (95% CI: 1-30%) in vleesveekalveren. In 32% van de 
melkveebedrijven en in 24% van de vleesveebedrijven werd minstens 1 
Cryptosporidium positief kalf gevonden. Een 4-testen Bayesiaan model voor de 
evaluatie van de conventionele diagnosetechnieken (ME, IFA, Techlab en Tetra) 
toonde aan dat de specificiteit van de IFA en beide ELISA testen hoger was dan die 
van ME. De IFA en de Techlab waren de meest gevoelige technieken. In het 6-testen 
model was de schatting van de gevoeligheid van de conventionele technieken 
duidelijk lager dan in het 4-testen model. Dit was vooral te wijten aan de hogere 
gevoeligheid van de bijkomende PCR testen. De schatting van de specificiteit van de 
conventionele technieken was vergelijkbaar in het 4-testen en in het 6-testen model. 
De resultaten van hoofdstuk 2 illustreren het potentieel van een Bayesiaanse analyse 
voor het bekomen van een betrouwbare schatting van testkarakteristieken en 
prevalentie in afwezigheid van een gouden standaard, maar geven aan dat de 
schattingen van de sensitiviteit en de specificiteit moeten worden gebruikt binnen de 
grenzen van de proefopzet. Voor Cryptosporidium werden de voordelen van de meer 
gevoelige PCR technieken duidelijk aangetoond in deze epidemiologische studie, 
vooral voor de diagnose van dieren met een lage uitscheiding van oocysten, die door 
de conventionele technieken moeilijk of niet worden aangetoond. 
 
In hoofdstuk 3 gebeurde de moleculaire identificatie van 115 Cryptosporidium 
positieve melkvee-en vleesveestalen op basis van het 18S rDNA en het HSP-70 gen. 
De hoge prevalentie van C. parvum, de lage prevalentie van C. bovis en de 
afwezigheid van C. andersoni en het cerviene genotype van Cryptosporidium zijn 
vooral te wijten aan de leeftijd van de dieren in deze studie, die maximaal 10 weken 
bedroeg. In 1 vleesveekalf werd een infectie met C. suis gevonden. Bij kalveren met 
klinische symptomen, alle jonger dan 6 weken, werd enkel C. parvum aangetoond, 
hetgeen het belang illustreert van dit species in het ontstaan van klinische 
cryptosporidiose. De subgenotypering op basis van het gp60 gen toonde aan dat alle 
C. parvum positieve stalen het zoönotische allel IIa (voornamelijk subtype 
IIaA15G2R1) waren, behalve in 1 kalf met klinische symptomen met allel IId.  
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In de 120 Giardia positieve stalen geselecteerd voor genotypering, werd op basis van 
het -giardin gen een hoge prevalentie en wijde verspreiding op bedrijfsniveau 
gevonden van het zoönotische assemblage A. Daarnaast werden ook gemengde 
assemblage A en E infecties gevonden met de nieuwe species specifieke tpi PCR. De 
identificatie van zoönotische isolaten in het merendeel (Cryptosporidium) of in een 
aanzienlijk (Giardia) deel van hun parasietpopulatie, duidt aan dat melkvee-en 
vleesveekalveren een reservoir zijn voor humane infecties.  
 
In het vierde hoofdstuk (hoofdstuk 4), werd de behandeling en de controle van 
klinische giardiose onderzocht. In het eerste deel (hoofdstuk 4.1), werd de efficaciteit 
en de veiligheid van verschillende doseringen van paromomycine tegen een 
experimentele infectie met Giardia nagegaan. Elf dagen na besmetting met 10
5 
Giardia assemblage E cysten, werden de dieren gedurende 5 opeenvolgende dagen 
dagelijks behandeld met 25, 50 of 75 mg paromomycine per kg lichaamsgewicht. De 
controlegroep werd niet behandeld. De efficaciteit werd geëvalueerd op basis van de 
reductie in cyst-uitscheiding, gewichtstoename en optreden van diarree. In de groep 
die werd behandeld met 75mg/kg werd een reductie in cyst-uitscheiding van 100% 
waargenomen tot 9 dagen na de start van de behandeling (D9) en een zeer hoge 
reductie (98%) tot D13. In de groepen behandeld met 25mg en 50mg/kg, werd een 
hoge reductie waargenomen tot respectievelijk D9 en D13. De cumulatieve cyst 
excretie was significant (P<0.05) lager in de groepen behandeld met 50 en 75mg/kg in 
vergelijking met de controlegroep. Hoewel een hogere gewichtstoename en minder 
diarree werd waargenomen in alle behandelde groepen in vergelijking met de 
controlegroep, waren deze verschillen niet significant. Er werden geen bijwerkingen 
gezien tijdens en na behandeling met paromomycine.  
In het tweede deel van hoofdstuk 4 (hoofdstuk 4.2), werd een combinatie van 
fenbendazole behandeling en omgevingsmaatregelen tegen een natuurlijke Giardia 
infectie geëvalueerd bij kalveren tussen 1 en 6 maand oud. Er werden 10 bedrijven 
bezocht met in totaal 94 dieren met giardiose, chronische diarree en slechte groei. Op 
de eerste 5 bedrijven werden alle dieren dagelijks behandeld met 15mg fenbendazole 
per kg lichaamsgewicht gedurende 3 dagen en werden omgevingsmaatregelen 
getroffen. Deze bestonden erin de mest weg te halen, en de stal grondig te kuisen en te 
desinfecteren met een 10% ammonia oplossing, of de dieren te verplaatsen naar een 
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Giardia vrije stal. De omgevingsmaatregelen werden op de derde dag van de 
behandeling toegepast. Deze maatregelen leidden tot een totale reductie in cyst-
uitscheiding gedurende tenminste 2 weken. In een tweede studie op 5 bedrijven werd 
de diagnostische techniek kwantitatief gebruikt. De resultaten van deze studie 
bevestigden dat er een totale reductie in cyst-uitscheiding was gedurende twee weken 
na behandeling, en gaven aan dat de uitscheiding significant (98.0%; P<0.05) was 
gedaald tot minimum 4 weken na de behandeling. Daarenboven werd bij alle dieren 
een klinische verbetering vastgesteld binnen de 4 weken na behandeling, en was de 
gezondheidstoestand normaal bij alle dieren 4 maanden na behandeling. 
 
Tot slot worden in het vijfde hoofdstuk (hoofdstuk 5) de belangrijkste voor-en 
nadelen van de gebruikte methodologie, de algemene conclusies en de 
toekomstperspectieven besproken. 
De resultaten van deze thesis tonen aan dat zowel Cryptosporidium als Giardia 
frequent voorkomen bij melkvee-en vleesveekalveren in Oost-Vlaanderen. Voorts 
bleek dat kalveren wel degelijk dienen beschouwd te worden als een reservoir voor 
humane infecties. Om het belang van kalveren in de humane epidemiologie verder uit 
te diepen zijn longitudinale studies nodig in welomschreven endemische locaties. 
Daarbij dienen moleculaire technieken gebruikt te worden die identificatie tot op het 
subgenotypeniveau voor Cryptosporidium en het opsporen van gemengde infecties 
voor Giardia mogelijk maken. Voor de behandeling van giardiose in kalveren zijn 
verschillende produkten, zoals fenbendazole en paromomycine beschikbaar, maar 
voor de controle van een infectie in natuurlijke omstandigheden, is enkel behandeling 
van de dieren niet voldoende en moet die worden gecombineerd met 
omgevingsmaatregelen. Vaccinatie zou een alternatief kunnen zijn, maar preliminaire 
gegevens tonen aan dat vaccinatie geen protectieve immuunrespons genereert bij 
runderen. De immuunrespons tegen Giardia bij runderen dient daarom verder 
bestudeerd te worden. 
 
